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Reports of low circulating ketone bodies (B-hydroxybutyrate, B-OHB & acetoacetate) in 
suckling piglets and evidence of minimal hepatic ketone body production from fatty acids in vitro 
suggested that, unlike previously-studied neonates, enhanced ketogenesis does not characterize the 
metabolism of the newborn pig. This apparent idiosyncracy of piglet metabolism prompted a series 
of studies examining development and regulation of ketogenesis in piglets, and the physiological 
implications of low ketonemia in piglets. The extent of alternative pathways (non-ketogenic routes 
of carbon flux into Krebs cycle intermediates, e.g.) of fatty acid B-oxidation was also assessed. 
Low ketogenic capacity in piglets was confirmed by the small change in plasma [B-OHB] relative 
to [C8:0] (regression slope) following a dose of C8:0. This slope was 1-2 orders of magnitude 
lower vs. that of mature pigs and newborn or mature rabbits. Minimal fatty acid carboxyl-carbon 
accumulated in ketone bodies after incubations of piglet liver homogenates or hepatocytes with [1-
14C]-C7:0, -C8:0, or -C16:0 in vitro, consistent with the in vivo results. The observed low activity 
of the ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMG-CoA 
synthase) increased plasma [insulin] with suckling (patterns opposite that seen in ketotic neonatal 
rats, e.g.) may in part explain attenuated ketogenic capacity in piglets. Piglets accumulated fatty 
acid carboxyl-carbon in acetate to a high degree relative to ketone bodies in incubations of liver 
tissue with radiolabeled fatty acids, a phenomenon previously unreported for any animal. It is thus 
speculated that acetate plays a more important physiological role than the ketone bodies in newborn 
piglets, an idea supported by the small contribution of ketone bodies to the energy budget of piglets 
(<3% of metabolic rate from ketone bodies at normal physiological plasma [B-OHB]), and the 10-
fold higher plasma [acetate] relative to the [ketone bodies] in piglets. 
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I. THE PHYSIOLOGY OF KETOGENESIS: 
REGULATION & POSTPARTUM CHANGES 
The following introduction to ketogenesis, its regulation, and its physiological importance 
is largely based on information obtained from studies with rats and humans (see reviews by 
McGarry & Foster 1980; Robinson & Williamson 1980; Mayes et al. 1981; Balasse & Fery 1989). 
A consideration of the data contained in the chapters to follow will clarify that the models described 
below may not apply to all organisms. Indeed, it has become evident that in the newborn piglet, 
the classic models of ketogenic control and developmental aspects of ketone body 
production/utilization may not apply. Nevertheless, information obtained in the rat or human 
models have been invaluable in characterizing this pathway of fatty acid metabolism. 
The ketone bodies, B-hydroxybutyrate and acetoacetate, are 4-carbon moieties resulting from 
accelerated B-oxidation of fatty acids in the liver (Fig. 1.1). Acetoacetate may be decarboxylated 
spontaneously to acetone, but this is believed to occur to a substantial degree only in pathological 
states (i.e., poorly-controlled diabetes, lactation ketosis in cows, prolonged starvation). In theory, 
any substrate giving rise to acetyl-CoA in the mitochondrial matrix of hepatocytes (where the 
ketone body-synthesizing enzymes reside) could give rise to ketone bodies. However, there is little 
evidence that substrates such as the "ketogenic" amino acids-leucine, isoleucine, for instance-
provide significant ketogenic precusor carbon relative to fatty acids in vivo. 
Increased B-oxidation of fatty acids in the liver, and the concomitant rise in ketogenesis, are 
observed in conditions of poorly controlled diabetes, fasting, neonatal suckling/high fat feeding, and 
lactation ketosis in cows. The metabolic changes associated with these states are a rise in ketogenic 
substrate (non-esterified fatty acids: NEFA), a fall in the insulin:glucagon ratio, and a depression 
of glycolysis and lipogenesis in the liver. These alterations promote production of the ketone 
bodies (see "Regulation of Ketogenesis" below), and lead to an increase in circulating 
concentrations of these metabolites (see Fig. 1.2 for changes in the suckling period). The liver is 
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the predominant producer of the ketone bodies due to the presence of the enzymes of the ketogenic 
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) pathway (Fig. 1.3) coupled to a low activity of the 
ketone body utilizing enzyme 3-ketoacid-CoA-transferase (McGarry & Foster 1980). It is 
recognized that extrahepatic ketone body producers such as the small intestine exist (Scofield et al. 
1983; B&esi & Williamson 1990; Serra et al. 1993a; Thumelin et al. 1993); however, the 
physiological relevance of ketogenesis in these organs remains unknown. 
Roles of the Ketone Bodies 
Oxidation. The fact that ketone bodies can represent a major fuel source under certain 
conditions was made clear by the classic study of Owen et al. (1967), who showed that up to 60% 
of the brain's 02 consumption could be accounted for by ketone body oxidation in fasted obese 
humans. This tissue normally utilizes carbohydrate because the blood-brain barrier effectively 
negates entry of long-chain fatty acids (Partridge 1991). However, the monocarboxylic acid carrier 
provides a means by which ketone bodies may cross the blood-brain barrier for oxidation. It is 
now recognized that the capacity to oxidize ketone bodies exists in numerous tissues, including the 
heart, kidney, and muscle (Robinson & Williamson 1980). These tissues possess the enzymes 
supporting oxidation of ketone bodies. At physiological concentrations (i.e., 500-100 /*M), uptake 
and oxidation of ketone bodies into brain (Hawkins et al. 1971), heart (Sultan 1990), skeletal 
muscle (Ruderman & Goodman 1973), and the whole-body (Reichard et al. 1974) are linear 
functions of circulating concentrations of the ketone bodies. This implies that the ketosis of fasting 
or suckling yields a higher rate if ketone body oxidation, thereby lowering glucose oxidation and 
the demand for gluconeogenesis (with its associated increase in amino acid catabolism). Indeed, 
whole-body studies have shown that in newborn (Bougneres et al. 1986; Bougneres 1987) or fasted 
obese humans (Reichard et al. 1974), > 25-30% of caloric demands can be met by ketone body 
oxidation. Thus, it is clear that the ketone bodies can serve as important fuels during certain 
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metabolic states. 
Lipogenesis. There is some evidence that the ketone bodies can serve as lipogenic 
precursors for central nervous system (CNS) lipids during development in the rat (reviewed by 
Nehlig & de Vasconcelos 1993). For instance, the enzymes involved in the conversion of B-
hydroxybutyrate and acetoacetate to cytosolic or mitochondrial acetyl-CoA are up-regulated 
following birth (Klee & Sokoloff 1967; Buckley & Williamson 1973; Ganapathi et al. 1987; Nehlig 
& de Vasconcelos 1993), and the rate of ketone body uptake into the CNS is higher in suckling 
newborns than in adults (Nehlig & de Vasconcelos 1993). Administration of 14C-radiolabeled 
ketone bodies to neonatal rats resulted in a prompt (within <30 min) rise in "C-label in CNS lipids 
(Webber & Edmond 1979). It is possible that the brain's utilization of ketone bodies for myelin 
lipogenesis soon after birth in the rat provides a teleological explanation for the neonatal 
hyperketonemia observed during this time (see Williamson 1973, 1982 & "Neonatal 
Hyperketonemia" below), and may be a critical component of normal CNS development. Auestad 
et al. (1990) questioned this reasoning based on studies which did not detect adverse effects upon 
various parameters of brain development in artificially-reared hypoketonemic rat pups relative to 
their hyperketonemic counterparts fed a rat milk replacer. Nevertheless, the potential for CNS 
lipogenesis, at least in species whose postnatal brain development is substantial, cannot be ignored. 
Theoretical Roles in Buffering the Intramitochondrial Coenzyme-A (CoA) and 
NAD+/NADH Ratio. In theory, the pathway from acetyl-CoA to acetoacetate and B-
hydroxybutyrate (which involves CoA and NAD+: Fig. 1.3) could modulate the limited CoA pool 
and the redox state of the mitochondrial matrix. For example, increased B-oxidation elicits a 
decrease in non-esterified CoA as greater numbers of acyl-CoA molecules are formed via the acyl-
carnitine shuttling system (Fig. 1.4). The subsequent B-oxidation of fatty acyl-CoA reduces the 
intramitochondrial environment via production of NADH (Fig. 1.1). It is intuitive that metabolic 
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systems should be designed to maintain a matrix concentration of non-esterifed CoA which supports 
B-oxidation and continued operation of the Krebs cycle (i.e., at the level of a-ketoglutarate 
dehydrogenase). Pathways such as ketogenesis may provide a means by which CoA is recycled. 
It has also been suggested that formation of B-hydroxybutyrate liberates hepatic B-oxidation from 
limitations imposed by a reduction in the matrix environment (i.e., increased NADH 
formation)(Owen & Schramm 1981). Indeed, the ratio of B-hydroxybutyrate:acetoacetate increases 
concomitantly with increases in B-oxidation (Owen & Schramm 1981). Theoretically, this 
phenomenon is adaptational under certain conditions (i.e., fasting) in that the liver can accelerate 
B-oxidation beyond constraints imposed by the redox state (and energy charge) within the matrix. 
Thus, a high rate of B-oxidation can be achieved concomitant with increased ketogenesis in order 
to provide fuel for glucose- or ketone body-dependent tissues such as the CNS. 
Regulation of Ketogenesis 
Interest in the regulation of ketogenesis has been rekindled in recent years as research has 
uncovered potential control points beyond regulation of lipolysis, carnitine palmitoyltransferase I 
(CPT I)(McGarry & Foster 1980) and availability of oxaloacetate (Krebs 1966; Bach 1978). 
Classically, control of ketogenesis has been described to exist at 3 major loci (see Fig. 1.4): 
lipolysis/availability of fatty acids, CPT I inhibition by malonyl-CoA, and acetyl-CoA entry into 
the Krebs cycle versus ketogenesis. More current studies have raised the possibility that, under 
certain conditions, important ketogenic modulation can occur at the level of the ketogenic enzymes, 
especially mitochondrial HMG-CoA synthase (Lowe&Tubbs 1985; Quant etal. 1989,1990,1993; 
Quant & Makins 1994; Casals et al. 1993; Serra et al. 1993a,b)(Fig. 1.4). A brief overview of 
the literature concerning ketogenic control is outlined below. 
Lipolysis. It is clear that ketogenesis is only supported when adequate supplies of precursor 
carbon is available as NEFA. Minimal ketone bodies are produced by the liver in vitro or in vivo 
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when fatty acids are not provided. Major control of substrate supply occurs at the level of the 
adipocyte, which is highly sensitive to the presence of insulin and the "lipolytic" hormones 
glucagon, catecholamines, and others. During ketogenic states (i.e., fasting), circulating insulin 
drops, lipolytic hormones rise, and hormone-sensitive lipase (HSL) in the adipose is activated via 
dephosphorylation mechanisms (Belfrage 1985; Jensen et al. 1987; also see Sztalryd et al. 1994). 
Thus, net NEFA release occurs, and plasma NEFA concentration is raised. High NEFA alone can 
elicit increased ketogenesis, but the effect is markedly enhanced in the presence of glucagon 
(McGarry et al. 1975; Miles et al. 1983)(see below). 
Oxidation vs. Esterification of NEFA in Liver. In a series of studies carried out by J.D. 
McGarry, D.W. Foster, and colleagues (1971-1979; see McGarry & Foster 1980), it was shown 
that an intermediate of lipogenesis-malonyl-CoA-strongly inhibits the enzyme CPT I in liver (see 
Fig, 1.4). Because it was known that this enzyme effects the entry of long-chain fatty acids 
(LCFA) into mitochondria, these workers speculated that malonyl-CoA regulation of CPT I is the 
major site of ketogenic control in liver. Indeed, the rates of LCFA B-oxidation and ketogenesis 
appear to be proportional to CPT I activity in rat liver (McGarry and Foster 1979), supporting a 
role for CPT I. Malonyl-CoA concentration in liver preparations had no effect upon ketogenesis 
from C8:0, a fatty acid known to diffuse freely into hepatic mitochondria and thus bypass CPT I 
(McGarry et al. 1977)(see Fig. 1.4). No effect of malonyl-CoA was observed for palmitoyl-
camitine (product of CPT I activity upon CI6:0) oxidation (McGarry et al. 1978a). Thus, the 
McGarry and Foster model predicts that cytosolic malonyl-CoA inhibits LCFA oxidation and 
increases LCFA esterification in liver by slowing the rate of CPT I. A low insulin:glucagon ratio 
supports such a metabolism in that glucagon inhibits while insulin activates acetyl-CoA carboxylase 
(Witters et al. 1979; Geelen et al. 1980), the enzyme which produces malonyl-CoA from cytosolic 
acetyl-CoA. The metabolic changes surrounding the fed-to-starved transition concur with this 
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model in that malonyl-CoA levels drop concomitant with depressed lipogenesis, while B-oxidation 
and ketogenesis increase in the rat. 
Entry of Acetyl-CoA into the Krebs Cycle: Availability of Oxaloacetate (OAA). It is still 
a matter of debate whether the condensation of acetyl-CoA with OAA via the citrate synthase 
reaction represents a ketogenic control point. It has been hypothesized (Krebs 1966; Bach 1978; 
Siess et al. 1982) that, concurrent with increased B-oxidation, a paucity of OAA exists as this 
metabolite is channeled toward gluconeogenesis or is reduced to malate by the malate 
dehydrogenase reaction: 
OAA + NADH + H+ —» Malate + NAD+ (Malate dehydrogenase reaction) 
This scenario would, in turn, lead to enhanced flux of acetyl-CoA toward ketogenesis. Support for 
this hypothesis stems from the finding that in vivo administration of OAA precursor (aspartate) to 
rats receiving medium-chain triglycerides (MCT) resulted in a 30% lower liver ketone body 
concentration relative to animals receiving MCT alone (Bach 1978). A blockage of gluconeogenesis 
in vivo (Bach 1978) led to a 30-40% fall in liver ketone body content. However, in this study 
(Bach 1978) and others (reviewed by Krebs 1966) which examined ketogenesis after alteration of 
OAA or Krebs cycle intermediates, the degree of depression in ketogenesis or ketone body content 
in liver did not match the observed changes in intermediates (see also Lehninger 1946; McGarry 
& Foster 1971). For instance, blockage of gluconeogenesis in fasted rats resulted in a 9.4- to 3-
fold rise in liver malate and citrate (respectively), with only a 40% drop in ketone body content. 
Siess et al. (1982), using an estimate of mitochondrial concentration of OAA, reported an inverse 
correlation between OAA level and the rate of ketogenesis. However, closer examination of their 
data clearly show that the data may be re-expressed such that mitochondrial OAA concentration is 
probably dependent upon the rate of B-oxidation/ketogenesis, and not vice-versa. There was a 
marked rise in liver malate concentration when OAA precursors were provided in conjunction with 
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medium-chain fatty acids in vivo (Bach 1978), and malate concentration was increased 3-fold in the 
livers of fasted non-lactating cows relative to the fed state (Baird et al. 1979). These data strongly 
support the notion that under normal circumstances, a "deficiency" of OAA due to gluconeogenesis 
does not cause enhanced ketogenesis. Rather, a shift toward a more reduced intramitochondrial 
matrix with increased B-oxidation leads to increased conversion of OAA to malate (see also Owen 
& Schramm 1981). Acetyl-CoA and NADH inhibit the pyruvate dehydrogenase (PDH) reaction, 
and acetyl-CoA enhances flux of pyruvate to OAA via pyruvate carboxylase (PC) (see reactions 
below); thus, during the B-oxidation of fasting, OAA could be replenished by the PC reaction: 
Pyruvate + CoA + NAD+ —> Acetyl-CoA + C02 + NADH + H+ (PDH Reaction) 
Pyruvate + ATP + HC03" —» OAA + ADP + P; (PC Reaction) 
It is concluded that the control over ketogenic rate exerted by the availability of OAA is not well-
defined, but is perhaps not as important as other loci such as CPT I modulation (see above). 
It is not unreasonable to hypothesize that entry of B-oxidation-derived acetyl-CoA into the 
Krebs cycle is controlled to some degree by the energy status and/or redox state of the liver 
mitochondrial matrix. Each round of B-oxidation yields 1 NADH + H+ and 1 FADH2, equivalent 
to 5 ATP (Fig. 1.1). As noted by Mayes (1993), a number of Krebs cycle enzymes are inhibited 
by NADH/NAD+ or ATP/ADP ratios, including citrate synthase (inhibited by ATP) and isocitrate 
dehydrogenase (inhibited by NADH and ATP). Thus, it is possible that as B-oxidation increases 
concomitant with a change in the hormonal milieu (low insulimglucagon ratio) and substrate supply 
(increased NEFA), flux into the Krebs cycle becomes limited not by OAA, but rather as a simple 
consequence of the increase in fatty acid-derived ATP and NADH (relevant to this assertion, 
Schreiber et al. 1994 recently reviewed ketogenic control in the context of the "upper limit" of B-
oxidation/ketogenesis being set by the ATP/ADP ratio). 
The HMG-CoA Synthase Pathway as the Rate-Limiting Step in Ketogenesis. Recently, the 
idea has been proposed that the rate of flux through the HMG-CoA pathway of ketogenesis (see 
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Fig. 1.3) is the rate-limiting step in ketogenesis (Quant et al. 1993; Quant & Makins 1994). This 
hypothesis differs substantially from classic models of control at the levels of CPT I or acetyl-CoA 
entry into the Krebs cycle (see above). Although this concept requires more rigorous testing, there 
is strong evidence that at least one enzyme in the pathway is acutely regulated by matrix metabolite 
concentrations, and altered at the level of gene expression. Based on data from the rat, 
mitochondrial HMG-CoA synthase (usually presumed to be rate-limiting in the HMG-CoA pathway: 
Dashti & Ontko 1979), is inhibited competively by succinyl-CoA (Lowe & Tubbs 1985). This 
inhibition can be released in vivo by injections of glucagon (Quant et al. 1989,1990), probably via 
a decrease in the matrix succinyl-CoA content (Siess et al. 1980; Quant et al. 1989). In addition, 
high-fat feeding, glucagon administration, and diabetes all elicit a rise in the gene expression and 
protein content of this enzyme, while insulin opposes this effect (Casals et al. 1992; Serra et al. 
1993b). The gene for mitochondrial HMG-CoA synthase is up-regulated during suckling (Serra 
et al. 1993a; Thumelin et al. 1993), and is maintained at a high level if rat pups are weaned onto 
a high-fat diet (Thumelin et al. 1993). Suckling in the rat is characterized by a low 
insulin:glucagon ratio (Girard et al. 1977, 1992), which points to control by these hormones as an 
important component to ketogenic regulation via modulation.of HMG-CoA synthase. 
It should be noted that Huth and his colleagues have questioned the rate-limiting character 
of HMG-CoA synthase, suggesting that control exists at hepatic mitochondrial acetoacetyl-CoA 
thiolase (Fig. 1.3)(e.g., Huth et al. 1973; Huth & Menke 1982; Quandt & Huth 1984; Balzer & 
Huth 1986). This enzyme is also controlled by metabolites (inhibited by free CoA), and has at least 
2 isozymes. This group has criticized the fact that the vast majority of studies have measured the 
activity of this ketogenic enzyme in the "backward" direction (i.e., production of acetyl-CoA), 
which they assert does not represent the true "forward" rate of activity. Their determinations of 
the forward rate of the enzyme (Huth et al. 1973) indicated that its rate was slower than those of 
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the other ketogenic enzymes (see Fig. 1.3), thus suggesting that the thiolase is rate-limiting in 
ketogenesis. However, a perusal of the literature does not uncover widespread support of this 
notion. 
Neonatal Hyperketonemia 
Within the first 24h postpartum, the rate of ketogenesis from fatty acids in liver preparations 
has been found to increase markedly in a number of species, including the rat (Ferre" et al. 1983), 
rabbit (Herbin et al. 1987), and guinea pig (Shipp et al. 1982; Stanley et al. 1983). In vivo, the 
increase in ketogenic capacity results in a sharp rise in circulating ketone body concentrations 
(>200 juM-1500 /xM: see Fig. 1.2) during suckling (rat, guinea pig, human) or fasting (rabbit, 
guinea pig, human), a phenomenon referred to as "neonatal hyperketonemia" (Williamson 1982). 
As reviewed by Williamson (1973,1982,1992) and Girard et al. (1992), the rise in ketonemia and 
ketogenesis are thought to be supported by an increase in the availability of NEFA from (1) the 
suckling of high-fat milk (or from lipolysis in animals born with lipid stores: i.e., rabbits and 
humans), (2) a drop in the insulin:glucagon ratio, (3) a rise in the activity of CPT I, and (4) a 
lowering of CPT I sensitivity to malonyl-CoA inhibition. Other evidence has pointed to an increase 
in acyl-CoA synthetase activity after birth in guinea pigs (Shipp et al. 1982) and a rise in cellular 
CoA content in rats (Escriva et al. 1986) as contributing to increased ketogenesis in the postpartum 
period. Recent data have demonstrated that in the rat, the gene expression (Serra et al. 1993a; 
Thumelin et al. 1993), enzyme protein (Serra et al. 1993b), and activity (Shah & Bailey 1977; 
Caswell & Bailey 1983) of HMG-CoA synthase increases after birth (see above), events which 
would foster accelerated ketogenesis. As noted previously (see "Roles of the Ketone Bodies"), the 
ketone bodies can serve as important lipid and energy precursors in the neonate, thus sparing 
glucose during a time when a good deal of the glucose needs of the animal are met by 
gluconeogenesis (see Girard et al. 1992). 
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The newborn piglet is a notable exception to the neonatal hyperketonemia paradigm (Fig. 
1.2). Circulating ketone bodies in this species during suckling have generally been reported to be 
below 200 /M (i.e., Bengtsson et al. 1967; Pegorier et al. 1981; Innes et al. 1993). When 
challenged with ketogenic medium-chain fatty acids (Odle et al. 1989, 1991; Adams & Odle 1993), 
piglets do not develop the ketonemia observed in rat pups given these acids (Pegorier et al. 1983). 
Our group and others (see Duee et al. 1994) have been interested in uncovering the basis for the 
low ketogenic capacity which is characteristic of pigs. In addition, the physiological impact of low 
ketogenic capacity is of interest in these animals, because they have a well-characterized propensity 
for hypoglycemia if undernourished in the postpartum period (Bengtsson et al. 1967; Swiatek et al. 
1968; Gentz et al. 1970). Certainly, it is possible that low ketonemia could exacerbate 
hypoglycemia in piglets, by not providing an alternative fuel source during undernourishment and 
perhaps during suckling. From the standpoint of comparative physiology, the regulation and 
developmental aspects of ketone body production in non-ketotic swine provide an interesting 
contrast to the studies of rats and other mammals. Work in the neonatal piglet model may uncover 
novel or subtle metabolic control mechanisms which are masked or do not exist in the rat. 
The objectives of the research described herein focused on the developmental patterns of 
ketone body production and the physiological ramifications of low ketosis in piglets. In addition, 
studies were developed to address the fundamental question: if ketone bodies are not the primary 
products of enhanced B-oxidation in piglets, what other metabolites may be formed during the 
oxidative catabolism of fatty acids? Further work examined parameters normally thought to 
modulate ketogenesis (i.e., pancreatic hormones, ketogenic enzyme activity) to probe the etiology 
of attenuated ketogenic capacity in pigs. 
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Figure 1.1. Schematic overview of hepatic B-oxidation of long-chain fatty acids (in this example, C16:0). Figure 
illustrates the production of reducing equivalents (NADH & FADKy, ATP, and acetyl-CoA produced with each round 
of B-oxidation. The fate of the acetyl-CoA could be combination with oxaloacetate to form citrate (citrate synthase 
reaction) for further combustion to C02 in the Krebs cycle, or metabolism to form acetoacetate and B-hydroxybutyrate 
(for more details of substrates, products, and enzymes see Fig. 1.3). Another pathway, traditionally thought to be 
minor, is acetogenesis via the action of acetyl-CoA hydrolase. 
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Figure 1.2. Comparative circulating ketone body concentrations during the neonatal period in rats (Robles-Valdes et 
al. 1976), humans (Melichar et al. 1967), guinea pigs (Duee et al. 1983), rabbits (Callikan et al. 1979), and piglets 
(derived from Bengtsson et al. 1967 & Pegorier et al. 1981). With the exception of the rabbits, which had been fasted 
since birth, animals were suckling. Note the minimal ketonemia observed in newborn piglets relative to other species 
studied. 
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ENZYMOLOGY OF KETOGENESIS 
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Figure 1.3. The enzymology of ketogenesis from acetyl-CoA in the liver mitochondrial matrix of mammals. This 
pathway, the 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) pathway, is the predominant route of ketogenesis. 
Ketogenesis to acetoacetate results in a net release of 2 coenzyme-A (CoA) molecules, while further metabolism to B-
hydroxybutyrate (B-OHB) via B-OHB dehydrogenase (B-OHB DH) is favored when the matrix environment becomes 
reduced. The arrow points to the presumed rate-limiting step in the pathway, catalyzed by HMG-CoA synthase. 
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Figure 1.4. Schematic overview of potential regulatory loci of ketogenesis in the liver. As discussed in the text, the 
rate of ketogenesis has traditionally been considered to be driven by: (1) availability of substrate (non-esterified fatty 
acids, NEFA) through changes in lipolytic rate/net release of NEFA to the plasma (upper left box); (2) modulation of 
long-chain fatty acid entry into the matrix via carnitine palmitoyltransferase I (CPT I) by changes in the cytosolic level 
of the lipogenic intermediate malonyl-CoA (inhibits CPT I in the fed state); (3) the availability of oxaloacetate to 
combine with B-oxidation-derived acetyl-CoA for further metabolism in the tricarboxylic acid cycle (TCA). Recent 
information suggests that control may be exerted at some point in the HMG-CoA pathway (4) of ketogenesis (see Fig. 
1.3), probably via succinyl-CoA inhibition of HMG-CoA synthase and/or altered gene expression of this enzyme. Note 
that medium-chain fatty acid (6-12 carbons) oxidation and ketogenic potential is not governed by CPT I regulation, 
because they enter the matrix by diffusion. 
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*II. PLASMA B-HYDROXYBUTYRATE AFTER OCTANOATE 
CHALLENGE: ATTENUATED KETOGENIC CAPACITY IN NEONATAL 
SWINE 
ABSTRACT. Suckling neonatal pigs (NP, 24 hr-old) do not exhibit elevated blood ketone 
bodies (KB: B-hydroxybutyrate and acetoacetate). Mature swine have relatively high KB under 
certain conditions, suggesting an ontogeny of ketogenesis. Thus, the hypothesis that NP possess 
a relatively attenuated ketogenic capacity versus weaned pigs (WP) and mature pigs (MP) was 
evaluated. Fasted animals were given an intraperitoneal dose of octanoate (C8), and plasma B-
hydroxybutyrate and C8 were monitored over 180 min. Newborn (NR, 24 hr-old) and mature 
rabbits (MR, > 1 yr old) were also compared. Linear regressions of plasma B-hydroxybutyrate 
(jiM) vs. plasma C8 (pM) were calculated for C8 < 1000 /*M. There was a significant linear 
relationship of B-hydroxybutyrate regressed against C8 in all ages of pigs (p < 0.001) and in NR 
(p = 0.024). The slope for NP (0.08) was 1-2 orders of magnitude below slopes for older pigs 
(WP = 1.19 and MP = 0.78; p < 0.01 vs. NP), NR (6.97; p < 0.05), and MR (4.04; NS). The 
B-hydroxybutyrate peak in NP (40.9 ± 4.4 /tM) was 1-8% of the maxima in other animals (p < 
0.05), despite a C8 maximum (2.3 ± 0.3 mM) similar to WP (1.9 ± 0.7 mM) and MR (2.9 ± 
1.2 mM)(p > 0.05, NS). The data are consistent with the hypothesis that NP have a poor capacity 
for ketogenesis. 
Introduction 
Relative to adult conspecifics, a number of neonatal animals display elevated blood ketone 
body (KB: B-hydroxybutyrate and acetoacetate) levels throughout the suckling period. "Neonatal 
hyperketonemia" (blood KB > 200 /xM; Williamson 1982) is caused by the increased dependence 
upon lipid-based metabolism after birth (Williamson 1982; Girard 1990; Girard et al. 1992). As 
*®The American Physiological Society: Adams, SH&J Odle (1993). Am J Physiol 265 (Regulatory Integrative Comp 
Physiol 34): R761-R765. Reprinted with permission in modified form. 
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the newborn liver is exposed to a high fat/low carbohydrate environment concomitant with milk 
ingestion, ketogenesis is accelerated and blood B-hydroxybutyrate and acetoacetate concentrations 
rise (Williamson 1982; Girard 1990; Girard et al. 1992). Upon weaning, levels decline to those 
observed during the normal fed state in mature animals. This phenomenon has been reported in 
suckling guinea pigs (Duee et al. 1983), humans (Lucas et al. 1981), rabbits (Callikan et al. 1979), 
and rats (Foster & Bailey 1976). The high circulating KB concentration during the neonatal period 
is thought to be advantageous in that KB can serve as an important fuel source for tissues such as 
brain and muscle, and may thus serve to spare glucose and amino acids (Robinson & Williamson 
1980; Williamson 1981, 1982; Girard 1990; Girard et al. 1992). Ketone body carbon can be 
incorporated into brain lipids during development in rats (Williamson & Buckley 1973; Williamson 
1981), and the necessary KB-utilizing enzymes are up-regulated in rat brain after birth (Klee & 
Sokoloff 1967; Williamson & Buckley 1973; Williamson 1981), leading to the speculation that KB 
provide significant lipid precursor carbon during suckling (Williamson & Buckley 1973; Robinson 
& Williamson 1980; Williamson 1981, 1982). 
The relatively low blood KB levels observed during suckling in piglets (Swiatek et al. 1968; 
Gentz et al. 1970; Pegorier et al. 1981) suggests that swine do not adhere to the neonatal 
hyperketonemia paradigm. This may be partially explained by the small lipid reserves of piglets 
at birth (Widdowson 1950; Newcomb et al. 1991), and thus the paucity of mobilizable ketogenic 
substrate as non-esterified fatty acids. However, plasma KB remain low even as piglets ingest milk 
with a fat content of -50% (Girard et al. 1992), and when they are fed medium-chain 
triacylglycerides (Odle et al. 1989, 1991). Further, in vitro data (Pegorier et al. 1983; Coffey et 
al. 1991) support the idea that ketogenesis is attenuated in newborn swine. Blood KB values 
obtained from the literature on weaned and adult pigs indicate that under certain conditions more 
mature animals display plasma KB well above that observed in suckling neonatal pigs (Gentz et al. 
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1970; Allee et al. 1972; Rosebrough et al. 1981; Newcomb et al. 1991). The experiment reported 
herein was designed to examine the potential ontogeny of ketogenic capacity in swine in vivo 
through serial blood determinations of B-hydroxybutyrate and octanoate (C8) after a C8 challenge 
in newborn, weaned, and mature pigs. Administration of C8, a medium-chain fatty acid (6-12 
carbons), bypasses control by carnitine palmitoyl transferase I (CPT I) on the mitochondrial 
membrane of hepatocytes, thus serving as an obligate fuel which enters the matrix freely to elicit 
a significant increase in ketogenesis (see Hamosh et al. 1991). Neonatal and adult rabbits subjected 
to a similar protocol were compared with pigs, because rabbits are highly ketogenic when substrate 
is made available (Callikan et al. 1979; Duee et al. 1985). The ratio of blood or plasma B-
hydroxybutyrate to acetoacetate is J> 1, especially under the reducing conditions of heavy lipid 
oxidation (Gentz et al. 1970; Allee et al. 1972; Bach et al. 1974; Robinson & Williamson 1980; 
Pegorier et al. 1981). Therefore, ketogenic capacity was assessed through a comparison of the 
linear regression slopes of plasma B-hydroxybutyrate relative to increased C8, as well as changes 
in absolute B-hydroxybutyrate concentration following intraperitoneal delivery of C8. 
Materials and Methods 
Animals. This study was approved by the Laboratory Animal Care Advisory Committee 
of the University of Illinois at Urbana-Champaign. Newborn piglets (n - 8), weaned pigs (n = 
5), and mature pigs (n = 6) of the Yorkshire/Duroc crossbreed from the University of Illinois 
Moorman Swine Research Farm were used. Neonatal piglets were withdrawn from the sow 1-3 
hr postpartum, and fasted for 24 hr prior to the initiation of the study in order to diminish liver 
glycogen stores (Swiatek et al. 1968; Pegorier et al. 1981) and promote hepatic oxidation of fatty 
acids. Weaned (28 d old) and mature (5 mos old) pigs were fasted for 48 and 72 hr, respectively. 
Newborn (n = 28) and mature (n = 5) New Zealand White rabbits were also studied. Neonatal 
rabbits (withdrawn from the doe 1-3 hr postpartum) and adults (> 1 yr old) were fasted for 24 hr 
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prior to experimentation. Mean body mass (+ SEM) values were: 1540 ± 74 g (neonatal piglets), 
8750 ± 510 g (weaned pigs), 96.42 ± 1.98 kg (mature pigs), 49 ± 2 g (newborn rabbits), and 
4130 ± 130 g (mature rabbits). 
C8 Delivery and Sample Collection. Animals were injected intraperitoneally (i.p.) with a 
dose of 0.25 M (newborn rabbits) or 0.5 M (others) Na-C8 (Sigma, St. Louis, MO) targeted to 
induce a significant increase in circulating C8. This approach was designed to yield a rapid 
increase in plasma C8 concentration which should elicit accelerated ketogenesis and bypass potential 
age- or species-specific differences in digestion or absorption of lipid. Based on pilot studies, the 
following doses were chosen to elicit elevated plasma C8 levels while minimizing narcosis: 3 mmol 
C8/kg0-75 (newborn piglets), 6 mmol C8/kg0-75 (weaned and mature pigs), 2 mmol C8/kg0-75 
(neonatal rabbits), and 9 mmol C8/kg075 (adult rabbits). Blood was serially collected from pigs into 
heparinized vacuum tubes (Becton Dickinson, Rutherford, NJ) via jugular venipuncture prior to C8 
injection (tO), and at 30 min (t30), 60 min («50), 120 min (tl20), and 180 min {tl80) post-C8. 
Adult rabbits were sampled by ear vein venipuncture into heparinized syringes at t0-t!20. For 
newborn rabbits, individuals representing a given time point (i.e., t30; see Statistics below) were 
sampled by cardiac puncture into heparinized syringes following anesthesia at t0-tl80 (102 mg/kg 
ketamine HC1, Ketaset, Aveco, Fort Dodge, IA). Following blood sampling, anesthetized neonatal 
rabbits were killed under C02. Samples were placed on ice until centrifugation at 5000 x g. 
Plasma was frozen at -20°C until analysis for C8 and B-hydroxybutyrate 1-4 wk later. 
Analyses and Statistics. Plasma C8 was determined on t30-tl80 samples by HPLC as 
described by Odle et al. (1989) using heptanoate (C7) as internal standard. Neonatal rabbits ingest 
milk containing significant medium-chain fatty acids in triacylglycerols during their once/day 
suckling bouts (Girard et al. 1992), and it was noted postmortem that 22/28 of the fasted neonatal 
rabbits had stomach contents resembling milk; tnus, tO plasma C8 analysis was carried out for this 
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group. Plasma B-hydroxybutyrate analysis was performed on deproteinized, neutralized samples 
per the spectrophotometry assay of Kientsch-Engel and Siess (1985). The assay was modified as 
follows: (a) sample blanks were sample plus all reagents except B-hydroxybutyrate dehyrogenase 
(enzyme replaced with distilled H20), and (b) absorbance values were taken at 0, 40, 45, 50, 55 
min post-enzyme addition. Absorbance change data were evaluated using the method of Bergmeyer 
and Grassl (1983). 
Differences in mean plasma B-hydroxybutyrate (t0-tl80) and C8 (t30-tl80) between periods 
in pigs were assessed using the SAS general linear model procedure for a split-plot design (SAS 
Institute, Gary N.C.). Changes in these parameters (t0-tl80) were evaluated in neonatal rabbits via 
analysis of variance (AOV) for a randomized complete block (blocked by litter) followed by a 
protected Fisher's least significant difference (LSD) procedure (Ott 1988). Adult rabbit B-
hydroxybutyrate (t0-tl20) and C8 (t30-tl20) data were analyzed by AOV followed by paired t-tests 
(Ott 1988). Preliminary analyses indicated that the relationship between B-hydroxybutyrate and C8 
was linear for C8 < 1000 uM (data not shown). Thus, for each group (newborn pigs, weaned 
pigs, mature pigs, neonatal rabbits, and mature rabbits) plasma B-hydroxybutyrate was regressed 
on plasma C8 for C8 concentrations below 1000 uM using linear regression (SAS), and slopes were 
tested for difference from zero using the F test (Ott 1988). Among the groups, differences between 
mean slopes, B-hydroxybutyrate at tO, and plasma B-hydroxybutyrate and C8 maxima were 
compared using unequal variance t-tests (Ott 1988). Means + SEM are reported. Differences 
between means were considered significant at p< 0.05. 
Results 
Intraperitoneal injection of C8 elicited an increase in plasma C8 in all groups, achieving 
significance over 30-180 min in newborn pigs, weaned pigs, and mature rabbits (Table 2.1). 
Twenty-four hour fasted neonatal rabbits displayed measurable plasma C8 prior to injection (Table 
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2.1). 
Compared to tO, plasma B-hydroxybutyrate increased in all groups by t30, although the 
increase did not achieve significance in neonatal pigs (Fig. 2.1 A and B). The concentration 
maxima were highly variable, ranging from 40.9 ± 4.4 /uM (neonatal piglets) to 3181.0 ± 704.3 
pM (adult rabbits)(Table 2.1; Fig. 2.1 A and B). Prior to C8 injection (tO), there were significant 
differences in fasting B-hydroxybutyrate concentrations among groups, with neonatal pigs and 
rabbits having the lowest and highest baseline concentrations, respectively (Table 2.1 and Fig. 2.1A 
andB). 
Linear regressions of plasma B-hydroxybutyrate as a function of plasma C8 in pigs are 
shown in Fig. 2.2 for C8 concentrations < 1000 pM. While there was a significant positive 
relationship of B-hydroxybutyrate to C8 in neonatal rabbits (Fig. 2.2), a linear relationship of B-
hydroxybutyrate vs. C8 did not hold for adult rabbits (see Fig. 2.2 legend). The slopes of the 
regression lines were significantly greater than zero for pigs regardless of age (p< 0.001) and 
neonatal rabbits (p<0.05), but not for adult rabbits (p > 0.05). For a given increase in plasma 
C8, neonatal pigs displayed a significantly attenuated increase in plasma B-hydroxybutyrate (i.e., 
the regression slope) relative to weaned pigs (p <0.01), mature pigs (p <0.01), and neonatal rabbits 
(p<0.05)(Fig. 2.2). 
Discussion 
Plasma concentration of a metabolite is a function of its flux into and out of the circulation. 
The plasma level of B-hydroxybutyrate is impacted upon by its tissue uptake, oxidation, conversion 
to acetoacetate, production, and excretion. Therefore, from the data in this report inferences 
relating to flux of B-hydroxybutyrate must be limited. However, tissue uptake of KB has been 
shown to be correlated with blood concentration at physiological levels of KB (see Robinson & 
Williamson 1980; piglets: Tetrick et al. 1993). In addition, work with other models of medium-
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chain triacylglycerides administration in rats (Wiley & Leveille 1973; Frost & Wells 1981), dogs 
(Bach et al. 1974), humans (Pi-Sunyer et al. 1969), and weaned to mature pigs (Allee et al. 1972; 
Rosebrough et al. 1981; Newcomb et al. 1991) has demonstrated that increased exposure to 
medium-chain fatty acids elicits an increase in blood KB. It follows that the change in plasma B-
hydroxybutyrate after introduction of a large dose of ketogenic substrate (i.e., C8) is valuable in 
assessing relative ketogenic capacity in vivo when baseline plasma B-hydroxybutyrate values are 
known and differences in plasma C8 are accounted for (via examination of changes in B-
hydroxybutyrate relative to C8 through regression analysis, e.g.). In support of this view are the 
significant linear correlations between plasma C8 and B-hydroxybutyrate (Fig. 2.2) for C8 values 
below 1000 uM in all ages of pigs (p<0.001) and in newborn rabbits (p<0.05). 
The results are consistent with the hypothesis that newborn pigs possess a reduced capacity 
for ketogenesis relative to rabbits and more mature swine. First, although plasma C8 rose 
following i.p. injection of Na-C8 in neonatal piglets (Table 2.1), regression data (Fig. 2.2) indicate 
that this group displayed a low incremental increase in B-hydroxybutyrate (regression slope 0.08 
+ 0.01) which was 1-2 orders of magnitude below that of weaned pigs (slope 1.19 ± 0.27), mature 
pigs (slope 0.78 ± 0.10), neonatal rabbits (slope 6.97 ± 2.91), and adult rabbits (slope 4.04 + 
4.28). It is not likely that the true increase in plasma B-hydroxybutyrate in piglets was masked by 
an extraordinary improvement in the utilization rate of B-hydroxybutyrate and acetoacetate (which 
would act to lower plasma B-hydroxybutyrate for a given rate of production). As noted above, 
tissue utilization of KB is proportional to blood KB when blood KB concentration is relatively low 
in other species (see Robinson & Williamson 1980) and day-old piglets (Tetrick et al. 1993). 
Second, from the low slope of B-hydroxybutyrate vs. C8 in piglets (see above), it follows 
that the peak concentration of plasma B-hydroxybutyrate in piglets was just 1-8% of the levels 
observed in other groups (p<0.01; see Table 2.1 and Fig. 2.1 A and B), even when the maximum 
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plasma C8 concentration in newborn pigs was similar to that observed in weaned pigs and mature 
rabbits (p > 0.05, Table 2.1). The relatively low maximum plasma B-hydroxybutyrate in newborn 
pigs is consistent with earlier studies which reported maxima of just 20-50 pM in whole blood after 
an intragastric load of 12 ml medium-chain triacylglycerides was administered to neonatal pigs 
(Odle et al. 1989; 1991). However, the data in newborn swine are in contrast to the marked 
increase in blood KB seen in dogs (> 800 pM plasma KB, Bach et al. 1974), man (> 500 /iM 
serum KB, Pi-Sunyer et al. 1969), mature pigs (253 uM plasma B-hydroxybutyrate, Newcomb et 
al. 1991), and rats (to 230 /iM blood B-hydroxybutyrate, Wiley & Leveille 1973) when exposed 
to medium-chain triacylglycerides via gastric intubation, infusion, or diet. 
The plasma B-hydroxybutyrate in 24-hr fasted newborn pigs was near the lower detection 
limit of the assay at tO, while weaned pigs, mature pigs, mature rabbits, and neonatal rabbits 
displayed levels ranging from 50-589 /iM (Table 2.1 and Fig. 2.1 A and B). This result might be 
partially explained by the negligible lipid reserves (1-2% of body mass: Widdowson 1950; 
Newcomb et al. 1991) available for mobilization of non-esterified fatty acids during the fasting state 
in piglets (Bengtsson et al. 1967; Swiatek et al. 1968; Gentz et al. 1970; Pegorier et al. 1981). It 
is reasonable to assume that lipid stores of older pigs, neonatal rabbits, and mature rabbits could 
have contributed significant ketogenic substrate as non-esterified fatty acids to the liver during 
fasting, thus leading to the high (relative to newborn pigs) B-hydroxybutyrate levels at tO. 
Differences in circulating non-esterified fatty acids and/or B-hydroxybutyrate flux (not measured 
in this study) might also explain the poor correlation of C8 and B-hydroxybutyrate observed in 
mature rabbits (see Fig. 2.2 legend). 
The data extend previous work which has suggested that there is an ontogenic pattern of 
ketogenesis in swine. For instance, blood B-hydroxybutyrate concentration in suckling or fasting 
newborn piglets (Bengtsson et al. 1967; Swiatek et al. 1968; Allee et al. 1972; Pegorier et al. 1981; 
29 
Odle et al. 1991) falls well below levels observed in older pigs under various conditions (Gentz et 
al. 1970; Allee et al. 1972; Rosebrough et al. 1981; Newcomb et al. 1991). Furthermore, in vitro 
data indicate that flux (pmol/min) of fatty acid carbon to acid-soluble products (ASP, presumably 
including ketone bodies) in isolated hepatocytes increases with age in pigs (Coffey et al. 1991). 
The results from rabbits indicate that the ability to increase plasma KB occurs soon after birth, a 
finding which is consistent with previous data in this species (Callikan et al. 1979; Duee et al. 
1985). 
Piglets are susceptible to hypoglycemia when underfed during the first few days postpartum 
(Bengtsson et al. 1967; Swiatek et al. 1968; Gentz et al. 1970). To what degree the lack of 
alternative substrate as KB contributes to this phenomenon is unknown. Ironically, piglets may 
supply up to -30% of their whole-body energy requirements from KB when exogenous 8-
hydroxybutyrate is made available (Tetrick et al. 1993). The idiosyncratic blood profile in piglets 
cannot be overcome by increased blood concentration of C8 (this study) or other medium-chain 
fatty acids (Odle et al. 1989, 1991). By virtue of their ease of entry into mitochondria, the 
medium-chain fatty acids bypass one control locus of ketogenesis: carnitine palmitoyltransferase 
I (CPT I), the enzyme responsible for shuttling impermeable long-chain fatty acids (LCFA) into 
mitochondria as LCFAcyl-carnitine (see Hamosh et al. 1991). Thus, it is reasonable to speculate 
that ketogenesis is down-regulated intramitochondrially in 24 hr-old pigs (also see Girard et al. 
1992). If true, does this attenuation decrease with age? The idea that medium-chain fatty acid 
activation to medium-chain fatty acyl-CoA (which occurs in the hepatocyte mitochondrial matrix 
and is necessary for B-oxidation to proceed) is up-regulated with age (Stanley et al. 1983) should 
be explored. The notion that at least one of the enzymes in the ketogenic pathway of piglets is 
compromised via inhibitory mechanisms (i.e., succinyl-CoA inhibition of HMG-CoA synthase: 
Lowe & Tubbs 1985) or low enzyme protein synthesis remains to be fully evaluated. 
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Table 2 .1 . Plasma concentrations (jM) of octanoate (C8) and B-hydroxybutyrate (B-OHB) and C8 concentration 
maxima in fasted pigs and rabbits dosed with Na-C8 intraperitoneally. 
NEONATAL 
PIGS 
WEANED 
PIGS 
MATURE 
PIGS 
NEONATAL 
RABBITS 
MATURE 
RABBITS 
Time Post- Plasma C8 
injection: 
Omin 
30 min 
60 min 
120 min 
180 min 
Time 0 Plasma 
B-OHB 
•Max. Plasma 
B-OHB 
Max. Plasma 
C8 
0.01 
2298.2a 
(266.2) 
387.4b 
(123.8) 
35.8bc 
(5.5) 
29.67bc 
(3.1) 
3.3* 
(1.1) 
40.9* 
(4.4) 
2298.2* 
(266.2) 
0.0 
1945.3a 
(700.9) 
160.0b 
(20.0) 
56.8bc 
(10.6) 
46.3bc 
(6.5) 
126.9Bt 
(14.5) 
523.7"? 
(84.8) 
1945.3*" 
(700.9) 
0.0 
473.1a 
(90.1) 
202.7a 
(31.3) 
69.3a 
(7.8) 
56.41a 
(7.2) 
50 .2* 
(8.4) 
494.4BCt 
(67.9) 
473.1"* 
(90.1) 
60.8a 
(16.4) 
142.5a 
(30.5) 
97.5a 
(17.8) 
49.8a 
(2.2) 
47.6a 
(4.9) 
588.9"" 
(71.3) 
1790.0* 
(386.0) 
142.5Bt 
(30.5) 
0.0 
2925.8a 
(1178.1) 
1397.8b 
(823.9) 
201.9ab 
(49.7) 
— 
145.7BC* 
(38.1) 
3181.0°* 
(704.3) 
2925.8*"™ 
(1178.0) 
Values are means ± SEM 
^Baseline plasma C8 assumed to be 0.0 pM for pigs and mature rabbits (see Materials and Methods) 
•Maximum plasma B-OHB occurred at 30 min post-injection for all groups except mature rabbits (60 min): see Fig. 
2.1 
'Different lower case letters denote significant differences (p<0.05) within a column 
*Different upper case letters denote significant differences (p<0.05) within a row 
*p<0.05, t p < 0 . 0 1 , significant difference vs. neonatal piglet (unequal variance t test) 
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Figure 2.1A-B. Changes in plasma B-hydroxybutyrate after i.p. dose of Na-octanoate in neonatal pigs (diamonds), 
weaned pigs (circles), and mature pigs (crosses) that were fasted 24 hr, 48 hr, and 72 hr, respectively (top panel, A). 
Error bars represent SEM. Plasma B-hydroxybutyrate was not significantly altered in neonatal pigs (p>0.05), despite 
elevated plasma C8 (see Table 2.1). 
"Different versus tO value within age (p<0.05); 'Different versus f/20 & t!80 values within age (p<0.05) 
A significant age x time effect exists for B-hydroxybutyrate (p<0.0001). 
(Bottom panel, B): changes in plasma B-hydroxybutyrate concentration after i.p. dose of Na-C8 in neonatal rabbits 
(circles) and mature rabbits (triangles) that were fasted 24 hr. Error bars represent SEM. 
"Different versus tO value (p<0.05); 'Different versus t60, tl20, & riSO values (p<0.05) 
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PLASMA OCTANOATE (JL/M) 
800 
Figure 2.2. Plasma B-hydroxybutyrate concentration as a function of plasma octanoate (C8) level in neonatal pigs 
(squares), weaned pigs (diamonds), mature pigs (triangles), and neonatal rabbits (circles). Animals had been fasted 
24 hr, 48 hr, 72 hr, and 24 hr, respectively, prior to a C8 dose administered i.p. Regression equations are as follows: 
NP (y = 0.0795x + 7.199; r2 = 0.64; p<0.0001, n = 21) 
WP (y = 1.192x + 104.806; r2 = 0.57; p<0.0005, n = 17) 
MP (y = 0.778x + 125.802; r2 = 0.72; p<0.0001, n = 24) 
NR (y = 6.969x + 337.820; r2 = 0.18; p = 0.024, n = 28) 
*p<0.05, "p<0.01: different from newborn piglet slope 
Mature rabbits did not display a significant correlation between B-hydroxybutyrate and C8 (y = 4.040x + 863.232; 
r2 = 0.10; p = 0.37, n = 10); thus, for clarity the regression line is not presented graphically. 
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*III. CONTRIBUTION OF B-HYDROXYBUTYRATE TO THE 
ENERGY EXPENDITURE OF NEONATAL PIGS 
ABSTRACT. In vivo oxidation rate of arterially infused D-(-)-3-hydroxybutyrate (B-OHB) 
was measured in 1-2 day-old-piglets. Twelve piglets (1.4 kg) were randomly assigned to a 12 h 
continuous infusion of B-OHB at 19.5, 37.8, 55.8 or 74.5 pmol/min along with approximately 31 
kBq/h of [3-14C]-B-OHB. Piglets were housed in respiration chambers allowing collection of total 
expired C02 over 20-min intervals for the 12-h infusion and 6 h "washout". Oxidation of B-OHB 
was calculated from the quantity and specific radioactivity of expired C02 for 20-min collection 
periods at 6,9 and 12 h for each piglet and collectively plotted against plasma B-OHB concentration 
measured in blood drawn during those 20-min periods. A Michaelis-Menton plot of these data 
yielded aK*of 0.62 ± 0.07 mM and V ^ of 0.74 + 0.02 mmol ATP equivalents/(min• kg075) 
(parameter estimate ± SD), which could account for 32% of the piglet mean total ATP turnover 
of 2.3 mmol/(min«kg0-75). These data show that B-OHB oxidation is a linear function of plasma 
concentration in the physiologic range measured in piglets (0.006 mM to 0.1 mM) and within this 
range would account for 0.3% to 4.5% of piglet energy requirement. Oxidation of B-OHB can 
meet a maximum of 30 to 40% of piglet energy requirement at unphysiologically high B-OHB 
concentrations (>3 mM). 
Introduction 
Animals rely on a variety of substrates for energy. However, newborn piglets are born with 
only 0.5-1.1% body weight as lipid (Manners & McCrea 1963; Widdowson 1968; Elliot & Lodge 
1977), and therefore initially rely on liver and muscle glycogen stores to maintain blood glucose 
and provide energy (Widdowson 1950; McCance & Widdowson 1959). Piglets deplete the majority 
of their glycogen reserves in 12 h (Elliot & Lodge 1977). The piglet is at imminent risk of 
*® American Institute of Nutrition: Tetrick, MA, SH Adams, J Odle, and NJ Benevenga (in press). J Nutr. Reprinted 
with permission in modified form. 
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hypoglycemia, hypothermia, and death if colostrum intake is not established by the time glycogen 
reserves in muscle and liver are depleted (Newland et al. 1952; McCance & Widdowson 1959). 
The smallest pig in the litter is at greater risk because its stores of glycogen are less than half those 
of its largest littermate (Widdowson 1968). Protein is the only other available endogenous fuel. 
Use of body protein for fuel puts the piglet at a disadvantage due to destruction of body proteins 
and the production of ammonia. Ammonia must be detoxified in the energy-consuming process of 
urea synthesis. 
Oral dosing of medium-chain triglycerides is one approach to providing energy to newborn 
piglets in order to conserve glycogen and body protein. Odle et al. (1992) showed that oxidation 
of parenterally infused medium chain fatty acids (MCFA) could provide 70% of 1-2 day-old piglets' 
ATP turnover. MCFA oxidation increased linearly up to a plasma MCFA concentration of 0.5 
mM. Oral supplementation of piglets with 12 mL of the medium-chain triglyceride mixture Captex 
300 (Karlshamns Lipid Specialties, Columbus, OH) did not reduce colostrum intake but tended to 
reduce nitrogen excretion and significantly reduced liver glycogen depletion (Benevenga et al. 1989; 
Odle et al. 1989). 
Low circulating ketone body concentrations (< 0.2 mM) have been consistently measured 
in newborn piglets (Bengtsson et al. 1969; Pegorier et al. 1981) and in piglets orally dosed with 
medium-chain triglycerides (Odle et al. 1989, 1991) or intravenously infused with MCFA (Odle 
et al. 1992). MCFA challenge has been observed to generate higher blood ketone body 
concentrations in the rat (> 2-3 mM) (Pegorier et al. 1983), in weaned pigs 28 d old (0.52 mM), 
pigs 5 mo. old (0.49 mM) and in newborn and mature rabbits (1.79 mM and 3.18 mM 
respectively) (Adams & Odle 1993). The blood or plasma concentration of free fatty acids and 
ketone bodies predicts their contribution to energy metabolism (Annison et al. 1967). Based on low 
circulating ketone body concentrations, it has been speculated that ketone bodies are not important 
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energy substrates in the peripheral tissues of the neonatal pig (Pegorier et al. 1981). This raised 
the question: how much of the piglet's energy requirement can be met by B-hydroxybutyrate (B-
OHB) oxidation? The current experiment was designed to determine the maximum contribution 
of B-OHB oxidation to total ATP turnover. B-OHB was infused at rates that if completely oxidized 
were predicted to provide 15%, 30%, 45% and 60% of the total ATP turnover in newborn piglets. 
Materials and Methods 
Animals. Twelve piglets (8 males, 4 females) less than 12 h old, weighing 1.39 ± 0.18 
kg (mean + SD), were obtained from Pig Improvement Company, Spring Green, WI. Piglets were 
obtained from several litters of predominantly Large White and Landrace breeding. Piglets were 
not fed after they were removed from the sow. Piglet intake while with the sow, before removal 
for this study, was not known. 
Chemicals. Gases for anesthesia, halothane USP and oxygen USP, were from Halocarbon 
Laboratories (North Augusta, SC) and Liquid Carbonic, (Chicago, IL), respectively. [3-14C]-D-(-)-
3-hydroxybutyrate ([3-14C]-B-OHB) potassium salt was from NEN Research Products (Du Pont, 
Boston, MA). Radiochemical purity was determined by HPLC using a C18 reversed phase 3.9 mm 
x 300 mm pBondapak column (Millipore Corp., Waters Chromatography Div., Milford, MA) and 
10% acetonitrile isocratic gradient at 1.5 mL/min. HPLC effluent was mixed with Bio-Safe II 
scintillation cocktail (3 mL/min) (Research Products International, Mount Prospect, IL) in the 
counting cell of a FLO-ONE\beta model DS Radiomatic radioactive flow detector (Packard 
Instruments, Meriden, CT). [3-14C]-B-OHB purity was >98% by examination of radio-HPLC 
chromatograms (data not shown). B-OHB sodium salt reported to be 93% (D)-isomer was from 
Aldrich (Milwaukee, WI). D-B-hydroxybutyrate dehydrogenase, Type 4, (EC 1.1.1.30); N-
Methyldibenzopyrazine methyl sulfate salt, 4,7-diphenyl-1,10-phenantroline-disulfonicacid and Tris 
were obtained from Sigma Chemical Co. (St. Louis, MO). 
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Animal Preparation. This experimental protocol was approved by the University of 
Wisconsin-Madison, College of Agriculture and Life Sciences Animal Care Committee and is in 
accord with the NIH Guide for the Care and Use of Laboratory Animals (publ. no. 85-23 rev.). 
Anesthesia was induced in piglets with 3% halothane in oxygen and maintained with 1 % halothane 
in oxygen. A polyvinyl chloride umbilical catheter (3.5 french Argyle, Sherwood Medical, St. 
Louis, MO) was inserted in an umbilical artery and threaded to the thoracic aorta as described 
previously (Benevenga et al. 1992). A catheter was also inserted, via a cut down to the linguofacial 
vein, in the right external jugular vein to the level of the heart. Piglets recovered from anesthesia 
for a minimum of 6 h, were unfed for 12-15 h and were 18-24 h old at the start of the infusion. 
Infusion Protocol and Sample Collection. Pigs were randomly assigned to treatments 
(n=3/infusion rate). Pigs were infused with [3-I4C]-B-OHB solutions for a total of 12 h through 
the umbilical artery catheter at rates projected to meet 15%, 30%, 45% or 60% of the estimated 
ATP turnover of 2.4 mmol ATP/(min • kg075) (see calculation section). The fluid delivery rate was 
set at 15 mL/h. The infusate delivered approximately 31 kBq/h [3-,4C]-B-OHB with added 
nonradioactive B-OHB sodium salt to yield planned B-OHB infusion rates of 19.5, 37.8, 55.8, and 
74.5 pmol/min and B-OHB specific activities (SA) of 25.2 + 0.8, 12.3 + 0.5, 7.6 ± 0.4 and 5.8 
+ 0.2 Bq/pmol B-OHB (mean ± SEM) for the groups of piglets infused at 15%, 30%, 45% and 
60% of calculated ATP turnover, respectively. Solutions were held in Viaflex infusion bags 
(Baxter Healthcare Corp., Deerfield, IL) for each piglet and delivered by Rainin Rabbit-Plus 
peristaltic pumps (Rainin Instrument Co., Woburn, MA). The rate at which [3-14C]-B-OHB was 
infused was calculated for each piglet from the measured infusate SA (Bq/g infusate) and the 
average pump rate (g infused/720 min) as described by Odle et al. (1992). Piglets were maintained 
in respiration chambers for a total of 18 hours allowing an additional 6-h "washout" period beyond 
cessation of the 12 h isotope infusion. Air was drawn through the chambers at 2 L/min. Carbon 
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dioxide was removed from air entering the chambers by passage through a 100 cm x 10 cm 
diameter column filled with Sodasorb soda lime (Dewey & Almy Chemical Div., W.R. Grace & 
Co., Atlanta, GA). Twenty-min samples of expired C02 exiting the chamber were trapped by 
passage through a 5 cm diameter glass column containing 80 ml of 2 mol/L NaOH over a sintered-
glass disc as described by Benevenga et al. (1992). The recovery of 14C02 (SA 0.8 Bq/^mol) 
released from NaH14C03 in a respiration chamber over 3.5 h at 933 pmol/min (a rate approximately 
twice that produced by a 1.4 kg piglet), was 96% (data not shown). Recovery of 14C02 was not 
corrected for 14C02 incorporation in intermediates that turn over slowly, relative to the duration of 
this experiment. Recovery of 14C02 in piglets infused with NaH14C03 has been shown previously 
to be 95% recovered in expired C02 (Benevenga et al. 1992). 
One mL blood samples were drawn from the jugular catheter at time 0 (before the start of 
the infusion) and at ten minutes before the hour at 1, 3, 6, 9, 12, 13, 14, 15, 16, 17 and 18 hours 
after commencing the infusion. These sampling times were selected because they fall in the middle 
of the 20 min collections of expired CO%. Plasma was separated at 4°C by centrifugation for 3 min 
at 3000 x g and stored at -20°C until analysis. Voided urine was collected while the piglets were 
in the respiration chambers and by cystocentesis at the end of the experiment. Urine from each pig 
was stored at -20°C until analyzed. Piglets were killed by intravenous injection of sodium 
pentobarbital (88 mg/kg). The abdomen and thorax were opened and catheters were inspected to 
confirm placement near the aortic arch and in the jugular vein at the level of the heart. Piglet 
brains were removed and stored at -20° C. 
Sample Analysis 
Total expired C02 (mmol) was determined gravimetrically by precipitation of BaC03of the 
C02 contained in 0.75 or 1.0 mL aliquots of collected NaOH. The specific activity of C02 was 
determined by releasing the C02 from known amounts of BaC03 and calculating the SA (Bq//xmol) 
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as described previously (Benevenga et al. 1992). 
Stored plasma was thawed and deproteinized using 3 mol/L perchloric acid. The perchloric 
acid was precipitated as potassium perchlorate by addition of potassium carbonate. The supernatant 
pH was adjusted to pH 8.50 ± 0.05 using potassium carbonate and HC1, frozen and stored at -
20°C until analyzed. B-OHB concentration was measured using the dye-linked spectrophotometry 
method described by Kientsch-Engel et al. (1982) and Kientsch-Engel and Siess (1985) with the 
following modifications. Sample absorbances were read at 40 min and corrected for a sample blank 
consisting of all reagents plus 0.1 mol/L Tris buffer without D-B-hydroxybutyrate dehydrogenase. 
Heat treatment of the sample (56°C for 15 min) was necessary to reduce the increase in absorbance 
not associated with enzymatic conversion of B-OHB to acetoacetate. 
Total radioisotope excreted in urine was estimated by liquid scintillation spectrometry (model 
LS3801 Beckman Instruments, Palo Alto, CA) of 100 /xL aliquots of urine in 15 mL of Bio-safe 
U scintillation cocktail. Because ketone bodies can be lipogenic precursors in suckling rat, lipids 
were extracted from ~ 1 g samples of brain tissue using the method of Folch (Folch et al. 1957) 
as modified by Patton et al. (1990). Radioisotope in extracted lipids was estimated by liquid 
scintillation spectrometry. 
Calculations. Evaluation of the importance of B-OHB as an oxidative fuel in piglets in these 
experiments is based on calculation of the fraction of piglet total ATP turnover derived from B-
OHB. The advantage in basing calculations on the basis of ATP is that efficiencies of ATP 
production from substrates vary (see Milligan 1971). For example, production of ATP from 
glucose requires 74.0 kJ of heat released per mole of ATP formed (2815/38), that from tripalmitin 
79.3 kJ (32422/409), and from amino acids (92-102 kJ) which indicates that amino acids are less 
efficient fuels. If 30% of the ATP production is from carbohydrate, 60% from fat and 10% from 
protein, then an average of 79.5 kJ of heat will be released per mol of ATP produced in integrated 
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metabolism. 
Piglet total ATP turnover was estimated prior to the experiment to determine the B-OHB 
infusion rates required to meet 15%, 30%, 45% and 60% of the piglets total ATP turnover. The 
estimated ATP turnover was based on anticipated CCy expiration of 388 /xmol C02/(min • kg0-75) 
(Benevenga et al. 1992). An RQ of 0.86 was used, assuming protein (RQ= 0.83) and B-OHB 
(RQ= 0.89) were the major fuels available to the piglets. Thus, piglet total ATP turnover was 
estimated to be 2.4 mmol ATP/(mhvkg0-75) based on the following calculations (see Kleiber 1975 
for explanation of conversion factors): 
(1) RQ=C02/02 .'. 0.388 mmol C02/(min-kg°-75) 4- 0.86 mmol C02 produced/mmol 02 
consumed = 0.451 mmol 02/(min«kga75) consumed 
(2) [0.451 mmol 02/(min-kg°-7S)] * [22.4 mL 0%/mmol OJ * [0.0192 kJ/mL OJ 
* [1000 mmol ATP/79.5 kJ] = 2.4 mmol ATP/(min • kg075) 
This projected ATP production above was an accurate prediction of the total ATP turnover 
in piglets used in this experiment. The C02 expiration rate measured during this study (mean of 
368 fimol C02/(min-kg°75)) yields an estimated ATP turnover of 2.3 mmol ATP/(min• kg075) 
according to the calculation above. 
B-OHB oxidation was estimated as follows. To estimate C02 SA at isotopic equilibrium 
(SAJ, a single pool exponential model was used to fit the rise in CO% SA with time for each piglet. 
Specific activity of infused B-OHB was calculated based on dilution of the tracer by added B-OHB. 
The endogenous B-OHB pool was assumed not to dilute the SA of infused B-OHB. Plasma B-OHB 
concentrations measured in these piglets at time zero averaged 6.3 pmol/L. Piglets infused with 
B-OHB reached B-OHB concentrations of approximately 350 /imol/L to > 15 mM. Plasma B-OHB 
concentrations in fasted piglets have consistently been reported to be less than 100 pmol/L 
(Bengtsson et al. 1969; Pegorier et al. 1981; Odle et al. 1989; Adams & Odle 1993). 
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The transfer quotient or fraction of expired C02 carbon derived from oxidation of the 3 
carbon of B-OHB (Shipley & Clark, 1972) was calculated by dividing the COj specific activity at 
isotopic equilibrium (SAJ, estimated for each piglet, by the calculated SA of the infused B-OHB: 
Transfer quotient = (Bq/pmol C02) / (Bq/pmol infused B-OHB). 
The rate of oxidation of the 3 carbon of B-OHB (/tmol carbon oxidized/min) was estimated for 
each piglet by multiplying the transfer quotient by the average rate of CO% expiration (pmol/min). 
The average rate of C02 expiration was calculated for each pig from the 20 min C02 collections 
(n=54/animal). For example, (467.8 jtmol CO2/min)(0.08 transfer quotient) = 37.4 pmol 3 carbon 
of [3-14C]-B-OHB oxidized/min). To calculate the oxidation of B-OHB, it was assumed that the 3 
carbon represented the fate of the molecule. Thus, the oxidation rate of the 3 carbon of B-OHB 
was considered equal to the B-OHB oxidation rate (jimollmm). 
ATP equivalents from B-OHB oxidation were obtained by assuming 2 ATP from each 
FADH2 and 3 ATP from each NADH produced in the conversion of B-OHB to acetoacetate 
followed by its conversion to acetyl-CoA and finally to C02 in the TCA cycle. A net total of 25 
ATP equivalents are produced per B-OHB oxidized to C02, when 1 ATP equivalent (as GTP) is 
accounted for in the activation of acetoacetate to acetoacetyl-CoA. If activation occurs via succinyl-
CoA then the estimation of ATP equivalents will be underestimated by 4% (26 vs 25 ATP/B-OHB 
oxidized). The rate of ATP production from B-OHB oxidation was scaled for metabolic body size 
(mmol ATP equivalents/(min'kg0-75)). 
B-OHB oxidation rates for individual 20 min periods at 6, 9, and 12 h were estimated using 
transfer quotients based on SAs measured for each 20 min collection period. This "instantaneous" 
transfer quotient was multiplied by the C02 production rate measured for the corresponding 
collection period to estimate the "instantaneous" B-OHB oxidation rate for that 20 min period. 
Instantaneous B-OHB oxidation rates (mmol ATP equivalents /(min-kg075, n=3/pig) were related 
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to plasma B-OHB concentrations (measured in samples taken during the corresponding 20 min 
collection) using Michaelis-Menten kinetics. The V ^ (mmol ATP equivalents/(min• kg075)) 
obtained was expressed as percent of the mean total ATP turnover (mean based on 12 pigs). 
Instantaneous B-OHB oxidation rates (mmol ATP equivalents/(muvkg075), n=3/piglet) were also 
expressed as percent of total ATP turnover rate calculated based on the 18 h mean CO> expiration 
rate for the corresponding piglet, plotted vs. B-OHB concentration and fit using Michaelis-Menten 
kinetics. In addition, a similar mathematical fit was used to relate oxidation rate of B-OHB (% of 
animals' total metabolic rate) to plasma concentration of B-OHB. Samples used in the calculation 
of instantaneous oxidation rates were limited to samples taken at 6, 9 and 12 h, corresponding to 
the period of the infusion when expired C02 SAs approached plateau. 
Recovery of radioisotope was expressed as B-OHB equivalents by dividing the total dpm 
recovered in C02, urine and brain lipid by the SA of the infused B-OHB. 
Statistics 
The single pool exponential model used to fit the C02 SA vs. time data was: 
SA, = A ( l - 0 , where: 
SA, = expired air C02 SA (Bq/pmol) at time (f) in (min) 
A = asymptotic equilibrium SA (SA, at f=infinity) 
k = fractional rate constant (min'). 
Instantaneous B-OHB oxidation (mmol ATP equivalents/(min• kg075) or % of total metabolic rate) 
vs. plasma B-OHB concentration (mM) was fit using the Michaelis-Menten kinetic model: 
B-OHB oxidation = (V^-s)/ (K^ + s), where: 
Vmix= maximum B-OHB ox. (mmol ATP eq./(min«kg°-7S) or % of metabolic rate) 
Km= Michaelis constant (mM) 
s= B-OHB plasma concentration (mM). 
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These models were fit to the data using the non-linear procedure of SAS version 6.07.02 and 
Gauss-Newton iterative method (SAS 1985). The B-OHB oxidation rate for each piglet vs. the B-
OHB infusion rate expressed as mmol ATP equivalents /(min • kg075) was fit with a quadratic model 
chosen using stepwise regression. 
Plasma B-OHB concentration differences among treatment groups were assessed by two-way 
ANOVA (Steel & Torrie 1980) using SAS (1985) general linear models procedure. Treatment 
group means were compared using orthogonal contrasts. Plasma B-OHB concentrations are 
expressed as means ± pooled SEM. 
Piglet C02 production (pmol C02/(min • kg075)) vs. time data were fit to a linear model and 
significance tested using an extra sums of squares test (Draper & Smith 1981). Recovery of 
isotope, expressed as B-OHB equivalents and reported as the percentage of the dose of B-OHB 
infused, was analyzed as a function of B-OHB infusion rate using a stepwise regression procedure. 
All tests of significance unless otherwise stated were at the a = 0.05 level. 
Results 
During the 12 h of the infusion, plasma B-OHB concentrations of pigs infused at a rate that 
met 74% of their estimated ATP turnover increased to over 15 mM and did not reach a plateau 
(Fig. 3.1). This observation differed from concentrations measured in pigs infused at rates that met 
16%, 32% or 46% of their estimated ATP turnover (P < 0.0001), suggesting that piglets infused 
at 74% of total ATP turnover were not able to dispose of B-OHB at a rate equal to that of infusion. 
SAe was reliably predicted from the expired C02 SA data. Expired C02 SA, during the 12th 
h, reached 94 + 0.9% (mean + SEM) of the SA« estimated from the curve fitting procedure. The 
average CV for the 12 estimates of SA* was 1.8% (range 1.3-2.5%). Examples of expired C02 
SA patterns are shown in Fig. 3.2. Mean total ATP turnover for this group of 12 piglets was 2.3 
+ 0.1 (mean ± SEM) mmol ATP equivalents/(min«kg0-75). Calculation of mean total ATP 
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turnover was based on an average CO^ expiration of 368 + 14 (mean + SEM) pmol 
C02/(min -kg0-75). This rate did not change significantly over the 18 h of this experiment nor was 
the rate affected by the rate of B-OHB infusion (P > 0.05 for extra sums of squares test). 
The instantaneous rate of B-OHB oxidation was related to plasma B-OHB concentration 
during steady state (6 to 12 h infusion) as seen in Fig. 3.3. These instantaneous rates of B-OHB 
oxidation were based on estimates of B-OHB oxidation from the amount and SA of expired COi 
measured in individual 20 min collections and related to plasma B-OHB concentrations measured 
on samples taken during that 20 min collection period. The V^ of the Michaelis-Menten kinetics 
fit was 0.74 ± 0.02 (parameter ± SD) mmol ATP equivalents/(min«kg0-75), corresponding to 32% 
of mean total ATP turnover. The estimated system K^ was 0.62 ± 0.07 mM, using plasma 
concentration as representative of tissue concentration. The V^« (% of total ATP turnover 
calculated based on 18 h mean C02 expiration rate) and K^ , (mM) were 33 ± 1% of total ATP 
turnover from oxidation of B-OHB and 0.54 + 0.08 mM respectively. 
The calculated oxidation rate of B-OHB in ATP equivalents vs. B-OHB infusion rate in ATP 
equivalents is shown in Fig. 3.4. The maximum of the quadratic fit was 0.870 mmol ATP 
equivalents/(min • kg0-75), equivalent to 38% of piglet mean ATP turnover. Even though B-OHB was 
infused at 15.6, 31.6, 45.8, and 74.0% of estimated total ATP turnover, it was oxidized to meet 
a maximum of 38% of piglet mean total ATP turnover [0.870 mmol ATP equivalents/(min«kg°-75) 
-r 2.3 mmol ATP equivalents/(min«kg0-75)] under steady state conditions. 
Recovery of isotope in CC ,^ urine and total recovered was converted to B-OHB equivalents 
and expressed as the percent of B-OHB infused (Fig. 3.5). The percentage of the infused dose 
recovered in total (percent of infused dose recovered in C02 + urine + brain lipid) and in C02 
declined with increasing B-OHB infusion level (P < 0.003 and P < 0.0001 respectively). 
Recovery of B-OHB equivalents in urine appeared to increase at the higher infusion rates. A line 
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was fit but statistical inference was compromised for urine recovery due to nonhomogeneous 
variance. The data for recovery of B-OHB in urine were not corrected by transformation. Recovery 
in brain lipid at 0.22 ± 0.02% of the infused dose (not depicted in Fig. 3.5) did not change with 
infusion level (P < 0.0001). Twenty-eight percent to 36% of the infused dose (calculated by 
difference) was unrecovered. 
Discussion 
Our interest in determining the contribution of B-OHB oxidation to the energy requirement 
of the neonatal pig stemmed from the observation of blood or plasma B-OHB concentrations less 
than 100 pmol/L in piglets, even when challenged with MCFA (Odle et al. 1989, 1991, 1992; 
Adams & Odle 1993). Weaned and adult pigs challenged with MCFA reach B-OHB concentrations 
of approximately 0.5 mM (Adams & Odle 1993). These concentrations of B-OHB in piglets were 
an order of magnitude lower than those measured in other species similarly dosed with MCFA. 
Because it has been shown in sheep that B-OHB's contribution to energy metabolism is linearly 
related to its plasma concentration (Annison et al. 1967; Pethick & Lindsay 1982) and because 
Pegorier et al. (1981) speculated that based on 6-OHB's low plasma concentration it was not an 
important fuel for peripheral tissues in neonatal piglets, we decided to determine the maximum 
contribution of B-OHB to piglet energy requirement and its contribution at physiological 
concentrations. 
Arterial infusion of B-OHB increased B-OHB plasma concentration 3000 fold (0.006 mM 
to 18 mM) in the piglets infused at a rate to meet 74% of their energy requirement. This dramatic 
increase in B-OHB concentration was in contrast to the concentrations observed in piglets infused 
at 16%, 32% and 46% of their energy requirement. Plasma concentration of B-OHB reached 
plateaus in piglets infused at 16%, 32%, and 46% of estimated ATP turnover but not in those 
infused at 74% (Fig. 3.1). This is an indication that the 74% infusion rate was greater than the 
ability of the piglet to oxidize B-OHB. Indeed, after the infusion ended, piglets infused at 74% 
continued to oxidize B-OHB at a maximum rate until the plasma B-OHB concentration fell to below 
the V ^ for B-OHB at which point the C02 SA started to fall (Figs. 3.1-3.2). The higher plasma 
concentration of B-OHB at the end of the 18 h in piglets infused at 74% could have accounted for 
retention in the carcass of at most 2% of the infused B-OHB (calculation based on piglet water 
space of 70% and assuming B-OHB concentration in the total water space equal to that of plasma 
at the end of the infusion, 1 mM). The remaining unrecovered 28-36% of the infused dose (see 
Fig. 3.5) was assumed to be retained in the carcass. 
Ketone bodies are known to be substrates for lipid synthesis in the brain (see reviews by 
Robinson & Williamson 1980; Nehlig & Vasconcelos 1993). Radioactivity recovered in brain lipid 
accounted for < 1 % of the infused B-OHB. Incorporation into brain lipid was apparently not a 
major fate for B-OHB over the course of this infusion. The pig brain growth spurt begins 
prenatally and continues postnatally over the course of several weeks (Dobbing & Sands 1979). 
The longer duration and lower intensity, relative to other species, of the pig's brain growth spurt 
may in part explain the low incorporation of B-OHB into lipid over the 12-18 h B-OHB was 
available in this experiment. 
B-OHB oxidation, based on the Michaelis-Menten system V ^ , accounted for a maximum 
of 32% of mean total ATP turnover in neonatal piglets. However, when B-OHB concentrations 
observed in fasted or MCFA-challenged 1-2 day-old piglets (eg. up to 60 /xmol/L) were applied to 
the system Michaelis-Menten kinetics estimated in this experiment, B-OHB oxidation accounted for 
less than 3% of total ATP turnover. Piglet oxidation of B-OHB increased linearly with B-OHB 
plasma concentration in the physiological range (<200 pM: Fig. 3.3). Although newborn piglets 
have the ability to oxidize B-OHB, it did not appear to be as major a contributor to total ATP 
turnover at the plasma concentrations measured in newborn piglets compared with the contribution 
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in other species. 
Ketone bodies (acetoacetate and B-OHB) have been estimated to account for about 25% of 
basal energy expenditure in neonatal humans (Bougneres et al. 1986; Bougneres 1987), while 
fasting adult obese humans could oxidize ketone bodies to meet 32% of their basal caloric 
expenditure (Reichard et al. 1974). Fasted pregnant ewes can oxidize ketone bodies to meet 30% 
of their energy metabolism with an estimated maximum of 40% of oxygen consumption accounted 
for by ketone body oxidation (Pethick & Lindsay 1982). 
Glucose, by comparison, may account for a similar proportion of total energy expenditure 
as ketone bodies. Glucose oxidation in neonatal humans can account for 36% of their basal energy 
requirement (Denne & Kalhan, 1986). Glucose turnover in the fasted 48-h-old piglet is 23-31 
pmol/(min'kg) (Pegorier et al. 1984, 1985). The maximum potential contribution of glucose to 
the piglet's energy expenditure can be estimated if it is assumed the glucose turnover is completely 
oxidized. Therefore, turnover of 23-31 pmol glucose/(min-kg), if completely oxidized, could 
account for at most 0.87 to 1.2 mmol ATP equivalents/(min • kg) or 38-52% of a 1 kg piglet's total 
ATP turnover of 2.3 mmol ATP equivalents/(min«kg075). 
In contrast, oxidation of MCFAs provided exogenously can account for up to 70% of the 
total ATP turnover in 1-2 day-old piglets (Odle et al. 1992). Medium chain fatty acids at plasma 
concentrations measured in piglets after an oral medium-chain triglycerides challenge were 
estimated to account for approximately 50% of total ATP turnover (Odle 1989; Odle et al. 1989, 
1994). Medium chain fatty acids at concentrations measured in plasma after an oral dose of 
medium-chain triglycerides can serve as a major fuel in the newborn piglet, accounting for a much 
higher proportion of the ATP turnover than ketone bodies or glucose. 
We conclude that fasted, resting one-day-old piglets have the capacity to oxidize B-OHB to 
meet a maximum of nearly 40% of their energy requirements. However, at physiological 
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concentrations of 30-100 pmol/L, (Bengtsson et al. 1969; Pegorier et al. 1981; Odle et al. 1989; 
Adams & Odle 1993) B-OHB oxidation is linearly responsive to changes in B-OHB concentration 
and meets <3% of the piglets energy requirement. These results are consistent with the 
supposition of Pegorier et al. (1981) that ketone bodies are not a major fuel for peripheral tissues 
in the neonatal piglet. The low plasma B-OHB concentrations in piglets are apparently due to a 
decreased ability relative to other species to synthesize B-OHB (Duee et al. 1994), not to a great 
capacity to oxidize B-OHB. 
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Figure 3.1. Plasma B-hydroxybutyrate (B-OHB) concentration during 12 h of B-OHB continuous infusion and subsequent 
6 h "washout" for piglets infused at rates that if completely oxidized would meet 16%, 32%, 46% and 74% of mean 
ATP turnover (points represent treatment means for n=3 pigs/treatment, pooled SEM = 0.87 mM). Vertical line at 
12 h marks the end of B-OHB infusion. 
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Figure 3.2: C02 specific activity (Bq/ftmol) during 12 h of [S-'^ Cj-G-OHB infusion and 6 h "washout." Data points 
represent C02 specific activity measured in expired C02 collected over 20 min periods (n=54 per pig). Data presented 
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Figure 3.4: Effect of arterial B-OHB infusion rate (mmol ATP equivalents /(min • kg0-75)) on the rate of B-OHB 
oxidation (mmol ATP equivalents /(min • kg0-75)) by neonatal piglets. The calculated mean total ATP turnover of this 
group of piglets, based on expired C02, was 2.3 mmol ATP equivalents /(min • kg0-73). Y = -0.24 X2 + 0.95 X - 0.07 
where Y = B-OHB oxidation rate and X = B-OHB infusion rate both expressed in (mmol ATP equivalents 
/(min• kg075)). Maximum 0.870 mmol ATP equivalents /(min• kg075) R2= 0.99. 
55 
(1) 
L_ 
03 
> 
o O 
CD 
£K 
-4-> 
c 0) 
u 
> 
3 
UJ 
03 
+-> 
>\ 
•+J 
_0 
>\ X 
o i _ 
JC 
1 
to 
1 
1 
1 
Q 
T3 
03 
en 3 
H -
C 
03 
- M 
o l _ 
>, 
- M 
3 
X 
o 
L_ 
T3 
>> 
x: 
1 
n 
1 
^ ^ 
1 
i 
i 
Q 
a 
O 
-4-J 
«4— 
o 
X 
100 
80 
o Total Recovered 
• CO, 
60 -
40 
20 -
0 
0 20 40 60 80 
D - ( - ) - 3 - h y d r o x y b u t y r a t e Infusion Level 
{% of Piglet mean total ATP turnover) 
100 
Figure 3.5: Percentage of infused B-OHB recovered in C02, urine and total (C02, urine and brain lipid). Isotope 
recovered in C02, urine and brain lipid was expressed as B-OHB equivalents, based on the SA of the infused B-OHB, 
for calculation of the proportion of the infused dose recovered in each fraction. Models selected by a stepwise 
regression procedure were, for total recovered Y= -0.16X + 76.8 (R2= 0.60), C02 Y= -0.005X2 + 0.23X + 68.48 
(R2= 0.87) and urine Y= 0.08X- 0.34 (R2 =0.46) Where Y = B-OHB equivalents recovered in the respective 
fraction, expressed as % of total B-OHB dose infused and X = B-OHB infusion level as % of piglet mean total ATP 
turnover. 
56 
References 
Adams, SH and J Odle (1993: see Chapter II.). Plasma B-hydroxybutyrate after octanoate 
challenge: attenuated ketogenic capacity in neonatal swine. Am J Physiol 265: R761-R765 
Annison, EF, RE Brown, RA Leng, DB Lindsay, and CE West (1967). Rates of oxidation 
of acetate, glucose, D(-)-6-hydroxybutyrate, palmitate, oleate and stearate, and rates of production 
and oxidation of propionate and butyrate in fed and starved sheep. Biochem J 104: 135-147 
Benevenga, NJ, JK Steinman-Goldworthy, TD Crenshaw, & J Odle (1989). Utilization of 
medium-chain triglycerides by neonatal piglets I. Effects on milk consumption and body fuel 
utilization. J Anim Sci 67: 3331-3339 
Benevenga, NJ, J Odle, & GL Asche (1992). Comparison of measured carbon dioxide 
production with that obtained by the isotope dilution technique in neonatal pigs: observations on 
site of infusion. J Nutr 122: 2174-2182 
Bengtsson, G, J Gentz, J Hakkarainen, R Hellstrom, B Persson (1969). Plasma level of 
FFA, glycerol, fi-hydroxybutyrate and blood glucose during the postnatal development. J Nutr 97: 
311-315 
Bougneres, PF, C Lemmel, P Ferre, and DM Bier (1986). Ketone body transport in the 
human neonate and infant. J Clin Invest 77: 42-48 
Bougneres, PF (1987). Stable isotope tracers and the determination of fuel fluxes in 
newborn infants. Biol Neonate 52(supl): 87-96 
Denne, SC and SC Kalhan (1986). Glucose carbon recycling and oxidation in human 
newborns. Am J Physiol 251: E71-E77 
Dobbing, J and J Sands (1979). Comparative aspects of the brain growth spurt. Early 
Human Development 3: 79-83 
Draper, NR and H Smith (1981). Applied Regression Analysis. NY: Wiley 
Duee, PH, JP Pegorier, PA Quant, C Herbin, C Kohl, and J Girard (1994). Hepatic 
ketogenesis in newborn pigs is limited by low mitochondrial 3-hydroxy-3-methylglutaryl-CoA 
synthesis activity. Biochem J 298: 207-212 
Elliot, JI GA and Lodge (1977). Body composition and glycogen reserves in the neonatal 
pig during the first 96 hours postpartum. Can J Anim Sci 57: 141-150. 
Folch, J, M Lees, and GH Stanley (1957). A simple method for isolation and purification 
of total lipids from animal tissues. J Biol Chem 226: 497-509 
Kientsch-Engel, R.I, EA Siess and OH Wieland (1982). Measurement of ketone bodies in 
subcellular fractions using a spectrophotometry iron-chelate assay. Anal Biochem 123: 270-275 
57 
Kientsch-Engel, RI and EA Siess (1985). D-(-)-3-hydroxybutyrate and acetoacetate, In: 
Methods of Enzymatic Analysis, (UH Bergmeyer, ed.). Deerfield Beach, FL: VCH Publishers 
Kleiber, M (1975). The Fire of Life. Huntington NY: R.E. Krieger Publishing 
Manners, MJ and MR McCrea (1963). Changes in the chemical composition of sow-reared 
piglets during the 1st month of life. Br J Nutr 17: 495-513 
McCance, RA and EM Widdowson (1959). The effect of lowering the ambient temperature 
on the metabolism of the new-born pig. J Physiol 147: 124-134 
Milligan, LP (1971). Energetic efficiency and metabolic transformations. Fed. Proc. 30: 
1454-1458 
Nehlig, A and AP De Vasconcelos (1993). Glucose and ketone body utilization by the brain 
of neonatal rats. Prog Neurobio 40: 63-221 
Newland, HW, WN McMillen, and EP Reineke (1952). Temperature adaptation in the baby 
pig. J Anim Sci 11: 118-133 
Odle, J (1989). Evaluation of even- and odd-chain medium-chain triglycerides as energy 
sources for neonatal piglets. Doctoral Thesis, University of Wisconsin, Madison, WI 
Odle, J, NJ Benevenga, and TD Crenshaw (1989). Utilization of medium-Chain 
triglycerides by neonatal piglets: U. effects of even- and odd-chain triglyceride consumption over 
the first 2 days of life on blood metabolites and urinary nitrogen excretion. J Anim Sci 67: 
3340-3351 
Odle, J, NJ Benevenga, and TD Crenshaw (1991). Utilization of medium-chain 
triglycerides by neonatal piglets: chain length of even- and odd-carbon fatty acids and apparent 
digestion/absorption and hepatic metabolism. J Nutr 121: 605-614 
Odle, J, NJ Benevenga, and TD Crenshaw (1992). Evaluation of [l-14C]-medium-chain 
fatty acid oxidation by neonatal piglets using continuous-infusion radiotracer kinetic methodology. 
J Nutr 122: 2183-2189 
Odle, J, X Lin, TM Wieland, and TATG van Kempen (1994). Emulsification and fatty acid 
chain length affect the kinetics of [14C]-medium-chain triacylglycerol utilization by neonatal piglets. 
J Nutr 124: 84-93 
Patton, GM, JM Fasulo, and SJ Robins (1990). Analysis of lipids by high performance 
liquid chromatography: part I. J Nutr Biochem 1: 493-500. 
Pegorier, JP, PH Duee, R Assan, J Peret, and J Girard (1981). Changes in circulating 
fuels, pancreatic hormones and liver glycogen concentration in fasting or suckling newborn pigs. 
J Dev Physiol 3: 203-217 
58 
Pegorier, JP, A Leturque, P Ferre, P Turlan, and J Girard (1983). Effects of medium-chain 
triglyceride feeding on glucose homeostasis in the newborn rat. Am J Physiol 244: E239-E334 
Pegorier, JP, PH Duee, CS Nunes, J Peret and J Girard (1984). Glucose turnover and 
recycling in unrestrained and unanesthetized 48-h-old fasting or post-absorptive newborn pigs. Br 
J Nutr 52: 277-287 
Pegorier, JP, C Simoes-Nunes, PH Duee, J Peret, and J Girard (1985). Effect of 
intragastric triglyceride administration on glucose homeostasis in newborn pigs. Am J Physiol 249: 
E268-E275 
Pethick, DW and DB Lindsay (1982). Metabolism of ketone bodies in pregnant sheep. Br 
J Nutr 48: 549-563 
Reichard, GA, OE Owen, AC Haff, P Paul, and WM Bortz (1974). Ketone-body 
production and oxidation in fasting obese humans. J Clin Invest 53: 508-515 
Robinson, AM and DH Williamson (1980). Physiological roles of ketone bodies as 
substrates and signals in mammalian tissues. Physiol Rev 60(1): 143-187 
SAS Institute Inc. (1985). SAS Users Guide: Statistics. Cary NC: SAS Institute 
Shipley, RA and RE Clark (1972). Tracer Methods for In Vivo Kinetics. NY: Academic 
Press 
Steel, RDG and JH Torrie (1980). Principles and Procedures of Statistics. NY: McGraw-
Hill 
Widdowson, EM (1950). Chemical composition of newly born mammals. Nature 166: 
626-628 
Widdowson, EM (1968). Growth and composition of the fetus and newborn, In: Biology 
of Gestation, Vol II, The Fetus and Neonate, (NS Assali, ed.). NY: Academic, pp. 1-49. 
59 
*IV. ACETATE IS A MAJOR PRODUCT OF B-OXIDATION IN 
HEPATOCYTES ISOLATED FROM NEONATAL PIGLETS 
ABSTRACT. The predominant radiolabeled end-products of accelerated B-oxidation of [U-
,4C]- or [l-14C]-fatty acids by rat liver preparations are ketone bodies (KB). It might be expected 
that in studies with hepatocytes isolated from animals with low ketogenic potential, accumulation 
of radiolabel in other metabolites (i.e., Krebs cycle intermediates) may be relatively important. An 
experiment was designed to explore the nature of the radiolabel distribution in acid-soluble products 
(ASP, including KB & water-soluble metabolites) produced by isolated piglet hepatocytes incubated 
with [1-14C]-C7:0 or -C8:0 (newborn piglets have been shown to have a negligible ketogenic 
capacity: i.e., Adams & Odle 1993). Chain-length differences were expected based on the theory 
that metabolism of odd-chain fatty acids yields propionyl-CoA, which might "replenish" the Krebs 
cycle (anaplerosis) and lower ketogenesis (ASP) by supporting acetyl-CoA entry into the cycle. 
The impacts of valproate (B-oxidation blocker) and malonate (Krebs cycle inhibitor) upon the rate 
of B-oxidation and ASP characteristics were tested. A minor amount of fatty acid carboxyl-carbon 
(<10% of organic acids identified by radio-HPLC) accumulated in the KB regardless of chain-
length or inhibitor used. In all cases, acetate represented the major reservoir of carboxyl-carbon 
(-60-70% of radiolabel in identified organic acids). 40-50% of ASP radioactivity could not be 
accounted for in Krebs cycle intermediates, KB, or acetate, and was found by radio-HPLC to reside 
in a/an unknown metabolite(s). Consistent with Odle et al. (1991a), cells given [1-,4C]-C7:0 
accumulated -50% more carboxyl carbon in C02+ASP. The biochemical basis of this 
phenomenon could not be elucidated, but the data do not support the hypothesis that anaplerosis 
impacts B-oxidation, at least in non-ketotic species. The piglet appears unique in that non-ketogenic 
routes of fatty acid carbon flow (i.e., acetogenesis) predominate in the liver of these animals. 
TTus chapter is based on studies done in collaboration with Drs. Xi Lin & Jack Odle, Division of Nutritional Sciences 
& Department of Animal Sciences, University of Illinois at Urbana-Champaign. 
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Introduction 
Ketone bodies, B-hydroxybutyrate and acetoacetate, are considered to be the predominant 
end-products of accelerated hepatic mitochondrial B-oxidation of fatty acids. It has been shown in 
numerous animal models that under conditions of fasting (Owen et al. 1967), diabetes (Krane 
1987), medium chain triglyceride (MCT) administration (Pi-Sunyer et al. 1969; Wiley and Leveille 
1973; Bach et al. 1974; Frost and Wells 1981) and during suckling (Foster and Bailey 1976; 
Callikan et al. 1979; Lucas et al. 1981; Duee et al 1983), fatty acid oxidation is brisk, and ketone 
bodies levels in the blood rise concomitant with a high ketogenic rate. Based on data from adult 
fasted rats (McGarry et al. 1977, 1978), it has been presumed that ketone bodies comprise the 
majority of the non-C02 carbon derived from oxidation of fatty acids with in vitro incubations of 
liver homogenates or hepatocytes from piglets (e.g. Lepine et al. 1991, 1993; Odle et al. 1991a). 
While this assumption may hold for species possessing significant hepatic ketogenic capacity, it may 
be questioned in animals whose capacity is low. 
Neonatal piglets are an interesting contrast to most previously-examined newborns in that 
neonatal hyperketonemia is not characteristic of this species (Bengtsson 1967; Pegorier et al. 1981, 
Innis et al. 1993), suggesting that the rate of ketogenesis is minimal in newborn pigs relative to 
other neonates. Medium-chain fatty acid (MCFA: 6-12 carbons) administration to 24 h old fasted 
piglets via an orogastric load of MCT (tri-C8:0 & tri-C10:0, Odle et al. 1989, 1991a), after 
intravenous infusion (Odle et al. 1992), or after an intraperitoneal dose of Na-C8:0 (Adams and 
Odle 1993), failed to increase plasma B-hydroxybutyrate concentration above 40-60 pM, even 
though comparable strategies induce marked ketonemia in dogs, humans, and rats (Pi-Sunyer et al. 
1969; Wiley and Leveille 1973; Bach et al. 1974; Frost and Wells 1981). Consistent with low 
ketogenic capacity in piglets, rates of acid-soluble product (ASP) generation (natom carboxyl-
carbon/(h-106 cells)) from hepatocytes incubated with [1-14C]-C8:0 or [1-14C]-C18:1 are 4- to 8-
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fold lower in piglets (Pegorier et al. 1981; Odle et al. 1991b) relative to neonatal rabbits (Duee et 
al. 1985; Pegorier et al. 1989). 
Accumulation of carboxyl-carbon in ASP from piglet hepatocyte incubations is far greater 
(by 45% vs. even-chain MCFA) for cells given odd-chain fatty acids (C7:0 & C9:0) as substrate 
(Odle et al. 1991b); these fatty acids were expected to provide anaplerotic carbon to the Krebs cycle 
and thereby diminish ketogenesis. These findings prompted Odle et al. (1991a) to suggest that ASP 
from piglet hepatocytes may include organic acids other than ketone bodies, and that chain-length 
differences may exist with respect to the organic acid profile in the ASP (i.e., greater abundance 
of Krebs cycle intermediates with odd-chain MCFA). In addition, the ASP organic acids resulting 
from hepatic fatty acid oxidation in the non-ketotic newborn piglet may differ markedly from other 
species. We examined these problems by using hepatocytes isolated from 24 h old, low birth 
weight (LBW), colostrum-deprived piglets. The effects of inhibition of B-oxidation (inclusion of 
valproate) or blockage of the Krebs cycle (addition of malonate) on accumulation of MCFA carbon 
in C02 and the various components of ASP were tested. The potential for carnitine (a) to 
ameliorate the potential inhibitory effects of valproate on fatty acid metabolism (Becker and Harris 
1983; Coude" et al. 1983; Thurston and Hauhart 1992a,b) as assessed by accumulation of fatty acid 
carbon in CCy and ASP and (b) to maintain cellular CoA status was addressed. 
HPLC/radiochromatographic characterization of identifiable radiolabeled organic acids resulting 
from [1-14C]-C7:0 or [1-,4C]-C8:0 B-oxidation led to the novel finding that the majority of carboxyl-
carbon does not accumulate in ketone bodies. Of the radiolabeled metabolites identified, the 
majority (i.e. > 65-70%) of carboxyl-carbon accumulation occurred in free acetate. These data are 
consistent with our previous description of major radioactivity residing in an HPLC peak 
corresponding to acetate/acetoacetate in ASP from [1-14C]-C8:0 or [1-I4C]-C16:0 incubations with 
hepatocytes derived from 24 h old newborn piglets (Lin et al., in preparation). 
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Materials & Methods 
Reagents. [1-14C]-C7:0 (3.2 pCi/pmol) and [1-14C]-C8:0 (55 uCi/umol) were obtained from 
American Radiolabeled Chemicals (St. Louis, MO). Carnitine was a gift from Lonza (Basel, 
Switzerland). Ethanolamine was from Eastman Kodak (Rochester, NY). All other chemicals, 
including organic acid salts (acetoacetate, a-ketoglutarate, B-hydroxybutyrate, citrate, fumarate, 
malate, pyruvate, and succinate), CoA and its derivatives, Na-valproate, and Na-malonate were 
purchased from Sigma (St. Louis, MO). 
Animals & Hepatocyte Isolation. Low-birth-weight (811 ± 50 g) Yorkshire/Duroc piglets 
(n = 5) were obtained at farrowing and deprived of colostrum until hepatocyte isolation was carried 
out 24 h postpartum. After animals were anesthetized with pentobarbital (20 mg/kg), livers were 
cannulated, perfused with collagenase in retrograde fashion, and cells isolated as described 
previously (Odle et al. 1991a). Yields ranged from 1.2-2.3 x 10* hepatocytes/liver. Hepatocyte 
viability (Trypan Blue exclusion) was routinely >95% using this method. 
Hepatocyte Incubations. The details of the in vitro hepatocyte incubations with [1-14C]-
radiolabeled fatty acids used herein are described elsewhere (Odle et al. 1991a). Briefly, 7.8-15.4 
x 106 hepatocytes were incubated with continuous shaking at 37°C in 25 ml Erlenmeyer flasks fitted 
with serum stoppers and center wells filled with 500 pL ethanolamine to capture 00%. For those 
flasks in which radioactivity in C02 and ASP were of interest, incubations were terminated when 
500 uL of 30% trichloroacetic acid was injected into the medium at 60 min, and flasks were 
allowed to stand for 2 h to capture all ,4C02 evolved. Contents of the flask were transferred to test 
tubes, centrifuged at 1200 x g for 10 min, and the supernatant extracted 6 times with H20-saturated 
hexane. Radioactivity contained in center wells and in 150 (iL aliquots of the acid-soluble fraction 
was determined using a Beckman LS600IC scintillation counter (Palo Alto, CA) after mixing with 
10 ml Biosafe II cocktail (Research Products International, Mt. Prospect, IL). All radioactivity data 
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were corrected for radioactivity in time 0 acid-killed blanks. When CoA and CoA esters were to 
be assayed, incubations using non-radioactive substrate were terminated by submersion of flasks 
in a 0°C shaking water bath (blanks were treatment-matched flasks submerged at time 0). Contents 
were subsequently transfered to pre-weighed polypropylene tubes, and centrifuged at 1200 x g for 
10 min at 4°C. Tubes were re-weighed after removal of the supernatant, cell weight was recorded 
(g wet wt), and cells and supernatant stored separately at -70°C and -20°C, respectively. Under 
these conditions, the relationship between cell wet weight and number averaged 5.18 + 0.11 mg 
wet wt/(106 cells). 
Experimental Design. Treatments (run in duplicate) were assigned in a 2 x 2 x 3 factorial, 
randomized complete block design, blocked by hepatocyte preparation. The experiment was 
replicated 5 times. Cells given either 1 mM C7:0 or C8:0 substrate were incubated in the presence 
or absence of valproate (1.5 mM) or malonate (10 mM), alone or in combination with L-carnitine 
(3 mM), resulting in a total of 12 treatments. Valproate flasks were preincubated for 10 min at 
37°C prior to fatty acid addition. The accumulation of substrate [l-14C]-carboxyl carbon in C02, 
ASP, and organic acids across treatments was monitored with addition of a tracer amount of [14C]-
MCFA (1.6-1.8 pCi/pmol for C7:0 & C8:0, respectively) in one set of flasks. A selected number 
of flasks were incubated for 20 min with non-radioactive MCFA/carnitine, 
MCFA/carnitine/malonate, and MCFA/carnitine/valproate. For these samples, 02 consumption was 
then measured polarigraphically using water-jacketed (37CC) Clark electrodes coupled to a YSI 
Model 5300 02 monitor (Yellow Springs, OH). The xanthine oxidase method was used for 
electrode calibration (Billiar et al. 1970). 
Organic acids. An aliquot of the acid-soluble fraction was subjected to ion-exchange 
HPLC/radiochromatographic analysis for organic acids as described previously (Lin et al., in 
preparation) and modified as follows: flow rate was changed to 0.65 ml/min and the final flow rate 
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of combined B-flowmonitor cocktail and HPLC eluent was 3.25 ml/min. This method resolves 
organic acids into 9 uV peaks corresponding to oxaloacetate, citrate, a-ketoglutarate, pyruvate, 
malate, succinate, B-hydroxybutyrate, acetate/acetoacetate, and fumarate (Fig. 4.1 and Lin et al., 
in preparation). Radioactivity accumulated in each of the organic acids was determined after 
collection of eluent into vials at appropriate times (see Fig. 4.1) using a fraction collector (Isco 
Retriever n, Lincoln, NE). The retention time of a number of acids were too close to allow for 
separate collection. In these cases (see Table 1), eluent was collected across the proximate organic 
acids (i.e., Fraction A in Fig. 4.1) and their radioactivity summed. For some samples (see 
Results), reversed-phase ion-pairing HPLC radiochromatography was used to characterize 
radioactivity accumulated in organic acids. This system employed a Beckman Ultrasphere IP 
column (5 /*, 4.6 x 250 mm) with an isocratic 0.3% phosphoric acid gradient at pH 2.1 (0.65 
ml/min, wavelength 210 nm). Organic acid peaks of interest were characterized by comparison to 
authentic standards, collected, and radioactivity determined in the same manner as for the ion-
exchange procedure. 
CoA and CoA esters. The CoASH and acid-soluble CoA esters in the cells were extracted 
with trichloroacetic acid as described by Corkey et al. (1988). To each sample was added 0.3 nmol 
isovalery-CoA (internal standard), followed by 750 uL of ice-cold trichloroacetic acid (0.6 N). The 
sample was vortexed, homogenized manually with a microcentrifuge pestle, and centrifuged for 10 
min at 12000 x g. The acid-insoluble precipitate was discarded, and the supernatant processed as 
follows. Supernatant was neutralized by removal of trichloroacetic acid by 6 ice-cold diethyl ether 
extractions, and the remaining sample evaporated to dryness using a Savant Speedvac (Model 
AS160, Farmingdale, NY). The residue was redissolved in 250 /iL of Buffer A (see below), and 
50 uL analyzed for CoASH and acid-soluble CoA esters by HPLC. The separation of CoA and 
acyl-CoA esters was performed using a Beckman IP Ultrasphere column (5 n, 4.6 x 250 mm), and 
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analyzed with a uV detector at a wavelength of 242 nm. For the initial 2.5 min of each run, eluent 
consisted of 99% of Buffer A (50 mM (NHJ3PO4, pH 5.3) and 1 % of Buffer B (a 50:50 mixture 
of Buffer A and acetonitrile, pH 5.65). A gradient was then initiated by successive changes in 
eluent composition as follows: eluent was changed to 7% B over 2.5 min, 10% B over 2.5 min, 
17% B over 2.5 min, 36% B over 8 min, and 100% B over 40 min. The final composition (100% 
B) was maintained for 10 min and then returned back to initial conditions over 2 min. The initial 
flow rate (1 ml/min) was maintained for 28.5 min and then increased to 1.2 ml/min over 15 min. 
Free CoASH acetyl-CoA in the cell pellet extracts were readily measured; however, other CoA 
esters were not detected using this method. 
Statistics. Data were analyzed statistically using the general linear models procedure of 
SAS (SAS Institute, Gary, N.C.), considering the effects of fatty acid substrate (C7:0 vs. C8:0), 
carnitine, inhibitor (valproate or malonate), and interactions thereof. Differences in least-squares 
means (Ismeans) for main effects or interactions were compared when found to be significant 
(p<0.05) in the analysis of variance. The least-squares means ± pooled SEM are reported unless 
otherwise noted. Statistical interactions between fatty acid*carnitine, carnitine*inhibitor, or fatty 
acid*carnitine*inhibitor were not significant for any variable tested (p>0.1), and for brevity are 
not reported in the text or figure/table legends. 
Results 
Accumulation of label in C02 & ASP (Figs. 4.2A-B). The accumulation of the carboxyl 
carbon of C7:0 or C8:0 in CO^ was affected significantly by fatty acid chain-length and inhibitor 
used (Fig. 4.2A). Across treatments, accumulation from C7:0 (12.1 natom carboxyl-carbon/(h • 106 
cells)) was 54% greater than from C8:0 (7.8 natom carboxyl-carbon/(h • 105cells)). Compared with 
substrate alone (10.7 natom carboxyl-carbon/(h• 10scells)), there was no effect of malonate (10.1 
natom carboxyl-carbon/(h«10^cells)), and a 14% depression with valproate (9.2 natom carboxyl-
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carbon/(h • 106 cells)). There was no effect of carnitine across substrates or inhibitors (p>0.1). 
Carboxyl-carbon accumulation in ASP was also significantly altered by substrate chain-
length and inhibitor (Fig. 4.2B). Accumulation was 46% higher with C7:0 (16.2 natom carboxyl-
carbon/(h • 106cells)) versus C8:0 (11.1 natom carboxyl-carbon/(h • 10scells)). Valproate-inhibited 
cells accumulated carboxyl-carbon in ASP to only 55% (8.8 natom carboxyl-carbon/(h • 106 cells)) 
of that observed in controls (16.0 natom carboxyl-carbon/(h • 10* cells)) or in cells incubated with 
malonate (16.2 natom carboxyl-carbon/(h • 106 cells)). No significant effects of malonate or 
carnitine were observed (p>0.1). 
Addition of inhibitor significantly (p< 0.0001) impacted the pattern of carboxyl radiolabel 
partitioning between C02 and ASP. Relative accumulation in ASP, expressed as a percentage of 
total radiolabel accumulation in ASP+C02 (i.e., % of total oxidative flux), was lower in cells 
incubated with valproate (49%) when compared with controls (59%) or those incubated with 
malonate (62%)(SEM=0.8). The difference (p=0.02) in relative ASP accumulation between C7:0 
(56%) and C8:0 (58%) was small (SEM=0.6). Across all treatments, the percentage of total 
accumulation of radiolabel into ASP ranged from 46-62% (data not shown). Again, no effect of 
carnitine was observed (p>0.1). 
Oxygen consumption. 02 consumption was not affected by inclusion of inhibitors in the 
medium (Fig. 4.3). However, fatty acid chain-length had a significant effect on the rate of 02 
utilization across treatments, being 7% greater for C7:0 (323 nmol 02/(h • 106 cells)) than C8:0 (301 
nmolO2/(h-106 cells)). 
Coenzyme A & Acetyl-CoA levels (Fig. 4.4A-B). Across fatty acid substrates, the 
treatments resulted in a substantial 52% (substrate alone or malonate) to 67% (valproate) drop in 
free CoA levels relative to the 13.9 nmol/(g wet wt cells) measured in time-zero blanks (Fig. 
4.4A). The drop in free CoA was unaffected by carnitine (p> 0.1; 5.9 vs. 6.1 + 0.4 nmol/(g wet 
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wt cells) with and without carnitine, respectively) or chain-length of fatty acid (p>0.1). 
The slight decrease in acetyl-CoA concentration with the addition of carnitine (Fig. 4.4B) 
was not statistically significant (p=0.1; 11.9 vs. 14.8 ± 1.3 nmol/(g wet wt cells) with and without 
carnitine, respectively). The difference between C7:0 and C8:0 (14.4 and 17.8 nmol/(g wet wt 
cells), respectively) was significant (Fig. 4.4 legend). Acetyl-CoA levels across treatments were 
just 55% (substrate only), 64% (malonate), and 45% (valproate) of that determined for blanks (24.3 
nmol/(g wet wt cells)). 
Organic acid profile (Table 4.1; Fig. 4.5). The radioactivity accumulated in the organic 
acid peaks resolved by ion-exchange HPLC/radiochromatography are presented in Table 4.1. Of 
the organic acids identified, which included the ketone bodies, accumulation of carboxyl-carbon in 
acetate was predominant across all treatments. Relative to acetate, the contribution of acetoacetate 
to the carboxyl accumulation in the acetate/acetoacetate HPLC fraction was presumed to be small 
because (a) accumulation in B-hydroxybutyrate was a small fraction of identifiable organic acid 
accumulation (Table 4.1), (b) ketogenesis from in vitro liver preparations incubated with fatty acids 
has been shown to be low (Pegorier et al. 1983; Duee et al. 1994), and (c) in vivo assessments of 
ketogenic capacity in piglets have repeatedly underscored their low ketogenic potential (i.e., Odle 
et al. 1989, 1991a, 1992; Adams & Odle 1993). Nevertheless, it was necessary to develop a 
method which resolved these metabolites in order to quantify radioactivity in acetoacetate. 
Reversed-phase ion-pairing HPLC (see Materials & Methods for details) was thus employed on ASP 
samples from 2 replicates. As judged by elution of radioactive compounds through on-line 
radiochromatography (Fig. 4.5), and by quantification of radioactivity associated with eluent 
corresponding to these metabolites (Fig. 4.6), only minor accumulation of carboxyl-carbon 
accumulated in acetoacetate (or B-hydroxybutyrate) relative to acetate. Across treatments or fatty 
acid chain-length, acetoacetate accounted for a maximum of only 3% of ASP radioactivity (-6% 
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of identifiable organic acid radioactivity). The primacy of acetate in the ion-exchange 
acetate/acetoacetate peak was further confirmed in a subset of samples through enzyme treatment 
of eluent corresponding to this peak, followed by radiochromatographic separation (Fig. 4.7). 
Upon conversion of acetoacetate to B-hydroxybutyrate using this method, radioactivity remained 
associated with the retention time corresponding to acetate/acetoacetate (Fig. 4.7). Furthermore, 
an aliquot of the ion-exchange acetate/acetoacetate eluent subjected to gas chromatographic analysis 
contained one major flame ionization detector peak with retention time identical to acetate (data not 
shown). 
Substrate chain-length significantly affected the distribution pattern of carboxyl-carbon 
accumulated in ASP organic acids (see Table 4.1). Across treatments, accumulation in citrate/a-
ketoglutarate and pyruvate/malate was > 2-fold higher from incubations with C7:0 versus those 
with C8:0. On average, valproate significantly lowered accumulation in citrate/a-ketoglutarate and 
pyruvate/malate by about 40%, and in fumarate by 30% to 84% (C8:0 and C7:0, respectively). 
There was a non-significant (p> 0.1) 22% drop in accumulation of label in succinate with valproate 
addition. Although carboxyl accumulation in B-hydroxybutyrate was similar for C7:0 and C8:0 in 
the presence of valproate, accumulation was -1 .5 fold higher for C7:0 across other treatments. 
Valproate addition markedly lowered accumulation in B-hydroxybutyrate to levels only 16% (C7:0) 
and 25% (C8:0) of controls (p< 0.0001). Relative to controls, malonate had no effect upon 
accumulation in B-hydroxybutyrate (p > 0.1). Accumulation of carboxyl-carbon in acetate dropped 
an average of 61% when cells were incubated with valproate (p< 0.0001), while malonate had no 
effect (Table 4.1). Carnitine had no effect across all treatments (p > 0.1). 
Interestingly, the summed radioactivity contained in the organic acids identified and 
separated by ion-exchange HPLC could account for just 35-61% of the radioactivity residing in 
ASP (Table 4.1, last column). With samples subjected to reversed-phase ion-pairing separation, 
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80-90% of ASP radioactivity was recovered in eluent corresponding to acetate, acetoacetate, and 
a(n) unidentified metabolite(s) (see Fig. 4.6). Significantly less ASP radioactivity accumulated in 
identified organic acids in the case of C7:0 relative to C8:0 (mean across treatments=45% & 54%, 
respectively, Table 4.1). Compared with controls (53%) or malonate-treated cells (56%), a smaller 
fraction (40%) of total carboxyl-carbon accumulation in ASP could be accounted for in identifiable 
organic acids when cells were incubated with valproate (Table 4.1). 
Discussion 
Organic Acid Profile. Numerous studies (Bengtsson et al. 1967; Pegorier et al. 1981; Odle 
et al. 1989; Adams and Odle 1993; Innis et al. 1993) have illustrated that neonatal pigs, whether 
suckled or fasted, fail to display the elevated circulating ketone body concentrations which are 
characteristic of previously-studied neonates (for review, see Girard et al. 1992). In vitro 
experiments using isolated hepatocytes incubated with [l-14C]-radiolabeled C8:0 or C18:1 indicated 
that carboxyl-carbon accumulation in ASP is 4-8 fold lower in piglets (Pegorier et al. 1983; Odle 
et al. 1991b) relative to newborn rabbits (Duee et al. 1985; Pegorier et al. 1989) signaling a lower 
rate of fatty acid oxidative flux in piglet hepatocytes. These data suggested that ketogenic rate in 
piglets is low, because the majority of ASP carbon has traditionally been presumed to reside in the 
ketone bodies in rats (McGarry et al. 1977, 1978) and piglets (Lepine et al. 1991, 1993). Further 
experimental evidence supporting the presence of a ketogenic deficit in piglets arose from the 
finding that relative to older pigs, newborn rabbits, and mature rabbits, newborn piglets generated 
a minimal rise in plasma B-hydroxybutyrate following an orogastric or intraperitoneal C8:0 
challenge in vivo (Odle et al. 1989, 1991a; Adams and Odle 1993). In a recent study, published 
during the preparation of this report, Duee et al. (1994) demonstrated minimal ketogenesis 
(compared with mature rats) from incubations of neonatal and mature pig mitochondria with CI8:1. 
These studies demonstrating low ketogenic capacity in piglets prompted the development of an ion-
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exchange HPLC/radiochromatograpnic method for analysis of organic acids in ASP from 
hepatocytes incubated with [l-,4C]-radiolabeled fatty acids (Lin et al., in preparation). That work 
showed that in hepatocytes from 24 h old suckled piglets, major carboxyl radioactivity could be 
found in a peak corresponding to acetate/acetoacetate. However, radioactivity in other organic 
acids was not obtained, and the complete characterization of B-oxidative end-products derived from 
piglet hepatocytes remained unclear. 
The current study extends the previous experiment (Lin et al., in preparation), and led to 
the finding that the fate of fatty acid carboxyl carbon during B-oxidation in hepatocytes isolated 
from colostrum-deprived neonatal piglets is accumulation in acetate and an unidentified entity 
(Table 4.1, Figs 4.5-4.6). Under any condition, the ketone bodies were a minor reservoir of 
carboxyl-carbon, a finding consistent with the low ketonemia observed in vivo in neonatal piglets. 
In preliminary observations, Duee et al. (1986), using isolated mitochondria from 48 h old 
colostrum-deprived piglets, concluded that the major end-product of B-oxidation was acetoacetate 
when mitochondria were treated with 10 mM malonate and given palmitoyl-carnitine as substrate. 
However, this inference was made based on the observed AO:Apalmitoyl-camitine ratio compared 
with the theoretical ratio expected for complete flux to acetoacetate, which is identical to that which 
would be obtained if acetate had been the primary end-product. 
The finding that free acetate production far surpasses ketogenesis as a result of B-oxidation 
in piglet hepatocytes appears unique. Nevertheless, substantial endogenous (non-fermentative) 
production of acetate has been described in rat liver perfused with C6:0 (Seufert et al. 1974), in 
liver slices isolated from rats or sheep (Knowles et al. 1974), and in livers from diabetic or 18 d 
old suckling rats (Buckley and Williamson 1977). Plasma acetate doubled in normal humans fasted 
4.5 d (Scheppach et al. 1991), and is elevated in diabetic humans, rats, and sheep (Knowles et al. 
1974; Buckley and Williamson 1977; Akanji et al. 1989), suggesting that endogenous acetogenesis 
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occurs concomitant with ketogenesis. Other moieties resulting from B-oxidation have been 
described. In experiments employing radiochromatographic techniques similar to this study but 
using fU-,4C]-C16:0 substrate in adult rat muscle mitochondrial preparations, Watmough et al. 
(1988) noted that production of acetyl-carnitine represents the predominant fate of fatty acid carbon 
in these preparations when incubated with 1 mM carnitine. Pourfarzam and Bartlett (1991) found 
that in rat hepatocyte mitochondria incubated with [U-14C]-hexadecanedionoyl-mono-CoA (diC16:0-
CoA) and flourocitrate (a Krebs cycle blocker), up to 30% of non-COj radiolabel accumulation in 
ASP was in acetyl-carnitine, with the remainder in ketone bodies and citrate (presumably citrate 
was from the radiolabeled succinate terminal end-product of this fatty acid). Our preliminary 
attempts to determine acetyl-carnitine levels by HPLC/uV absorption (Kempen and Odle 1992) in 
supernatant from cold-killed piglet hepatocytes have been unsuccessful (data not shown). 
The intracellular site(s) of acetogenesis from fatty acid oxidation in piglet hepatocytes is not 
clear. However, there is evidence in rats that acetate is produced in mitochondria (Knowles et al. 
1974; Seufert et al. 1974, 1978), peroxisomes (Leighton et al. 1989; Hovik et al. 1991), and 
cytosol (e.g., Crabtree et al. 1989). Leighton et al. (1989) demonstrated that acetate is produced 
in hepatocytes isolated from fed adult rats and incubated with C12:0, a mitochondrial and 
peroxisomal substrate. In support of peroxisomal acetogenesis from C12:0, cells from bezafibrate-
treated rats (peroxisome-proliferated) produced acetate at a rate 6-fold higher than controls (H202 
production rose 8-fold), while ketogenesis increased just 2-fold. A major radiolabeled peak 
corresponding to acetate was observed using HPLC/radiochromatographic separation of ASP from 
peroxisome-proliferated hepatocytes incubated with [l-14C]-diC12:0 (Leighton et al. 1989). Hovik 
et al. (1991) incubated peroxisomes with [l-14C]-C16:0-CoA and subjected the ASP fraction to 
HPLC/radiochromatography. Peroxisomal generation of acetate was evidenced by the major 
radioactivity observed at the retention time of acetate. Good evidence exists for mitochondrial 
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acetogenesis, as well. Rates of free acetate production (nmol/(min • mg protein)) from cells given 
C4:0 and C6:0 (poor peroxisomal substrates: Lazarow 1978) were 48% and 76% of that observed 
with C12:0, despite minimal H202 production, suggesting mitochondrial acetogenesis is active in 
rat hepatocytes. Furthermore, mitochondrial preparations generated free acetate when incubated 
with C6:0 (Seufert et al. 1978), and free acetate production increased 3.7-fold in rat livers perfused 
with C6:0 (Seufert et al. 1974). Pourfarzam and Bartlett (1991) did not report the presence of 
radioactive acetate in the organic acid fraction derived from rat liver mitochondrial incubation with 
[U-14C]-diC16:0-CoA and subjected to HPLC/radiochromatography. 
Although the predominant site(s) of acetogenesis in pigs is equivocal, mitochondria are 
probably contributors to free acetate production in these animals. First, valproate significantly 
depressed accumulation of carboxyl-carbon in ASP and acetate (Table 4.1 & Fig. 4.23). However, 
valproate is poorly activated by peroxisomes, is peroxisomally oxidized only when provided as its 
valproyl-CoA ester, and has been shown only to inhibit mitochondrial B-oxidation of 
monocarboxylates (Draye and Vamecq 1987; Vamecq et al. 1993). Second, in work completed 
recently, we demonstrated a 2-fold rise in C16:0 carboxyl-carbon accumulation in acetate from 
piglet liver homogenates incubated with 10 mM malonate (Adams et. al., in press). This treatment 
was presumed to inhibit acetyl-CoA entry into the Krebs cycle, and thus should not have impacted 
peroxisomal acetogenesis. Nevertheless, carboxyl accumulation in acetate was observed to occur 
at 60% of the control level despite addition of antimycin/rotenone (agents assumed to slow 
mitochondrial B-oxidation). Until peroxisomal and mitochondrial incubations are carried out in 
piglets, the exact site(s) of acetogenesis will remain unknown. 
It is intriguing that when ASP samples were subjected to reversed-phase ion-pairing HPLC, 
a large fraction (up to 70%, Fig. 4.6) of non-CQz carboxyl-carbon radiolabel was found to be in 
a radiochromatography peak as yet unidentified (Fig. 4.5). It is plausible that this peak represents 
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at least one metabolite, rather than result of residual substrate or substrate-derived contaminants. 
Samples were hexane-extracted to minimize residual substrate inclusion in ASP, and radioactivity 
values associated with ASP were blank-corrected. Blanks separated by HPLC contained only 5% 
of sample radioactivity in the eluent associated with the unidentified peak (Fig. 4.6 legend). It is 
notable that the percentage of unidentified ASP radioactivity was significantly affected by 
differences in fatty acid (55% and 46% for C7:0 and C8:0, respectively) and by the presence of 
valproate (60% versus 47% for valproate and substrate alone, respectively)(see Table 4.1; Fig. 
4.6), supporting the view that this fraction is in some way related to cellular metabolism. Most 
(80%), but not all, of ASP radioactivity resulting from B-oxidation of diC16:0-CoA could be 
accounted for in organic acids (citrate, ketone bodies) and acetyl-carnitine in the rat liver 
mitochondria incubations of Pourfarzam and Bartlett (1991). The unidentified fraction could, in 
theory, represent such metabolites as acetyl-carnitine, glucose, glutamate, etc. Clarification of this 
phenomenon is under current investigation. 
Carboxyl-carbon Accumulation in C02 and ASP. Accumulation rates of C8:0 carboxyl-
carbon into C02 and ASP were similar to rates reported previously for fasted, LBW 24 h old 
piglets (Lin et al., in preparation). As described previously for odd- versus even-chain MCFA 
(Odle et al. 1991b), C7:0 significantly increased accumulation in both components relative to C8:0. 
The etiology of this chain-length difference remains obscure, but does not appear to be completely 
explained by the substrate-specific differences in metabolic rate (Fig. 4.3). For instance, although 
0 2 consumption was 7% higher in C7:0 cells versus C8:0 cells, C7:0 hepatocytes displayed 
accumulation in ASP and C02 which was -50% higher relative to C8:0 (Figs. 4.2A-B). Odle et 
al. (1991a), in work done with piglet hepatocytes provided [1-14C]-MCFA of different chain-
lengths, explored the hypothesis that odd-chain fatty acids may attenuate ketogenesis by "expansion" 
of the Krebs cycle organic acid pool (anaplerosis) at the level of propionyl-CoA conversion to 
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succinyl-CoA. As in this study (Fig. 4.2B), they reported a higher (by 45%) accumulation of 
carboxyl-carbon in ASP from cells given odd-chain MCFA. Although carboxyl-carbon 
accumulation in citrate/a-ketoglutarate and pyruvate/malate was higher with C7:0 (Table 4.1), the 
accumulation in B-hydroxybutyrate was also higher. Taken together, the results of this report 
(Table 4.1 and Fig. 4.2B) and those of Odle et al. (1991b) do not support the hypothesis that 
anaplerosis of odd-chain MCFA lowers ketogenesis in newborn pigs. 
As expected, valproate significantly lowered accumulation of fatty acid carboxyl carbon in 
ASP by 45%, regardless of fatty acid employed (Fig. 4.2B). This was reflected in a significant 
40-80% drop in carboxyl-carbon accumulation (natom carboxyl-carbon/(h • 106 cells)) in all but one 
of the organic acids identified relative to substrate alone (Table 4.1). The capability of valproate 
to lower B-oxidative flux and ketogenesis has been documented repeatedly in vivo (Thurston et al. 
1981, 1985; Thurston and Hauhart 1992a) and in vitro (Becker and Harris 1983; Coude" et al. 1983; 
Veitch and van Hoof 1990; Ponchaut et al. 1992), and is thought to be due to a combination of 
competition with fatty acid substrate for a limited mitochondrial CoA pool (Becker and Harris 1983; 
Thurston et al. 1985; Ponchaut et al. 1992; Thurston and Hauhart 1992a), and to some degree an 
effect upon B-oxidative enzymes (Ito et al. 1990). Indeed, free CoA was lowered by 32% in cells 
incubated with valproate versus those incubated with substrate alone or with malonate (Fig. 4.4A), 
consistent with CoA sequestration by valproate or its metabolites. There is evidence that carnitine 
may help to relieve some negative effects of valproate in vivo, presumably through formation of 
acyl-carnitine esters which may liberate free CoA. In support of this notion, patients under 
valproate therapy excrete valproyl-carnitine and other medium-chain acyl-camitines (Millington et 
al. 1985; Schmidt-Sommerfeld et al. 1992). The diminished circulating ketone bodies and liver 
CoASH concentration which occurs concomitant with acute valproate or valproate-derivative 
exposure in suckling mice may be overcome by co-injection of carnitine and CoASH precursors 
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(Thurston & Hauhart 1992a,b). However, carnitine addition to isolated piglet hepatocytes failed 
to increase hepatocyte free CoA concentration (Fig. 4.4A), and had no effect upon carboxyl-carbon 
accumulation in ASP or C02 under any condition (Figs. 4.2A-B). Kempen and Odle (in press), 
in studies employing constant infusion of C8:0 in piglets in vivo, found that carnitine co-infusion 
with valproate did not impact liver or muscle CoA profiles relative to animals infused with C8:0 
+ carnitine only. However, initiation of carnitine co-infusion did raise C8:0 oxidation to C02 by 
~l%in vivo, and depressed C8:0-induced dicarboxylic acid excretion by -50% in animals given 
C8:04-valproate (Kempen and Odle, in press). Thus, the precise role of carnitine in alleviating the 
negative effects of valproate upon B-oxidation is not totally clear. 
Inclusion of malonate at 10 mM failed to affect carboxyl-carbon accumulation in ASP, CO% 
(Fig. 4.2A-B), or B-hydroxybutyrate (Table 4.1). Malonate, an inhibitor of succinate 
dehydrogenase, acts to channel acetyl-CoA towards ketogenesis (and acetogenesis) versus entry into 
the Krebs cycle, and would thus be expected to increase radiolabel accumulation in ASP. The lack 
of strong malonate effects upon ASP and C02 in this study might be related to the use of 
hepatocytes versus mitochondria. Consistent with this, incubation of neonatal piglet liver 
homogenates with C16:0 and 10 mM malonate caused an 80% drop in carboxyl-carbon 
accumulation in C02 (by 8 nmol/(mhvg liver)) coupled to an equivalent absolute rise in 
accumulation in ASP (Adams et al., in press). Malonate lowered the rate of citrate formation from 
glucose by 50% in Ehrlich ascites cells (Suzuki et al. 1968), indicating that this inhibitor can impact 
the Krebs cycle in some cell types. It is notable that changes in the carboxyl-carbon accumulation 
profile which were consistent with partial inhibition of succinate dehydrogenase by malonate were 
detected (see Table 4.1). For instance, addition of malonate increased accumulation in succinate 
by 3.6-1.5 fold (C7:0 and C8:0, respectively), depressed accumulation in pyruvate/malate by 25% 
(C7:0 only, p=0.1 for fatty acid*inhibitor interaction), and in fumarate by 39% (C7:0 only). 
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Other studies using valproate in hepatocyte preparations in rats and mice have found that 
although valproate at 1-1.5 mM acts to depress carboxyl-carbon flux to ASP relative to fatty acid 
alone, accumulation in C02 increases by 50-90% (Becker and Harris 1983; Coude" et al. 1983). 
This increase occurs despite markedly decreased (up to 75% lower with valproate-*-CI8:1 vs. 
CI8:1 alone) acetyl-CoA concentration as measured at the end of incubation (Becker and Harris 
1983; Coude" et al. 1983). These results might be explained by a metabolic adjustment in which 
acetyl-CoA becomes increasingly partitioned toward the Krebs cycle in order to gain energy in a 
system in which production of reducing equivalents via B-oxidation has been slowed. In this 
experiment, 0 2 consumption was not affected by inclusion of valproate (Fig. 4.3), indicating that 
cells in our preparation maintained energy status despite attenuated B-oxidation as evidenced by a 
lower accumulation of label in ASP (Fig. 4.2B). The 14% drop in carboxyl-carbon flux to C02 
in the presence of valproate (Fig. 4.2A) may indicate that in the face of markedly diminished 6-
oxidation, piglet hepatocytes began to utilize alternative endogenous energy sources. Relative to 
cells given MCFA alone, acetyl-CoA concentration in cells exposed to valproate was not different 
(Fig. 4.4B). 
Marked changes in the relative flux of fatty acid carbon to C02 versus ASP in hepatocytes 
normally occur with alterations in nutritional status or age in ketogenic species. For instance, in 
hepatocytes isolated from adult rats, relative oxidative flux of C18:1 to C02 drops from about 30% 
to < 10% of total carboxyl-carbon flux during the transition from feeding to fasting (McGarry et 
al. 1978; Ferre et al. 1983). In newborn rabbit hepatocytes given C8:0 or C18:1 substrate, relative 
oxidative flux to C02 changes from -40% at term to < 10% with fasting over 24 h as ketogenic 
capacity develops during this period (Duee et al. 1985; Pegorier et al. 1989). It is believed that 
increases in the relative flux of fatty acid carbon to ASP occurs with fasting due to a rise in B-
oxidative flux and ketogenesis brought about by activation of carnitine palmitoyl transferase I (CPT 
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I) and mitochondrial HMG-CoA synthase by a decrease insulin:glucagon ratio (McGarry et al. 
1975; Quant et al. 1990). Considering the results of this report (Figs 4.2A-B) and the findings of 
other studies examining fatty acid oxidation in newborn piglet hepatocytes, it is concluded that 
substantial alterations in the relative flux of fatty acid carboxyl-carbon into C02 or ASP do not 
occur in newborn pigs. Indeed, the percentage of total carboxyl carbon flux to CO2 remains at a 
level of around 30-40%, regardless of age (e.g., 24-48 h old) and nutritional state (e.g., suckled 
versus fasted)(see Pegorier et al. 1983; Odle et al. 1991b, Lin et al., in preparation; [for oleate, 
see Lepine et al. 1991, 1993]). Some intramitochondrial step in the oxidation of fatty acids may 
be the basis for a stable relative flux, as similar results are obtained regardless of whether long-
er medium-chain fatty acids are used as substrate (Odle et al. 1991b; Lin et al., in preparation; this 
study). 
Free CoA & Acetyl-CoA. The oxidation of fatty acids, which requires free CoA, should 
theoretically increase the level of acetyl-CoA and lower the content of free CoA in hepatocytes. 
Consistent with this, neonatal piglet hepatocytes displayed a free CoA content much lower than that 
in blank preparations (Fig. 4.4A). As noted above, valproate further lowered free CoA 
concentration, probably via formation of valproyl- and other acyl-CoA esters. Across treatments, 
cellular acetyl-CoA content was diminished relative to blanks (Fig. 4.4B). Explanations for this 
finding are only speculative, but it is possible that free CoA became bound in other acyl-CoA 
moeties (i.e., butyryl- and hexanoyl-CoA for cells given C8:0) which were not detectable with the 
HPLC analysis employed. 
Role of Acetate. It is not clear what role acetogenesis plays in the overall metabolism of 
the neonatal pig. We have recently demonstrated that under physiological conditions, oxidation of 
ketone bodies meets less than 3% of a piglet's caloric needs (Tetrick et al., in press). Certainly, 
acetate might serve as a fuel source and/or a fatty acid precursor in tissues possessing acetyl-CoA 
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synthetase. Is acetate analagous to the ketone bodies in newborn pigs? In light of the findings 
reported herein, and recent evidence that circulating acetate levels in 24 h fasted, colostrum-
deprived newborn piglets are 1-2 orders of magnitude higher than B-hydroxybutyrate concentration 
(Adams and Odle, in preparation), one may hypothesize that acetate can be an important metabolite 
in species whose ketogenic capacity is compromised. 
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Figure 4.1. Ion-exchange chromatograph of organic acid standards indicating the collection times for fractions collected 
for determination of radioactivity in acid-soluble product (ASP) samples obtained after incubation of piglet hepatocytes 
with radiolabeled C7:0 or C8:0 (see Materials & methods for incubation conditions and chromatography details). Each 
fraction coeluted with the following organic acids (from left to right): (A) oxaloacetate, citrate, a-ketoglutarate; (B) 
pyruvate, malate; (C) succinate; (D) B-hydroxybutyrate; (E) acetate/acetoacetate; (F) fumarate. 
82 
SUBSTRATE SUBSTRATE VALPROATE VALPROATE 
+ + 
CARNITINE CARNITINE 
MALONATE MALONATE 
+ 
CARNITINE 
SUBSTRATE SUBSTRATE 
+ 
CARNITINE 
Figure 4.2A-B. Accumulation of carboxyl-carbon in C02 (top panel, A) and acid-soluble products (ASP; bottom panel, 
B) from [l-,4C]-radiolabeled C7:0 (crossmatched; C7) and C8:0:0 (filled, C8) plus carnitine or carnitine+inhibitors 
incubated with hepatocytes isolated from 24 h old, colostrum-deprived low-birth-weight (LBW) piglets (incubation 
conditions given in text; n=5 piglets throughout figures). 
•Difference between C7:0 vs. C8:0 (p< 0.0001) 
^"Groups of bars sharing a common letter do not differ (p>0.1). Valproate values significantly lower vs. substrate 
only values (p<0.01 for C02 and p< 0.0001 for ASP) 
No effect of carnitine was observed (p>0.1) 
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SUBSTRATE VALPROATE MALONATE 
TREATMENT 
Figure 4.3. 02 consumption of hepatocytes isolated from 24 h old, colostrum-deprived LBW piglets and incubated for 
20 min with either C7:0 (crosshatched) or C8:0 (filled) substrate ± inhibitors (incubation conditions given in text). 
All cells were incubated with 3 mM carnitine. 
•Difference between C7:0 vs. C8:0 (p< 0.0001) 
No significant effect of inhibitors was observed (p>0.1). 
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BLANK SUBSTRATE SUBSTRATE VALPROATE VALPROATE MALONATE MALONATE 
+ + + 
CARNITINE CARNITINE CARNITINE 
BLANK SUBSTRATE SUBSTRATE VALPROATE VALPROATE MALONATE MALONATE 
+ + + 
CARNITINE CARNITINE CARNITINE 
Figure 4.4A-B. Free CoA (top panel, A) and acetyl-CoA (bottom panel, B) concentrations in hepatocytes isolated from 
24 h old, colostrum-deprived LBW piglets before incubation (blanks) and after incubation with non-radioactive C7:0 
(crosshatched) or C8:0 (filled) substrate ± carnitine with or without inhibitors (incubation conditions given in text). 
'Difference between C7:0 vs. C8:0 observed only for acetyl-CoA (p<0.05). 
•Different from blank value (p< 0.0001-0.01) 
"Different from valproate value (p<0.05) 
No effect of carnitine was observed (p>0.1) 
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Figure 4.5. Example radiochromatogram of uV absorbance (top panel: 1= acetate; 2=acetoacetate; 3=B-
hydroxybutyrate standards) and radioactivity counts (bottom: sample derived from cells incubated with [1-"C]-C7:0 
and carnitine+malonate) observed in acid-soluble products subjected to reversed-phase ion-pairing HPLC coupled to 
on-line B-flowmonitoring (details of procedure and incubation given in text). This method resolves Krebs cycle 
intermediates, acetoacetate and B-hydroxybutyrate, and acetate. The example shows the 2 major radioactive peaks 
present in every sample analyzed from 2 replicates of the experiment. No organic acid standard tested coeluted with 
the first radioactive peak; thus, this fraction remains unidentified. Only minor radioactivity could be attributed to the 
ketone bodies (see Table 4.1 and Fig. 4.6). 
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C7:0 C8:0 
1 0 0 - 1 1 
Figure 4.6. Distribution of acid-soluble product (ASP) radioactivity in acetoacetate (solid bars), acetate (dotted bars), 
and a(n) unidentified compound(s) (crosshatched bars) from hepatocytes isolated from 24 h old, colostrum-deprived 
piglets and incubated with [l-^CJ-radiolabeled C7:0 or C8:0 ± carnitine (CARN) with or without inhibitors (incubation 
conditions in text). Aliquots of ASP across all treatments in 2 replicates were subjected to reversed-phase ion-pairing 
HPLC (see Materials & Methods and Fig. 4.5 legend for details), and peaks eluting with retention times corresponding 
to acetoacetate, acetate, and an unidentified radioactive entity (Fig. 4.5) were collected and counted for radioactivity 
(fractions corresponding to other organic acids were not retrieved). Radioactivity in each peak was corrected for dpm 
determined at equivalent retention times from replicate-and treatment-matched ASP blanks (acid-killed at time 0 
incubation). Blank radioactivity in eluent corresponding to these retention times did not differ across the 3 metabolites 
(data not shown). Values are means over the 2 replicates, and are expressed as a percentage of treatment & replicate-
matched total ASP radioactivity (see Table 4.1 legend). 
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Figure 4.7. Example ion-exchange HPLC chromatograms illustrating the minor radioactivity associated with 
acetoacetate in acid-soluble products (ASP) derived from neonatal piglet hepatocytes incubated with [1-I4C]-C7:0 or 
C8:0. Organic acids in a subset of ASP samples were separated by HPLC as described in Materials & Methods, and 
eluent corresponding to the retention time of acetate/acetoacetate was collected for re-analysis using on-line 
radiochromatography. Prior to re-injection, the collected fraction was divided into 2 portions. After acetoacetate 
standard was added and samples neutralized with concentrated KOH, one portion was treated with B-hydroxybutyrate 
dehydrogenase per Kientsch-Engel & Siess (1985), while the other was treated with an equal volume of buffer. Panels 
A-B depict the radioactivity associated with the retention time of acetate/acetoacetate in the untreated subsample (also 
see Fig. 4.5). Panels C-D (enzyme-treated subsample) illustrate that although a significant amount of added acetoacetate 
was converted to B-hydroxybutyrate (arrow), the elution profile of radioactivity remained unchanged. 
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*V. ACETOGENESIS & PEROXISOMAL B-OXIDATION 
IN THE NEWBORN PIGLET 
ABSTRACT. Recent evidence (Yu, Odle, & Drackley, unpubl.) indicates that the rate of 
peroxisomal B-oxidation (B-Ox) in piglet liver is high (-50% of total) versus the rat (15-30%). 
Radio-HPLC characterization of the acid-soluble products (ASP) produced by piglet hepatocytes 
oxidizing fatty acids have underscored their relatively high degree of acetogenesis vs. ketogenesis 
(Lin et al., in prep.). The extent of peroxisomal B-Ox [1-14C]-C16:0 in liver homogenates derived 
from fasted, day-old piglets and mature 24h-fasted rats was estimated by analysis of total oxidative 
flux (rate of accumulation of carboxyl-carbon in CQj+ASP) in the presence of the electron-
transport poisons antimycin and rotenone (A/R). It is assumed that these inhibitors do not affect 
the rate of peroxisomal B-Ox. The difference in oxidative flux prior to and after inhibition is 
commonly used as an estimate of peroxisomal versus total hepatic B-Ox. Radiolabeled organic 
acids were characterized from ASP in control, A/R, and malonate (Krebs cycle blocker) treated 
liver homogenates. The relative rate of estimated peroxisomal B-Ox in piglet liver was elevated 
(60%) compared to the rat (28%). Total B-Ox in piglet homogenates was only - 3 3 % of that in 
rats, and 02 consumption was 45% lower in piglet homogenates. Subsequently, the absolute rate 
of peroxisomal B-Ox in piglet homogenate was 40-50% of that in rats. Ketone bodies (KB) 
accounted for only 3-7% of carboxyl-carbon accumulation in piglet incubations (vs. 50% in the rat), 
with acetate as the major identifiable organic acid. Interestingly, radiochromatographic separation 
of radiolabeled metabolites in rat and piglet ASP revealed a number of compounds yet to be 
identified. The data provide further evidence for a predominant role of acetogenesis vs. ketogenesis 
in piglets, and suggest that peroxisomal B-Ox in piglets is significant. The assumption that ASP 
are composed primarily of KBs may not be valid under some conditions in the rat. 
*In press: Adams, SH, X Lin, XX Yu, I Odle, & JK Drackley, Proceedings of the 2nd Fatty Acid Oxidation & 
Ketogenesis Conference, Cambridge, U.K., (PA Quant, ed.) 
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Introduction 
Traditional models of fatty acid metabolism in the mammalian liver emphasize the 
accelerated ketogenesis occurring concomitant with a high rate of B-oxidation. Elevated circulating 
concentrations of B-hydroxybutyrate (B-OHB) and acetoacetate (AcAc) are particularly evident 
during the suckling period in many species (see Girard et al. 1992 for a review). Neonatal 
hyperketonemia is thought to be supported by a decrease in the insulin:glucagon ratio, increased 
availability of non-esterified fatty acids (NEFA), a drop in the sensitivity of carnitine palmitoyl-
transferase I to malonyl-CoA, and up-regulation of mitochondrial hydroxymethyl-glutaryl-CoA 
synthase (HMG-CoA synthase) activity via increased gene expression (Serra et al. 1993; Thumelin 
et al. 1993) and enzyme activity (Quant et al. 1991). 
In contrast to other animals, plasma ketone body (KB) concentration in newborn piglets is 
at least an order of magnitude below that of other neonates (Bengtsson et al. 1967; Pegorier et al. 
1981), suggesting a species-specific limitation of ketogenesis in the piglet. Consistent with this 
idea, the rates of acid-soluble product (ASP) generation (nmol carboxyl carbon/(h • 10s cells)) from 
hepatocytes incubated with [1-14C]-C8:0 or [1-14C]-C18:1 are 4- to 8-fold lower in newborn piglets 
(Pegorier et al. 1983; Odle et al. 1991b) relative to neonatal rabbits (Duee et al. 1985; Pegorier 
et al. 1989). In vivo estimates of ketogenic capacity (rise in plasma B-OHB following a medium-
chain fatty acid challenge) have shown negligible capacity in piglets compared to older conspecifics 
and newborn or mature rabbits (Odle et al. 1989, 1991a; Adams & Odle 1993). These data 
prompted the suggestion (Adams & Odle 1993) that attenuation of ketogenesis is intramitochondrial 
in piglets, an idea supported by the finding that mitochondrial HMG-CoA synthase specific activity 
(mU«mg protein"1) in piglets is only 10-25% of that determined in newborn rabbits (Adams & 
Odle, in preparation) or mature rats (Duee et al. 1994). 
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A limited capacity for ketogenesis in newborn swine (Pegorier et al. 1983; Adams & Odle 
1993; Duee et al. 1994), coupled with the lower rate of hepatic B-oxidation in piglets (Pegorier et 
al. 1983; Odle et al. 1991b) versus rats or rabbits (Duee et al. 1985; Pegorier et al. 1989; Duee 
et al. 1994), raises the possibility that alternative (non-ketogenic) routes of carbon flow may 
predominate in piglets. Implementation of radio-HPLC methods to characterize organic acids 
contained in ASP from piglet hepatocyte incubations with radiolabeled C7:0 or C8:0 have revealed 
that carboxyl-carbon accumulation in acetate surpasses that in KB (Lin et al., in preparation; see 
(Lin et al. 1994)). Determinations of the potential contribution of peroxisomes to hepatic B-
oxidation have indicated that a large fraction (i.e., —50%) of fatty acid oxidative capacity may 
reside in peroxisomes in newborn pigs (Yu, Drackley, & Odle, unpublished data). This study was 
initiated to further clarify the hepatic fatty acid oxidation profile in the non-ketogenic piglet via a 
comparison of peroxisomal B-oxidation (antimycin/rotenone-insensitive B-oxidation) and oxidative 
end-products (ASP organic acids) between the newborn pig and mature rat. 
Materials & Methods 
Commercial crossbred piglets collected within 12h of birth (1690 ± 33 g, n=3) and mature 
Sprague-Dawley rats aged >1 yr (284 ± 8 g, n=3) were fasted 24h prior to experimentation. 
Livers obtained from piglets or from rats were placed in ice-cold isolation buffer (Mersmann et al. 
1972), and portions were homogenized manually in 10 volumes of buffer using a Potter-Elvehjem 
homogenizer. Protein yield (mg protein «g wet wt liver1 by biuret method) averaged 420 + 33 and 
238 + 66 for rats and piglets, respectively. Liver mass was 2.4% (rats) and 1.8% (pigs) of body 
weight. 
Homogenate incubations to assess the rates of total and peroxisomal B-oxidation from CI6:0 
were performed using a modification of the technique employed by Grum et al. (in press) as 
follows: 450 /xL homogenate aliquots (40.5 mg liver) were incubated in medium containing 1.0 
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mM L-carnitine, 0.5 mM Na-C16:0 (5:1 palmitate:BSA; plus [1-14C]-C16:0, ICN Biochemicals, 
Irvine, CA), but without malate, in a final volume of 3 mL. Some flasks included 
antimycin/rotenone (A/R, 50/10 iiM) dissolved in ethanol or Na2-malonate (MAL, 10 mM) 
dissolved in buffer (all flasks contained 150 uL ethanol to match A/R flasks). Radioactivity in ASP 
and C02 was determined as previously described (Odle et al. 1991a) after termination of incubations 
with 250 itL of 60% trichloroacetic acid. Peroxisomal B-oxidation was assumed to be the rate of 
accumulation of carboxyl radiolabel in ASP following incubation with A/R. Oxygen consumption 
of homogenates was determined as in (Odle et al. 1991a). 
The ASP samples were subjected to reversed-phase ion-pairing HPLC to characterize the 
radioactivity associated with KB and acetate (Lin et al., in preparation). The acids were separated 
using a mobile phase of 0.3% H3P04 (pH 2.1, 0.65 mL/min) with a Beckman Ultrasphere IP 
column (5 /x, 4.6 x 250 mm), and volumes of eluent with retention times corresponding to 
radioactive peaks of interest (see Fig. 5.1) were retrieved by a fraction collector. Radioactivity in 
these samples was quantified using liquid scintillation spectrometry. Krebs cycle intermediates were 
resolved using ion-exchange HPLC employing a mobile phase of 10.5 mM H2S04 (pH 2.1, 0.65 
mL/min) and a BioRad (Richmond, CA) Aminex HPX-87H cation-exchange column (Lin et al., 
in preparation). Radioactivity in fractions quantified as above indicated that cycle intermediates 
constituted only 1-5% of total ASP radioactivity. 
Data were analyzed by analysis of variance for a split-plot design with species as the main 
plot and treatments as the sub-plot (Statistical Analysis System, Cary, NC). Values are means ± 
SEM. 
Results & Discussion 
fi-Oxidation & Oxygen Consumption. Accumulation of C16:0 carboxyl carbon in oxidative 
end-products (ASP + CO%) is shown in Table 5.1. Malonate, an inhibitor of the Krebs cycle at 
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the level of succinate dehydrogenase, did not significantly affect total B-oxidative flux, but increased 
the percentage of carboxyl carbon in ASP to 96% of total accumulation in piglets (p<0.0001). 
Total oxidation observed in piglet homogenates was just 34-36% (control & MAL) to 61% (A/R) 
of that in rat preparations. These data are consistent with previous work indicating a minimal rate 
of B-oxidation in hepatocytes from fed or fasted piglets when compared with neonatal rabbits or 
mature rats (Pegorier et al. 1983; Odle et al. 1991b; Duee et al. 1985; Pegorier et al. 1989; Duee 
et al. 1994). The basis for relatively low fatty acid oxidation in piglet hepatic tissue is not clear, 
but might be related to a lower tissue-specific metabolic rate and thus a diminished demand for fatty 
acid oxidation to meet cellular ATP requirements (Odle et al. 1991a). Although the rate of Q, 
consumption in control homogenates from piglets was 51% of that in rats (Table 5.1), the total 
oxidation rate of C16:0 was - 65 % lower in piglets, indicating that lower B-oxidation in piglet liver 
is only partially related to a difference in metabolic rate. However, in the system employed for 
this study, such comparisons are confounded by the potential impact of extramitochondrial 
metabolic pathways that consume 02 but are not directly linked to ATP production. Oxygen 
consumption in liver homogenates may be affected by peroxisomal acyl-CoA oxidase and catalase 
activities, which utilize and liberate 02, respectively (Tolbert 1981). In addition, the inclusion of 
ethanol (which acts as a reducing agent) to hepatic preparations has been reported to increase net 
peroxisomal 02 consumption by lowering the rate of the catalase reaction (Tolbert 1981). 
As expected, addition of A/R (electron-transport inhibitors) slowed metabolism significantly 
in both species. Liver 02 consumption fell significantly in the presence of these agents to levels 
that were 45% of controls, while carboxyl accumulation in CCy was lowered by 85% and 95% in 
pigs and rats, respectively (Table 5.1). The diminished but continued 02 consumption of 
homogenates in the presence of A/R (Berry et al. 1983) may be explained by continued activity of 
peroxisomal B-oxidation (A/R-insensitive) and/or incomplete blockage of mitochondrial B-oxidation 
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(see Acid-Soluble Product Analysis). 
The estimated percentage of total B-oxidation rate derived from peroxisomal activity was 
about 2-fold higher (p<0.0001) in homogenates from piglets (60 ± 3%) versus rats (28 ± 0.4%). 
Using similar incubation protocols with liver homogenates, others have made similar estimates of 
the contribution of peroxisomes to total B-oxidation in rats (Kondrup & Lazarow 1985; Veerkamp 
& van Moerkerk 1986). Grum et al. (in press) estimated the percentage contribution of 
peroxisomal B-oxidation in bovine liver to be similar in magnitude (-50%) to that in piglets. 
Although the contribution of peroxisomes versus mitochondria appears elevated in some species 
such as the piglet or the cow, the estimated absolute rate of peroxisomal B-oxidation (ASP in the 
presence of A/R) was 40-50% lower in piglets (Table 5.1) and in cows (Grum et al., in press) 
relative to the fasted rat. Thus, piglets do not have an elevated peroxisomal capacity per se, but 
rather possess a total oxidative capacity per gram of liver that is smaller than the fasted rat (Table 
5.1 and Duee et al. 1994). 
Acid-Soluble Product Analysis. Radioactivity in ASP from incubations of liver preparations 
with radiolabeled fatty acids has been assumed to be associated primarily with the KB in the rat 
(McGarry et al. 1978) and piglet (Lepine et al. 1993). However, observations made in vitro 
(Pegorier et al. 1983; Duee et al. 1994) or in vivo (Odle et al. 1989, 1991a; Adams & Odle 1993) 
have consistently underscored the lack of ketogenic capacity in the piglet relative to other newborns 
or more mature swine. These findings prompted our group to develop HPLC methodology 
designed to clarify better the metabolic end-products of B-oxidation in piglet liver (Lin et al., in 
preparation). As shown in Fig. 5.1, major differences in the pattern of carboxyl-carbon flow to 
various metabolites were observed across species and treatments when ASP samples were subjected 
to reversed-phase chromatographic separation. Six radioactive peaks were observed (Fig. 5.1), but 
only acetate, AcAc, and B-OHB could be positively identified. A number of important observations 
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may be made from the data. First, acetate is the predominant identifiable end-product of fatty acid 
oxidation in the piglet (Fig. 5.1), constituting 17 ± 1%, 31 + 2%, and 17 ± 2% of the total 
carboxyl accumulation in ASP under control, MAL, and A/R treatments, respectively (Fig. 5.2). 
Similar results were obtained from hepatocytes isolated from newborn 24h fasted piglets and 
incubated with [1-14C]-C7:0 or -C8:0 (Lin et al., in preparation; see (Lin et al. 1994)). 
Acetogenesis has long been recognized as an alternative end-product of fatty acid oxidation 
(Knowles et al. 1974; Seufert et al. 1978), but it operates at a rate (nmol C2 equivalents • min1 • mg 
mito protr1) just 2-6% of ketogenesis in mitochondrial preparations from rats (Seufert et al. 1978), 
which is consistent with our control preparations (i.e., carboxyl accumulation in acetate was 9% 
of that in KB for rats). It is probable that the predominance of acetate versus KB as an end-product 
of B-oxidation in piglets does not constitute a markedly up-regulated pathway that is specific to the 
piglet, because the absolute rate of carboxyl accumulation in acetate was not different between 
species (Fig. 5.2). The intracellular sites of acetogenesis in liver are equivocal, but there is 
evidence for acetogenesis in mitochondria (Knowles et al. 1974; Seufert et al. 1974, 1978), cytosol 
(e.g., Crabtree et al. 1989), and peroxisomes (Leighton et al. 1989; Hovik et al. 1991). The data 
in Fig. 5.2 indicate that a significant portion of acetate production may occur intramitochondrially 
in piglets and rats. Addition of MAL caused significant 1.8- and 2.1-fold increases in carboxyl 
accumulation (nmol«min1 «g liver1) in acetate in rats (to 14.2 + 2.3) and piglets (to 18.2 ± 3.8), 
respectively (Fig. 5.2). These data strongly suggest that mitochondrial acetyl-CoA resulting from 
B-oxidation can serve as an acetate precursor when the Krebs cycle is slowed by MAL. Duee et 
al. (1986, 1994), based on the AO/AC16:0-camitine ratio observed during B-oxidation in the 
presence of 10 mM MAL, assumed that Ac Ac was the primary end-product from B-oxidation of 
C16:0-carnitine in piglet liver mitochondria. This finding may be explained by the fact that the 
theoretical ratio is identical for AcAc and acetate. In our study, peroxisomes may have contributed 
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to acetogenesis, because inclusion of A/R did not completely abolish carboxyl accumulation in 
acetate in rats (40% of control) or piglets (60% of control) (Fig. 5.2). Dual sites of acetogenesis 
is supported further by the similar results (Lin et al., in preparation) obtained when piglet 
hepatocytes were incubated with 1-14C-C7:0 or C8:0 ± the inhibitor valproic acid (a poor substrate 
for peroxisomal B-oxidation (Draye & Vamecq 1987; Vamecq et al. 1993). 
Second, it is clear that under all conditions studied, newborn piglet liver homogenates 
produced minimal KB (just 3-7% of ASP carboxyl carbon), in stark contrast to rats (Figures 1-2). 
Carboxyl-carbon accumulation in KB was just 2-5% of that in the rat (Fig. 5.2). The data are 
consistent with the low ketogenesis in isolated piglet hepatic mitochondria compared with the rat 
(Duee et al. 1994), and indicate that the assumption that KB compose the majority of ASP carbon 
in liver preparations from animals with low ketogenic capacity may not be valid. It should be noted 
that under the conditions used, KB accounted for only - 50% of ASP radiolabel in rats (% of ASP 
label in B-OHB and AcAc were, respectively: 22 ± 2% & 33 ± 2% [controls], 9 ± 0.3% & 41 
± 1% [MAL], and 45 ± 3% & 8 ± 0.2% [A/R)). The remaining radioactivity was largely found 
in the unidentified Peaks AC (see Fig. 5.1 legend). While the identification of Peaks AC is not 
yet known, it is of interest to note that Peak A (a peak also observed with piglet hepatocytes 
incubated with [1-14C]-C7:0 or -C8:0: Lin et al., in preparation) accumulated little radiolabel in 
incubations containing MAL or A/R (to -2-15% of controls, see Fig. 5.1). Radiochromatography 
separation of acyl-CoA and acyl-carnitine metabolites of l-14C-fatty acid B-oxidation in rat liver and 
muscle preparations has shown significant radioactivity associated with acyl-CoAs, acyl-carnitines, 
and various other intermediates (Watmough et al. 1988, 1989; Eaton et al. 1993). Whether the 
identities of Peaks AC correspond with these compounds is under current investigation. 
Third, substantial C16:0 carboxyl-carbon accumulation in KB continued in rats despite the 
addition of A/R (Figs. 5.1-5.2). Although accumulation in AcAc and B-OHB fell to 7% and 64% 
102 
of controls (controls: 54.6 ± 5.6 and 35.4 + 2.0 nmol-nuV'g liver'1, respectively) in the 
presence of A/R (Fig. 5.2), KB still accounted for 53% of total ASP under these conditions (see 
Table 5.1). A reduced intramitochondrial environment with A/R (Eaton et al. 1993) was evidenced 
by the dramatic shift of the KB ratio toward B-OHB (Figs. 5.1-5.2 & Berry et al. 1983). 
Production of KB in the presence of mitochondrial inhibitors has been shown previously in rat liver 
preparations (Berry et al. 1983; Mannaerts et al. 1979). The origin of the 2-carbon precursors for 
ketogenesis is unclear when mitochondrial B-oxidation is presumably slowed by electron-transport 
inhibition by A/R (carboxyl accumulation in C02 dropped by 95% in rats: Table 5.1). The data 
might be explained by (a) incomplete inhibition of mitochondrial B-oxidation by A/R or (b) 
carboxyl-carbon shuttling from peroxisomes to mitochondria following peroxisomal B-oxidation of 
C16:0. In the case of (a), peroxisomal B-oxidation rate using traditional estimations (residual ASP 
after A/R treatment) may overestimate the true rate significantly. 
Summary. This study is the first to detail the radiolabeled organic acids included in ASP 
from incubation of piglet liver with [l-14C]-fatty acids, and to our knowledge is one of the few to 
report such compounds in liver preparations from the rat. The data support previous observations 
of low ketogenic capacity in piglets (Pegorier et al. 1983; Adams & Odle 1993; Duee et al. 1994), 
and emphasize the high (relative to ketogenesis) rate of acetogenesis in piglet liver oxidizing fatty 
acids. Piglet liver homogenates display an apparent rate of peroxisomal B-oxidation (% of total B-
oxidation) that is double that of the rat, while having a total B-oxidative capacity per gram of liver 
which is 34% of that in rats. Under some conditions, only 50% of ASP radioactivity from liver 
homogenate incubations resides in the KB in the fasted rat. The physiological role of acetogenesis 
and peroxisomal B-oxidation in piglets remains to be clarified. 
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Table 5.1. Carboxyl carbon accumulation (nmol«min'1 • g liver1) in acid-soluble products (ASP) & C02 from 
incubations of liver homogenates with [1-14C]-C16:0 (0.5 mM, 2-4 /tCi//unol) ± additions of malonate (10 mM) or 
antimycin (50 /*M) & rotenone (10 pM). Animals were fasted 24 hr (see Methods for details). 
Adult 
Rats 
Newborn 
Piglets 
Treatment 
Control 
Malonate 
Antimycin/Rotenone 
Control 
Malonate 
Antimycin/Rotenone 
ASP 
165.7 ± 2O.Oa* 
161.4 ± 15.6a* 
49.9 ± 5.1b* 
50.6 ± 5.8a 
58.3 ± 9.3a 
29.7 ± 1.9b 
C02 
11.4 ± 1.1a 
6.9 ± 0.5b* 
0.6 ± 0.03c 
9.9 ± 1.1a 
2.1 ± 0.3b 
1.3 ± 0.2b 
Total Oxidation 
(ASP + COj) 
177.1 ± 21.0a* 
168.3 ± 16.1a* 
50.5 ± 5.2bf 
60.5 ± 6.6a 
60.3 ± 9.5a 
31.0 ± 1.7b 
o2 
Consumption 
744 ± 141* 
679 ± 223 
341 ± 6 
379 ± 24 
416 ± 10 
168 ± 9 
Values represent means ± SEM for n=3 replicates/treatment 
'Letters within a column denote significant difference within a species (p<0.05) 
"Significantly different versus treatment-matched piglet value (p<0.05); fp=0.07 
*02 consumption was lower in piglets (p<0.01), and an effect of treatment was observed (control=malonate > 
antimycin/rotenone, p<0.01) 
Incubations were for 30 min at 37°C (pH 7.4) 
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Figure 5.1. Example radiochromatograms of the acid-soluble fraction derived from 24h-fasted newborn piglet and 
mature rat liver homogenate incubations with [1-14C]-C16:0 in the absence (control, bottom panel) or presence of 
malonate (middle panel) or antimycin/rotenone (top panel)(incubation details in Methods). Radioactive compounds were 
characterized using a Radiomatics Flo-One B-flowmonitor (Packard Instruments, Meridian, CT). Reversed-phase ion-
pairing HPLC was used to separate Peaks 1-6, which correspond to Unknown A, acetate, acetoacetate (AcAc), B-
hydroxybutyrate (B-OHB), Unknown B, and Unknown C, respectively. Radioactivity in these peaks accounted for 84% 
and 98% of ASP radioactivity in rats and piglets, respectively. Note the predominance of radiolabel in AcAc for 
malonate-treated samples, the relatively higher proportion in B-OHB vs. AcAc in antimycin/rotenone-treated samples, 
and the minimal radioactivity in ketone bodies in piglet samples. 
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Figure 5.2. Accumulation of carboxyl-carbon from C16:0 in the major identifiable organic acids in ASP derived from 
incubation of liver homogenates from fasted rats (left) and fasted piglets (right). Pooled SEM are depicted in the first 
set of bars. Letters correspond to control homogenates (C: substrate only), C+malonate (M), and 
C+antimycin/rotenone (A+R)(incubation details in Methods). Treatments had no effect upon accumulation in the 
ketone bodies in piglets (p>0.1). However, in the rat, accumulation in acetoacetate rose in the presence of M 
(*p<0.05 vs. C) but fell with A+R Cp<0.0001 vs. C & M). Carboxyl-carbon in B-OHB dropped with M 
("p<0.0001 vs. C) and with A+R (**p<0.01 vs. C & M). There was a significant effect of treatment upon 
accumulation in acetate across species, with M causing an increase (*p<0.01 vs. C) and A+R a decrease f*p<0.05 
vs. C and M). 
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VI. ACETATE PRODUCTION FROM B-OXIDATION OF FATTY ACIDS 
IN NEONATAL PIGLETS: in vivo EVIDENCE FOR MITOCHONDRIAL 
ACETOGENESIS AND OBSERVATIONS ON ITS PHYSIOLOGICAL 
RELEVANCE 
ABSTRACT. In vitro studies examining oxidative end-products arising from fatty acid 
metabolism in neonatal swine liver preparations have shown that the accumulation of carboxyl-
carbon in acetate is greater than that in ketone bodies (KB). Furthermore, at the low circulating 
KB levels observed in piglets, <3% of the animals' energy budget may be by KB (Tetrick et al., 
in press). These results imply that acetate may serve a more important role in neonatal piglets 
relative to KB. As a first attempt to explore this possibility, circulating acetate levels were 
measured over the first 2 days of life in pigs. Furthermore, potential indices of ketogenic control 
(activity of the ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase, plasma 
insulin & glucagon levels) were measured in companion studies. Because the intracellular sites of 
acetogenesis in vivo are uncertain, the rise in acetate levels following an intraperitoneal dose of 
mitochondria-specific fatty acid (Na-C4:0) was analyzed as a measure of mitochondrial acetogenic 
potential in vivo (Na-C8:0 was also injected for comparison). Plasma acetate during the newborn 
period in piglets (200-350 iiM) were at least 10-fold higher than KB (< 20 /xM). Values in animals 
with high ketogenic capacity (rat and rabbit) were of the same magnitude (100-200 /xM), but are 
>5 times lower than KB normally observed in these species. It is speculated that the minimal 
ketogenesis observed in piglets may be explained in part by (a) low HMG-CoA synthase specific 
activity (mU/mg mito. protein 4-fold lower than newborn rabbits) and (b) postpartum changes in 
plasma insulin which mirror (and perhaps antagonize the actions of) glucagon. Plasma acetate 
doubled with injection of Na-C4:0 or Na-C8:0 in 24h-fasted piglets, indicating that acetogenesis 
responds actively to increased B-oxidation in vivo in these animals, and that mitochondrial 
acetogenic potential is significant. The data are consistent with the hypothesis that acetate is an 
important energy and/or lipid precursor during the neonatal period of the non-ketotic pig. 
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Introduction 
It has become clear that the intermediary metabolism of fatty acids in newborn piglets differs 
substantially from that observed in previously-studied neonatal mammals. In particular, the 
enhancement of hepatic ketogenesis (and raised circulating ketone body concentration) which occurs 
concomitant with the onset of suckling in rats (Robles-Valdes et al. 1976), humans (Lucas et al. 
1981), and guinea pigs (Duee et al. 1983) is not characteristic of newborn swine. This is the result 
of poor ketogenic capacity (Adams & Odle 1993; Duee et al. 1994; Adams et al., in press; Lin et 
al., in preparation) and relatively low rates of B-oxidation (Pegorier et al. 1983; Odle et al. 1991b; 
Duee et al. 1994; Adams et al., in press) in the hepatocyte. Ketogenesis in piglets remains 
negligible even in the face of in vivo (Odle et al. 1989; 1991a; Adams & Odle 1993) or in vitro 
(Pegorier et al. 1983; Adams et al., in press; Lin et al., in preparation) provision of medium-chain 
fatty acids (MCFA: 6-12 carbons), which diffuse into hepatic mitochondria and thus bypass 
ketogenic control at carnitine palmitoyl transferase I (CPT I)(see Hamosh et al. 1992). 
Our analysis of the organic acid profile of the acid-soluble products (ASP) derived from 
piglet hepatocyte preparations incubated with [1-,4C]-C7:0, C8:0, or C16:0 have proven that, unlike 
in the rat (McGarry et al. 1977, 1978; Adams et al., in press), ketone bodies represent a nominal 
reservoir (i.e., -7-10% of organic acids resolved and identified by HPLC) of carboxyl-carbon 
during B-oxidation in this species (Adams et al., in press; Lin et al., in preparation). The organic 
acid characterization in piglet preparations led to the novel finding that free acetate could account 
for up to 75% of identifiable organic acids resulting from B-oxidation of C7:0 or C8:0 (Lin et al, 
in preparation). Endogenous (non-bacterial) production of acetate by the liver has been shown 
previously (e.g., Seufert et al. 1974, 1978; Leighton et al. 1989), but acetate is a minor end-
product of hepatic B-oxidation relative to ketone bodies in the rat (Seufert et al. 1978; Adams et 
al., in press). It is possible that acetate serves a more important role than ketone bodies in newborn 
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swine. At the low circulating ketone body concentrations observed in vivo (Bengtsson et al. 1967; 
Pegorier et al. 1981; Innis et al. 1993), ketone bodies provide only <3% of the daily caloric needs 
of day-old piglets (Tetrick et al., in press). However, the extent of acetate oxidation to CO% in 
piglets is not known. 
Studies with liver tissue indicated that free acetate production from fatty acids can occur in 
mitochondria (Seufert et al. 1978), peroxisomes (Leighton et al. 1989; Hovik et al. 1991), and the 
cytosol (Crabtree et al. 1989). Fatty acid carbon accumulation in acetate was altered substantially 
when piglet hepatocytes or liver homogenates were incubated in the presence of mitochondrial 
inhibitors (Adams et al., in press; Lin et al., in preparation), suggesting a mitochondrial 
contribution to acetogenesis in pigs. 
The in vivo work described herein is an extension of our in vitro experiments examining 
acetogenesis in piglet liver (Adams et al., in press; Lin et al, in preparation). As an initial attempt 
to describe the physiological relevance of acetate to the neonatal pig, plasma acetate concentration 
was determined in fed or fasted piglets through the first 2 days of life. The potential for 
mitochondrial acetogenesis was assessed by quantifying the increase in plasma acetate following an 
acute intraperitoneal dose of Na-C4:0 (mitochondrial substrate) or Na-C8:0 (mitochondrial and, to 
some extent, peroxisomal substrate: Lazarow 1978). A rise in circulating acetate following fatty 
acid injection should reflect whether acetate production is responsive to increased B-oxidation, with 
the changes following C4:0 injection associated with mitochondrial metabolism. These studies 
confirmed that the acetogenic potential of mitochondria is significant in piglets. Consistent with 
a more important role for acetogenesis versus ketogenesis in the newborn piglet, acetate 
concentration in plasma was at least 10-fold higher than the ketone bodies, and doubled with an 
acute dose of C4:0 or C8:0. Companion studies measuring mitochondrial 3-hydroxy-3-
methylglutaryl CoA synthase (mtHMG-CoA synthase, E.C. 4.1.3.5) activity and plasma insulin and 
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glucagon were carried out to probe the etiology of low ketogenesis in newborn piglets. The 
patterns observed may in part explain why ketone body production is minimal in piglets. 
Materials & Methods 
Chemicals. Reagents for radioimmunoassay of glucagon and insulin (see below) were 
purchased from Linco Research, Inc. (St. Louis, MO). Acetoacetyl-CoA and 1,4-dithiothreitol 
(DTT) were from ICN (Costa Mesa, CA), phosphotransacetylase (PTA: E.C. 2.3.1.8) was 
purchased from Boehringer Mannheim (Indianapolis, IN), and tris-hydroxymethyl-aminomethane 
(Tris) and MgCl2 were from from Baker (Phillipsburg, NJ) and Fisher (Pittsburgh, PA), 
respectively. The sodium salt of [l-14C]-acetate used in chromatography method development was 
from Research Products International (Mt. Prospect, EL). All other chemicals were purchased from 
Sigma (St. Louis, MO) and included: bovine serum albumin, Na-butyrate, Na-octanoate, B-
nicotinamide adenine dinucleotide (B-NAD & B-NADH), ethylenediamine-tetraacetic acid (EDTA), 
phenazine methosulfate, Na-D-(-)-B-hydroxybutyrate, Li-acetoacetate, bathophenanthroline 
disulphonic acid, triethanolamine-HCl, acetyl-CoA, acetyl-PQ*, B-hydroxybutyrate dehydrogenase 
(E.C. 1.1.1.30), and pure fatty acid standards. 
Animals & Blood Sampling Protocol. All work was approved by the University of Illinois 
Laboratory Animal Care Committee. Commercial crossbred piglets (birthweight 1850 ± 70 g: 
mean ± SEM) were obtained from the University of Illinois Moorman Swine Farm or from a local 
swine farm. For the study of changes in acetate, hormone, and ketone body concentrations over 
the first 2 days postpartum in piglets, newborn animals from attended farrowings were assigned 
randomly to the following groups: newborn unsuckled (0.5-2h old; n=6), 24h old unsuckled (n=5, 
except n=10 for hormones and ketone bodies), 24h old suckled (n=5), and 48h old suckled (n=5). 
Blood was obtained in heparinized Vacutainer tubes (Becton-Dickinson, Rutherford, NJ) by jugular 
venipuncture at the following times postpartum: 0.5-2h (newborns), 24h (unsuckled & suckled), 
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and 48h. The exact time of the last feeding prior to sampling of suckled animals was not recorded. 
Blood was kept on ice, centrifuged at 5000 x g at 4°C, and plasma frozen at -70°C until analysis. 
For comparative purposes, plasma acetate was determined in samples derived from blood collected 
by cardiac puncture from pentobarbitol anesthetized (0.1 mg/g) suckling rabbits aged 1 day (24-36h, 
1 litter) or 2 days (48-60h, 1 litter)(n=6/litter). Previously-frozen (-70°C) serum samples (pooled 
within litters) from land 2 day-old suckling Sprague-Dawley rat pups (n=3 litters/age) were kindly 
provided by Dr. Sharon Donovan, University of Illinois Division of Nutritional Sciences. 
For comparative analysis of mtHMG-CoA synthase specific activity (mU/mg mitochondrial 
protein), newborn piglets obtained prior to suckling (727 ± 35 g, n=5), 3.5 week old newly-
weaned (within 48h) pigs (2729 + 173 g, n=6), and newborn (24-36h old at sampling) once-
suckled rabbits (54 ± 3 g, n=7) were used following a 24h fast. After pentobarbitol administration 
(20 mg/kg) in pigs or C02/ketamine anesthesia in rabbits (Adams & Odle 1993), livers were 
excised and processed as described for mtHMG-CoA synthase below. 
Fatty Acid Injections For Assessment of Mitochondrial Acetogenesis. Twenty-four hour-
old unsuckled piglets from attended farrowings (1200 ± 50 g at the time of the study) were injected 
intraperitoneally with either Na-C4:0 (5.0 mmol/kg075, n=3) or Na-C8:0 (2.5 mmol/kg075, n=3). 
These doses were designed to raise circulating C4:0 or C8:0 levels without induction of coma 
associated with high exposure to MCFA (Wieland et al. 1993a), and delivered equivalent moles of 
potential 2-carbon precursors for each chain-length. Blood was collected serially by jugular 
venipuncture prior to fatty acid injection (tO), and at 15 min (tl5), 30 min (60), and 60 min (t60) 
post-injection. Plasma was then obtained as above prior to freezing at -70°C. 
Ketone Body & Hormone Analyses. Deproteinized plasma was analyzed for ketone bodies 
using the method of Kienstch-Engel & Siess (1985) as modified by Adams & Odle (1993). The 
concentration of acetoacetate was taken to be the difference in [B-OHB] of aliquots of a given 
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sample before and after processing with B-hydroxybutyrate dehydrogenase + NADH. Insulin and 
glucagon were determined using standard radioimmunoassay procedures (Linco Research, St. Louis 
MO) based on guinea pig-derived anti-porcine insulin serum and anti-porcine glucagon serum 
(pancreatic specific), normal guinea pig carrier, goat anti-guinea pig IgG, and 125I-labeled insulin 
or glucagon. 
Analysis of Volatile Fatty Acids (VFA). Plasma samples were analyzed using a modification 
of the gas-liquid chromatography (g.l.c.) method of Remesy & Demigne (1974). To precipitate 
protein and extract volatile fatty acids, -2-3 volumes of ice-cold 100% ethanol was added to 
plasma (450-700 itL) combined with internal standard (0.1 itmol isobutyric acid). Samples were 
centrifuged at 13000 x g for 10 min at 4°C, and the supernatant was added to microcentrifuge tubes 
containing 6 itmol NaOH (final pH= - 8). Contents were evaporated to dryness using a Speedvac 
(Savant, Farmingdale, NY). Prior to injection, samples were re-dissolved in 80 /xL of ice-cold 
6.25% metaphosphoric acid, and clarified by centrifugation (4000 x g 15 min at 4°C) through 0.45 
tim nylon microcentrifuge tube filter units (Lida Manufacturing Corp., Kenosha, WI). Samples 
were placed into 200 uL autosampler vial inserts in crimp-top vials, loaded onto a Hewlett-Packard 
HP 7673 autosampler (Hewlett-Packard, Wilmington, DE), and 2 iiL were injected into a Hewlett-
Packard HP 5890 Series II gas chromatograph. This system employed a Supelco (Bellefonte, PA) 
GP 10% SP-100/1% H3PO4 on 80/100 Chromosorb WAW column (6 ft. x 4 mm i.d.), with N2 (73 
mL/min) carrier, injector temperature 175°C, oven temperature 125°C, and a flame ionization 
detector (FID) set at 180°C. Water injections chromatographed between each sample eliminated 
sample carryover (column "memory"). Conversion factors (/tM/FID peak area) and assay linearity 
were determined each day from standards (fatty acid chain-lengths C2-C5, including isobutyrate and 
isovalerate) covering the range of sample concentrations. No loss of acetate or isobutyrate was 
observed in samples through at least 12h or mixed standards in crimp-top vials over 5 days at room 
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temperature (data not shown). The gas chromatographic method separated VFA and medium-chain 
fatty acids through at least C6:0 with high resolution based on analysis of VFA and C6:0 mixed 
standards (see Fig. 6.3). The coefficient of variation averaged 4% over all samples analyzed. 
Because some authors have cautioned that acetate concentration may be artifactually elevated 
due to environmental contamination (David et al., 1994), the equivalency of acetate and isobutyrate 
recovery was checked via the following procedures. Mixed standards were processed through the 
normal procedure, and the recovery of individual volatile fatty acids was determined by comparison 
of FID peak areas relative to those from standards directly injected. In our hands, recovery was 
consistently 10% higher for acetate versus isobutyrate (confirmed by recovery of radioactivity in 
a subset in which Na-[l-14C]-acetate had been added along with standards). Thus, all samples were 
adjusted to account for this difference in recovery, and acetate recovery calculated in this manner 
averaged 74 + 1%. When recovery of acetate through processing was checked based on recovery 
of radioactivity in 2 piglet plasma samples in which Na-[l-14C]-acetate had been added, it was 68% 
& 76%-similar to typical sample acetate recovery estimates. No contamination of acetate in assay 
reagents could be detected when individual reagents were subjected to chromatography. 
Mitochondrial HMG-CoA Synthase. Livers obtained from 24h fasted animals (see above) 
were placed in ice-cold isolation medium (220 mM mannitol, 70 mM sucrose, 2 mM HEPES, 0.1 
mM EDTA, pH 7.2: after Mersmann et al. 1972), blotted dry, and weighed. Minced portions were 
homogenized manually with 2 strokes of a Potter-Elvehjem homogenizer, using a ratio of 1:4 
sample:buffer (w/v), and centrifuged 5 min at 600 x g (4°C). Supernatant was centrifuged at 
15000 x g for 20 min, and the resulting pellet washed and re-centrifuged 2 times in isolation buffer. 
Pellets were resuspended to a concentration of -20-40 mg protein/mL, which was diluted further 
when necessary. Protein was determined by the biuret method using bovine serum albumin as 
standard. Mitochondria were treated with a 20% (w/v) solution of Triton X-100 in a ratio (v/v) 
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of 13.3:1 (mito. suspension:Triton X-100) and vortexed. Mitochondrial HMG-CoA synthase 
activity was measured using a modification of the spectrophotometric method described by Quant 
et al. (1989). Reagents were added into a 30°C water-jacketed cuvet and had the following final 
concentrations in a total volume of 1 mL: Tris (50 mM, pH 8.1), MgClj (10 mM), DTT (200 
itM), acetyl-P04 (5.5 mM), acetoacetyl-CoA (10.5 itM), acetyl-CoA (260 /xM), and PTA (10 U). 
After mixing, the reaction was started by the addition of 5-10 /xL mitochondrial suspension, and 
the initial linear rate of disappearance of the enol-form of acetoacetyl-CoA was monitored as the 
change in OD303 over 30 s (Quant et al. 1989). Reagent blanks included all components except 
mitochondria which were replaced by the same volume of isolation buffer/Triton X-100, and an 
absorbance detection limit was calculated daily based on blank absorbances. Mitochondrial HMG-
CoA synthase activity was calculated based on an extinction coefficient of 12.2*10 M"1 -cm1 for 
the enol-form of acetoacetyl-CoA (Lowe and Tubbs 1985), with 1 unit defined as activity effecting 
the conversion of 1 ximol acetoacetyl-CoA to product* min'1. Pilot studies indicated that to measure 
activity in pig samples, it was necessary to add > 100 /xg of mitochondrial protein/cuvet due to 
their low enzyme activity. Similar to the rat synthase (Quant et al., 1989), neonatal rabbit enzyme 
activity could be measured at least down to 20 xxg protein/cuvet (data not shown). 
Statistics. Differences in means across ages and nutritional state were assessed using the 
general linear models (GLM) procedure of SAS for a completely randomized design, followed by 
comparison of least squares means (SAS Institute, Gary N.C.). Changes over time post-injection 
of fatty acid were analyzed by the repeated measures analysis of variance (AOV), followed by 
single degree of freedom contrasts (SAS). Means + SEM are reported. 
Results 
Postpartum Acetate & Ketone Body Concentrations. Plasma acetate concentrations were 
quite variable, as seen in the wide ranges observed (Table 6.1). No significant effect of age or 
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suckling status was detected for newborn piglets (p>0.1). The concentration of acetate averaged 
across all groups of piglets (291 ttM) was of the same magnitude as that observed in the other 
species. Plasma ketone bodies (data not shown) were not detectable (<2 itM) in newborns or 24h 
unsuckled piglets, and were very low in 24h and 48h suckled animals (<20 uM). 
Pancreatic Hormones. Suckling status and age had a significant (p<0.01) impact upon 
plasma insulin and glucagon concentrations (Fig. 6.1 A). Insulin level with 24h of suckling (94 + 
16 pM) was 4.5- to 5.2-fold higher than that observed in 24h old unsuckled or newborn animals, 
respectively. Insulin fell slightly between 24h and 48h suckling (p^O.Ol), remaining at a level by 
48h (68 ± 6 pM) which was 3.2- to 3.8-fold higher than fasted or newborn animals. A 
qualitatively similar pattern held for glucagon, whose concentration at 24h suckling (108 ± 37 pM) 
was 3.6- to 2.6-fold higher versus 24h fasted and newborn piglets, respectively (Fig. 6.1 A). 
Concentration of glucagon at 48h of age (97 + 14 pM) was similar to that observed in 24h suckled 
pigs (p>0.1), and was 3.2- to 2.3-fold higher relative to 24h old unsuckled and newborn animals. 
Insulin and glucagon concentrations in unsuckled animals were not different than in newborns 
(p>0.1)(Fig. 6.1 A). 
From - 1 hr postpartum through 24h of suckling, the mean insulin:glucagon molar ratio 
(I:G ratio) rose 2.4-fold to a ratio of 1.08 ± 0.32 (Fig. 6. IB). The ratio dropped by 48h suckling 
to 0.64 ± 0.08 (p<0.05 versus 24h suckled), reaching a level not statistically different (p>0.1) 
from the newborn value of 0.45 + 0.07 (Fig. 6. IB). Although the concentrations of hormones did 
not differ statistically between 1 hr old and 24h unsuckled pigs (see above), the 30% fall in 
glucagon during this time (Fig. 6.1 A) yielded a significantly higher I:G ratio (p=0.05) in the 24h 
unsuckled pigs (Fig. 6. IB). 
Volatile Fatty Acids (VFA) Following Na-C4:0 or Na-C8:0 Injection. The tO plasma 
acetate concentration (i.e., the 24h old, unsuckled value) did not differ (p>0.1) between piglets 
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receiving either Na-C4:0 or Na-C8:0 (135 + 31 /xM and 105 + 31 /xM, respectively). However, 
the tO concentrations of these piglets were less than previous animals (c.f., Table 6.1). 
Intraperitoneal administration of Na-C4:0 or Na-C8:0 elicited a prompt rise in plasma acetate 
concentration in piglets (Fig. 6.2A). By 15 min post-injection, plasma acetate had risen by - 2 -
fold relative to tO (p<0.0001). The concentration remained high through the 60 min time-frame 
of the experiment (Fig. 6.2A). 
Unexpectedly, significant FID peaks with retention times corresponding to C4:0 and C6:0 
appeared in chromatographs of samples obtained from animals given Na-C8:0 (Figs. 6.2B-6.3). 
These compounds were not observed in samples taken from animals at tO (Fig. 6.2B), nor were 
they noted in any chromatographs of the samples from the suckling or fasting neonates used to 
derive the data in Table 6.1 (not shown). In samples from Na-C4:0-injected animals, only C4:0 
was detected (see Fig. 6.2 legend). In the Na-C8:0-injected animals, plasma C4:0 and C6:0 levels 
rose to maxima of 88 ± 11 /xM and 135 ± 11 xxM (respectively) at OO, and then fell to 42 + 12 
iiM and 27 + 13 /xM by 60 min post-injection (Fig. 6.2B). 
Mitochondrial HMG-CoA Synthase. The specific activity of mtHMG-CoA synthase was 
significantly lower (p<0.0001) in pigs versus fasted newborn rabbits (Fig. 6.4). The activities 
measured in 24h old unsuckled and fasted weaned pigs (5.0 + 0.4 and 5.6 + 0.8 mU/mg 
mitochondrial protein, respectively) were only 27% of that observed in neonatal rabbits. 
Discussion 
Circulating Acetate During the Neonatal Period. The in vitro finding that fatty acid 
carboxyl carbon accumulation in acetate surpasses that in ketone bodies in the newborn piglet liver 
(Adams et al., in press; Lin et al., in preparation) prompted an evaluation of circulating acetate 
concentration in piglets. To our knowledge, this study represents only the second to examine 
developmental aspects of blood acetate in neonates (see also Buckley and Williamson 1977). At 
119 
all time periods, plasma acetate concentrations in piglets (Table 6.1) were at least an order of 
magnitude higher than the ketone body concentrations normally observed during this time 
(Bengtsson et al. 1967; Pegorier et al. 1981; this study). Although suckling rabbits and rats had 
acetate concentrations of similar magnitude to piglets (Table 6.1), the levels observed (80-200 /xM) 
are just a fraction of ketone body concentrations characteristic of these species (up to 1000-2500 
/xM) during suckling or fasting in the perinatal period (Robles-Valdes et al. 1976; Callikan et al. 
1979). The plasma acetate concentration in newborn or suckling rats has been reported to be 
between 100-200 uM (Knowles et al. 1974; Buckley and Williamson 1977), values which compare 
favorably with the ranges given in Table 6.1. Freeman et al. (1993), in a study of acetate turnover 
in piglets, reported that peripheral blood acetate concentration was <30 uM. The plasma acetate 
levels reported herein for newborn piglets (Table 6.1) are substantially higher than those determined 
with HPLC techniques by Freeman et al. (1993). This discrepancy is likely due to methodological 
differences, because Freeman's group: (a) pooled data from a wide range of piglet ages (1-6 days 
old), (b) fed piglets an artificial sow-milk replacer since birth, and (c) used anesthetized animals. 
It should be noted that when plasma acetate concentration was determined by g.l.c. in 12h 
overnight-fasted normal adult humans (n=4, 71 + 6 kg), we obtained values (73 + 8 /xM, range 
59-88 /xM) similar to those reported elsewhere (Chalmers 1982; Pomare et al. 1985; Wolever et 
al. 1993). 
The acetate levels in piglets (Table 6.1) are consistent with the hypothesis that the 
physiological role of acetate (i.e., its use for oxidation and lipid synthesis) is more important than 
that of ketone bodies in newborn swine. At the low circulating ketone bodies observed in suckling 
neonatal piglets (< 100 /xM: Bengtsson et al. 1967; Pegorier et al. 1981; Innes et al. 1993; this 
study), <3% of the animal's caloric demand may be met by ketone body oxidation (Tetrick et al., 
in press). Whole-body oxidation of ketone bodies is a linear function of plasma concentration at 
120 
physiological levels of ketone bodies in 1-2 day old piglets (Tetrick et al., in press). To our 
knowledge, this relationship has not been tested extensively for acetate in newborns, but in adult 
humans (Skutches et al. 1979) and sheep (Annison et al. 1967) turnover/oxidation of acetate is 
proportional to blood concentration. Data for femoral arterial-portal venous concentration 
differences of acetate in 1-6 day old piglets (Freeman et al. 1993) suggest that uptake of acetate is 
a linear function of acetate concentration in some tissues. Although portal acetate concentration 
was increased from 46 to 333 itM via intracolonic acetate infusion (Freeman et al. 1993), the 
percentage uptake of acetate across the liver, heart, and lungs remained stable at - 40%. A strong 
linear relationship between acetate concentration and tissue uptake has also been noted across the 
sheep hindlimb (Knowles et al. 1974; also see Crabtree et al. 1987) and in the periphery of the rat 
(Buckley and Williamson 1977). Thus, it is speculated that the high (relative to ketone bodies) 
concentration of acetate in neonatal piglets may reflect a greater utilization (i.e., oxidation) of 
acetate versus ketone bodies in the non-ketotic newborn piglet. The circulating acetate 
concentrations determined in other neonates (Table 6.1; also see Knowles et al. 1974; Buckley and 
Williamson 1977) are not insignificant; however, the physiological relevance of this metabolite 
during the neonatal period in mammals is not yet clear. 
Newborn and 24h old unsuckled piglets, in whom gut fermentation would be nominal, 
maintained a plasma concentration of acetate equal to that observed in suckled pigs (Table 6.1), a 
pattern similar to what is observed in newborn and suckling rats (Buckley and Williamson 1977). 
The precursors for and tissue source(s) of blood acetate in newborn, suckling, or fasted piglets 
could not be determined from the data in this report. In theory, acetate may be derived from gut 
fermentation or endogenous production from fuels giving rise to acetyl-CoA. In vivo, acetate 
production from fatty acids has been demonstrated to occur to some degree in cows or sheep 
(Palmquist 1972), and in vitro in the liver of rats (Knowles et al. 1974; Seufert et al. 1974, 1978; 
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Crabtree et al. 1989; Leighton et al. 1989) and piglets (Adams et al., in press; Lin et al., in 
preparation). Initiation of suckling over 24-48h in piglets yields a > 3-fold rise in non-esterified 
fatty acids (Swiatek et al. 1968; Pegorier et al. 1981; Lepine et al. 1989), which could serve as 
acetate precursors. Perhaps it is noteworthy that blood pyruvate levels almost double in newborn 
piglets fasted from birth, in contrast to suckled animals in which no change occurs (Pegorier et al. 
1981). Whether metabolism of pyruvate to acetate could help explain the maintenance of plasma 
acetate with 24h of fasting in neonatal pigs (Table 6.1) is not known. Non-hepatic acetogenesis is 
not well-characterized, but acetate production has been noted in such diverse tissues as rat and 
sheep heart (Knowles et al. 1974) and hamster brown adipose tissue (see Bernson 1976). Acetyl-
CoA hydrolases exist in liver, brain, kidney, muscle, lung, brown adipose, and testes of some 
animals (i.e., Knowles et al. 1974; Bernson 1976; Robinson et al. 1976; Matsunaga et al. 1985), 
but to our knowledge activities have not been measured in swine. 
Evidence for Mitochondrial Acetogenesis & Chain-Shortening of C8:0 in vivo. In vitro, 
rat liver mitochondria (Seufert et al. 1978) and peroxisomes (Leighton et al. 1989; Hovik et al. 
1991) are capable of acetogenesis. We observed accumulation of fatty acid carbon in acetate 
following incubation of piglet liver preparations with C7:0, C8:0, or C16:0 (Adams et al., in press; 
Lin et al., in preparation), but from these studies the capacity for mitochondrial acetogenesis per 
se was equivocal. The idea that mitochondria contribute to acetate production in piglets was 
supported by studies (Adams et al., in press; Lin et al., in preparation) showing that accumulation 
of fatty acid carboxyl-carbon in acetate doubled with addition of malonate (a Krebs cycle blocker), 
and was diminished by 60% in the presence of valproate (mitochondrial B-oxidation inhibitor shown 
not to inhibit peroxisomal B-oxidation of C8:0 in rats: Vamecq et al. 1993). Mitochondrial 
acetogenesis in piglets was tested by following plasma acetate after an injection of Na-C4:0 (Fig. 
6.2A). The chain-length specificity of the enzymes involved with B-oxidation in rat liver 
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peroxisomes preclude the oxidation of C4:0 in these organelles (Lazarow 1978; Osmundsen 1982; 
Shindo & Hashimoto 1978; Skorin et al. 1992). Hepatic peroxisomal B-oxidation of C8:0 may 
occur (Lazarow 1978; Vamecq et al. 1993; Skorin et al. 1992), but at a rate which is only -30% 
of the rate for C12:0 (Lazarow 1978; Skorin et al. 1992). Thus, the data in Fig. 6.2A strongly 
support the hypothesis that a significant mitochondrial acetogenic capacity exists in newborn piglets. 
For example, 15 min following a dose of Na-C4:0, plasma acetate had risen by 100% (Fig. 6.2A). 
This rise reflects a marked increase in mitochondrial acetogenesis from C4:0 if the following 
assumptions are true: (1) chain-length specificity of peroxisomal B-oxidation in piglets is the same 
as in the rat, and (2) the increased circulating concentration of acetate in unsuckled, fasted piglets 
following Na-C4:0 injection is proportional to increased endogenous production of acetate (i.e., rate 
of appearance, RJ by the liver or other tissues. The equivalent rise in acetate concentration with 
injection of Na-C8:0 (Fig. 6.2A) is more difficult to interpret, because this fatty acid may also be 
metabolized by peroxisomes to some degree (see above). Although the data strongly support a role 
for mitochondria in acetogenesis in newborn piglets, peroxisomal acetate production cannot be ruled 
out. 
The increase in plasma acetate following Na-C8:0 injection is in marked contrast to the 
minimal increase in ketone bodies (to a maximum of <50 xiM plasma B-hydroxybutyrate) observed 
in newborn piglets subjected to a similar protocol (Adams & Odle 1993). This low ketogenic 
response to a fatty acid challenge was again observed in piglets given Na-C4:0 or Na-C8:0 in a 
preliminary study (data not shown). This phenomenon supports the view that acetogenesis from 
fatty acid oxidation predominates over ketogenesis in newborn pigs. 
It was surprising to find FID peaks corresponding to compounds eluting with the retention 
times of C4:0 and C6:0 in samples from piglets given Na-C8:0 (Figs. 6.2B-6.3). The sharp rise 
in these fatty acids in plasma by 15 min post-injection (Fig. 6.2B) indicates that the oxidative and 
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esterification pathways for C8:0 could be overcome by an acute dose of medium-chain fatty acid 
(MCFA), leading to alternative fates of acyl-CoA metabolism such as direct hexanoyl- or butyryl-
CoA hydrolysis. It is hypothesized that this chain-shortening phenomenon occurs in tissues whose 
metabolic capacity for C8:0 becomes saturated, yielding non-esterified fatty acid "by-products" 
which enter the bloodstream for further metabolism or excretion. The C4:0 and C6:0 concentration 
fell after reaching their peaks (Fig. 6.2B) in a similar fashion to what is observed when they are 
given orally to piglets in the form of triacylglycerols (Wieland et al. 1993b; Odle et al. 1994). 
Although the production of chain-shortened non-esterified fatty acyl moieties during B-oxidation is 
unusual, it has recently been described in mature rabbits infused with a total parenteral nutrition 
formula containing tri-C9:0 (Linseisen & Wolfram 1993). These workers demonstrated that such 
a regimen induced a rise in plasma concentrations of C3:0 and C5:0. Hydrolases specific to 
shorter-chain fatty acyl-CoA have not been described to our knowledge, but other acyl-CoA 
hydrolases have been reported in the rat (see Odmundsen et al. 1994). Because our experimental 
system employed an unphysiological substrate (C8:0) at high doses, it is not known what impact 
such alternative routes of fatty acid metabolism have on normal lipid metabolism. However, the 
increasing use of MCFA in infant formulas and parenteral nutrition solutions (Lima 1989) suggests 
that this area deserves further study. 
Insulin & Glucagon. Current dogmas (see Girard et al. 1992 for review) ascribe to the 
view that immediately following birth (within lh), the plasma concentration of insulin falls and 
glucagon rises. This pattern has been observed in newborn rats (Girard et al. 1977), rabbits 
(Callikan et al. 1979), humans (Sperling et al. 1974), and pigs (Pegorier et al. 1981). In rats, 
insulin remains low and glucagon high throughout suckling (Girard et al. 1977). The pattern for 
other neonates during suckling is poorly-characterized, but it is often inferred from the rat data 
(i.e., Girard et al. 1977; Girard et al. 1992) that a similar diminished insulin:glucagon (I:G) molar 
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ratio persists until weaning. Piglets do not adhere to this model of insulin and glucagon changes 
during suckling. Indeed, upon initiation of feeding, the insulin level rose by about 5-fold in concert 
with a sharp increase in glucagon (Fig. 6.1 A). An identical pattern has consistently been reported 
in newborn swine (Pegorier et al. 1981; Lepine et al. 1989; for insulin: Swiatek et al. 1968). The 
insulimglucagon ratio rose 2.4-fold in the first 24h of life in the piglet (Fig. 6.2B), an increase 
similar in magnitude to the 2.5- and 1.5-fold increases in the mean I:G ratios demonstrated over 
the same time period in pigs by Pegorier et al. (1981) and Lepine et al. (1989), respectively (note: 
Lepine et al. reported no change in the I:G ratio, but a rise is noted upon recalculation of their Oh 
old data). 
Glucagon is commonly considered to be a ketogenic hormone in that it enhances entry and 
oxidation of long-chain fatty acids in hepatic mitochondria by lowering hepatic malonyl-CoA 
concentration concomitant with attenuation of lipogenesis via inhibition of acetyl-CoA carboxylase 
(see reviews by Geelen et al. 1980; McGarry & Foster 1980; Unger 1985). This effects an 
increase in carnitine palmitoyltransferase I (CPT I) activity, thereby raising the rate of acyl-
camitine formation and thus B-oxidation/ketogenesis. In addition, glucagon depresses 
intramitochondrial succinyl-CoA content (Siess et al. 1980) and thereby releases the inhibition of 
this metabolite upon mtHMG-CoA synthase (Quant et al. 1989, 1990). Expression of the gene 
encoding mtHMG-CoA synthase (and the liver concentration of enzyme protein) is rapidly enhanced 
in the rat by conditions of high glucagon (diabetes, fasting, high fat diet, suckling) coupled to low 
insulin (Casals et al. 1992; Serra et al. 1993a,b; Thumelin et al. 1993). Insulin opposes many of 
the ketogenic effects of glucagon in vitro (Witters & Trasko 1979; Harano et al. 1982; Vons et al. 
1991) and in vivo (McGarry et al. 1975; Miles et al. 1983; Serra et al. 1993b). The ketogenic 
effect of glucagon is only manifested when insulin concentration is diminished during in vivo 
infusions of non-esterified fatty acids with artificial induction of hyperglucagonemia (Miles et al. 
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1983). Thus, it is not unreasonable to speculate that the parallel rise in insulin with glucagon over 
the first 2 days of suckling in piglets could negatively impact ketogenesis. The potential of insulin 
to increase malonyl-CoA in piglet liver (and thereby diminish CPT I activity) is unclear, especially 
in light of the fact that most lipogenesis occurs in adipose tissue in swine (Mersmann et al. 1973). 
However, the sensitivity of CPT I to malonyl-CoA inhibition in 48h old unsuckled piglets is 2 
orders of magnitude higher than that determined in mature fasted rats (Duee et al. 1994). It is 
conceivable that maintenance of a relatively high insulin concentration could affect mtHMG-CoA 
synthase activity, as well (see below). 
HMG-CoA Synthase Activity in Pigs & Rabbits. Based on the low ketogenic capacity of 
newborn piglets when exposed to MCFA in vivo (which would bypass regulation by CPT I in 
liver), Adams and Odle (1993) speculated that limitation of ketogenesis in neonatal pigs is 
intramitochondrial. A likely candidate for ketogenic attenuation was activity of the mitochondrial 
HMG-CoA synthase enzyme which, due to (1) its relatively low activity in the steps converting 
acetyl-CoA to acetoacetate (Dashti & Ontko 1979; Duee et al. 1994) and (2) its acute and long-term 
regulation by hormones and metabolites (see above), is usually assumed to be rate-limiting in the 
ketogenic HMG-CoA synthase pathway. Consistent with this hypothesis, the activity of mtHMG-
CoA synthase in unsuckled piglets was only one-fourth that determined in the ketogenic fasted 
newborn rabbit (Fig. 6.4). In the course of preparation of this paper, Duee et al. (1994) reported 
a qualitatively similar pattern in enzyme activity when 48h old unsuckled piglets were compared 
to mature fasted rats. Thus, the low activity observed in neonatal pigs differs markedly from the 
greatly increased activity of mtHMG-CoA synthase which was observed in the livers of newborn 
rats over the first 24h postpartum (Shah & Bailey 1977; Caswell & Bailey 1983). Interestingly, 
the specific activity of mtHMG-CoA synthase in weaned fasted (Fig. 6.4) or mature fasted pigs 
(Duee et al. 1994) was similar to unsuckled newborn piglets, and in vitro rates of ketogenesis from 
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C18:l in isolated mitochondria (nmol/mg mitochondrial protein) were the same in 48h old 
unsuckled newborns versus fasted mature pigs (Duee et al. 1994). This is ironic because older pigs 
have a 10-fold higher ketogenic capacity in vivo (proportional rise in B-hydroxybutyrate following 
an MCFA challenge) than do unsuckled day-old pigs (Adams & Odle 1993), and hepatocytes 
isolated from suckling 15 day old pigs produce ketone bodies from C18:l at a rate 3-fold higher 
than 48h old suckled pigs (Pegorier et al. 1983). It is possible that the similarity of ketogenesis 
and mtHMG-CoA synthase specific activity between unsuckled and older pigs in isolated 
mitochondria (Duee et al. 1994; Fig. 6.4) is not reflected in ketogenic capacity in vivo (Adams & 
Odle 1993) or in hepatocytes (Pegorier et al. 1983) because of changes in hepatic mitochondrial 
number or volume. Although these parameters increase through development in rats (Aprille 1986) 
and within 24h of suckling in the piglet (Mersmann et al. 1972), proliferation might be attenuated 
in piglets left unsuckled for 24-48h. The factors limiting mtHMG-CoA synthase activity in swine 
are not known, but it is notable that the expression of the gene for this enzyme is up-regulated by 
glucagon (see above), which is low in the plasma of fasted piglets (Pegorier et al. 1981; Lepine et 
al. 1989; Fig. 6.1A). Mitochondrial HMG-CoA synthase activity was not determined in suckled 
piglets, but would be expected to be low based on the minimal ketonemia observed in these animals 
(Bengtsson et al. 1967; Pegorier et al. 1981; Innes et al. 1993). To what degree the pattern of 
plasma insulin or glucagon concentration (Pegorier et al. 1981; Lepine et al. 1989; Fig. 6.1 A) 
regulates the production of this enzyme in swine remains to be tested. 
Summary & Conclusions. During the first 2 days of life, newborn pigs display a plasma 
acetate concentration which is 10-fold higher than ketone bodies. This finding is consistent with 
the hypothesis that acetate utilization (oxidation and/or other metabolic uses) predominates over 
ketone body use in neonatal swine. Mitochondrial acetogenesis in piglets, as judged by the rise in 
plasma acetate following a dose of mitochondria-specific substrate (Na-C4:0) in vivo, appears to 
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be significant. The appearance of C4:0 and C6:0 in plasma following an acute intraperitoneal dose 
of Na-C8:0 was evidence for acyl-CoA hydrolytic pathways which liberate CoA and chain-
shortened moieties of C8:0. The profile of plasma pancreatic hormones (insulin and glucagon 
raised with suckling) and low mtHMG-CoA synthase activity in newborn pigs differs substantially 
from the pattern reported for newborn rats, and may in part explain the limit of ketogenic capacity 
in neonatal piglets. 
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Table 6.1. Circulating acetate concentration through the first 48 hours of life in neonatal animals. 
Species & Age 
Piglets 
Newborn unsuckled, n=6 
24h suckled, n=5 
24h unsuckled, n=5 
48h suckled, n=5 
Rabbits* 
24-36h suckled 
48-60h suckled 
Rats 
24h suckled, n=3 
48h suckled, n=3 
Acetate QM) 
311 ± 19 
234 ± 75 
276 ± 54 
343 ± 56 
99 ± 6 
197 ± 12 
77 ± 9 
173 ± 43 
Range (pM) 
273-399 
95-443 
163-416 
221-546 
80-117 
159-237 
62-94 
112-255 
Values are means ± SEM of plasma (pigs & rabbits) or serum (rats) concentrations 
"Rabbit values are means from 1 litter/age (n=6 animals/litter) 
No significant effect (p>0.1) of suckling status/age was observed in piglets 
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Figure 6.1A-B. Changes in plasma concentration of insulin (circles) and glucagon (triangles)(top panel, A) and 
changes in the insulin:glucagon molar ratio (bottom panel, B) in piglets aged ~ lh (unsuckled), 24h (suckled and 
unsuckled), and 48h (suckled). Error bars represent SEM. Conversion factors: 3.48 for glucagon pM-*pg/mL 
(based on a molecular weight of 3485), and 1/6 for insulin pM-*/iU/mL. 
"Different from newborns (p<0.05); 24h unsuckled concentration not different vs. newborns (p>0.1) 
'Different from 24h old suckled piglets (p<0.05) 
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TIME POST-INJECTION (min) 
Figure 6.2A-B. The rise in plasma acetate following intraperitoneal injection of Na-C4:0 (squares) or Na-C8:0 
(triangles)(top panel, A) in 24h old unsuckled piglets (see Materials & Methods for details), and the increase in 
plasma C4:0 (circles) and C6:0 (crosses) in the piglets given Na-C8:0 (bottom panel, B). Plasma C4:0 in animals 
given Na-C4:0 was 2.48 ± 0.60 mM, 1.78 ± 0.72 mM, and 0.88 ± 0.42 mM at 15, 30, and 60 min post-
injection, respectively. 
"Different from pre-injection value (p^O.Ol); no significant time x chain-length effect was observed (p>0.1) 
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Figure 6.3. Example gas chromatograph derived from plasma in a 24h old unsuckled piglet given an 
intraperitoneal injection of Na-C8:0 and sampled 30 min later (top panel), illustrating the apparent chain-shortening 
of C8:0 during its metabolism. Note the FID peaks from compounds eluting with retention times of C4:0 and 
C6:0. For comparison, a chromatograph of mixed standards of volatile fatty acids and C6:0 is shown in the lower 
panel. Neither the C4:0 or C6:0 peak were detected in suckling or fasted animals not given fatty acid (see Table 
6.1; Fig. 6.2B), and only the C4:0 peak appeared following an intraperitoneal dose of Na-C4:0 (not shown). 
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NEWBORN WEANED NEWBORN 
PIGLET PIG RABBIT 
Figure 6.4. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase specific activity in 24h old 
unsuckled piglets, 24h-fasted weaned pigs, and 24-36h old rabbits. The activity in rabbits was about 4-fold higher 
than in pigs. Rabbits had been fasted 24h prior to enzyme determination, but had not been obtained immediately 
postpartum and thus had probably suckled once. 
"Different from pig values (p<0.0001) 
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VII. CONCLUDING REMARKS 
The series of reports presented in this thesis have led to a number of important findings 
regarding the metabolic biochemistry of the newborn piglet. With respect to lipid metabolism in 
species studied to date, the piglet appears unique in its negligible capacity for ketogenesis. Thus, 
the oxidative end-products (non-COz) of fatty acid B-oxidation in the liver of newborn piglets is 
composed primarily of other entities, including a relatively high proportion of acetate. However, 
studies of the physiological impact of acetogenesis versus ketogenesis in the newborn piglet are in 
their infancy. 
The work reported in Chapters II., IV., and V. firmly establish that the ketogenic capacity 
of the newborn piglet pales in comparison to what is observed in other species. Especially striking 
was the finding that although piglets do not differ from other animals in that their livers are capable 
of oxidizing fatty acids to acid-soluble metabolites (i.e., ketone bodies in the rat), the relative 
proportion of acetate in these products is markedly elevated. In contrast to the rat, the ketone 
bodies were shown to represent a small fraction of the B-oxidative end-products observed. Notably, 
the absolute rate of accumulation of fatty acid carbon in acetate was similar in the rat and piglet, 
indicating that the phenomenon of acetogenesis is not unique to the pig. However, the rates of total 
B-oxidation and 02 consumption in the piglet were only 30% and 50% of that in rat (respectively); 
thus, it may be argued that absolute acetogenesis as a proportion of total flux of fatty acid carbon 
is greater in the piglet. If true, this further underscores the novel nature of acetogenesis in piglets. 
Because whole-animal ketogenic capacity rises with maturity in swine (Chapter II.), it would be of 
interest to map the ontogenic changes in acetogenesis, as well. For instance, one may question if 
acetyl-CoA hydrolase is developmental^ regulated. The tissue and subcellular location of this 
enzyme, its potential regulation, and aspects of its gene expression in swine should be studied. 
140 
Certainly, the results of future biochemical work must be viewed in light of in vivo data 
which demonstrate the piglet's ability to utilize acetate for important physiological functions in the 
neonatal period. The future direction of acetate research in piglets must include an assessment of 
this metabolite's physiological relevance. One may question, for instance, what developmental 
changes and tissue-level differences exist in the pathways of acetate uptake and metabolic 
utilization. Although capacity to oxidize B-hydroxybutrate to C02 in vivo is well-developed in the 
piglet within the first 1-2 days of life (Chapter HI.), oxidation of ketone bodies in reality 
contributes little to the piglet's normal energy budget. Similar studies with acetate have not been 
performed. Although plasma concentration of acetate was 10-fold higher than ketone bodies in 
newborn, suckling, or fasted piglets (Chapter VI.), it is not yet clear if this translates to a greater 
degree of oxidation of or lipogenesis from acetate at the tissue level. Related to this issue, the idea 
that endogenously-produced acetate is an important metabolite under certain conditions in other 
species (i.e., in premature human neonates) should not be discounted, and warrants further 
investigation. 
In the course of the studies outlined in Chapters IV.-VL, a number of non-ketogenic, 
"alternative" metabolic pathways involving fatty acid B-oxidation were revealed in the piglet and 
rat. First, it was demonstrated in pigs that medium-chain fatty acids, when present at the high 
concentrations observed after an acute challenge in vivo, may undergo partial B-oxidation resulting 
in chain-shortened unesterified products (Chapter VI.). There are data to support the notion that 
incomplete B-oxidation occurs, but the resulting acyl-CoA fragments are usually thought to become 
esterifed to carnitine or other conjugating agents for further metabolism or excretion (theoretically 
liberating free CoA within the mitochondrial matrix). Is hydrolysis of medium-chain acyl-CoA also 
a mechanism by which an animal defends its free CoA pool, or does the phenomenon have no 
physiological implications? Second, radiochromatographic analysis of the acid-soluble fraction from 
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liver preparations incubated with radiolabeled fatty acids illustrated a diverse pattern of metabolite 
labeling (Chapters IV. & V.). The identity of these fatty acid-derived metabolites remains a 
mystery; however, one may speculate as to their nature by analysis of changes in amount observed 
in preparations incubated with inhibitors. The first radiochromatographic peak (preceding that 
associated with acetate) observed in the reversed-phase chromatography of piglet samples is of 
particular interest. Radiolabel accumulation in this compound disappeared when liver homogenates 
were incubated with malonate or antimycin/rotenone. Does this suggest that its production is in 
some way associated with fatty acid-derived acetyl-CoA entry into the Krebs cycle? Malonate 
increased accumulation of fatty acid carbon in acetate almost 2-fold (Chapter V.), a finding which 
suggests that if the metabolite were acetyl-carnitine (a major end-product of B-oxidation in the non-
ketogenic muscle), accumulation of label might mimic that observed for acetate. The fact that the 
peak is abolished with malonate treatment supports the idea that the unknown metabolite is not 
acetyl-carnitine. It is possible that the peak corresponds to a compound associated in some way 
with the Krebs cycle (oxaloacetate —» aspartate?; malate —* gluconeogenesis —* glucose?). 
Many issues remain unresolved with respect to lipid metabolism in the non-ketotic newborn 
piglet. What is certain is that the continued study of nutritional biochemistry in this species 
promises to offer further insight into metabolic pathways which defy dogma and open fresh new 
vistas of research in other animal models. 
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